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ABSTRACT 
 
FORKHEAD TRANSCRIPTION FACTORS FOXP1 AND FOXP4 REGULATE T CELL 
DEVELOPMENT AND FUNCTION 
Karla R. Wiehagen 
Jonathan S. Maltzman 
 
Transcription factors regulate T cell fates at every stage of development and 
differentiation. Members of the FoxP family of Forkhead transcription factors are 
essential for normal T lineage development; Foxp3 is required for regulatory T cell 
generation and function, and Foxp1 is necessary for the development of naïve T cells. 
FoxP family member Foxp4 is highly homologous to Foxp1 and has been shown to 
dimerize with other FoxP proteins.  
In this thesis, we report the first studies of Foxp4 in T lymphocytes. Using a 
CD4Cre-mediated conditional knockout approach we evaluated the roles for Foxp4 
regulation in the T lineage. T cell development and homeostasis are normal in the 
absence of Foxp4. Despite effective control of infection with Toxoplasma gondii or acute 
Lymphocytic choriomeningitis virus in vivo, cytokine production during antigen-specific 
rechallenge is reduced in the absence of Foxp4. We conclude that Foxp4 is dispensable 
for T cell development, but necessary for normal memory T cell recall responses to 
antigen in acutely or chronically infected mice. 
Next we determined whether FoxP family members compensate for one another 
in Foxp1- or Foxp4-knockout models. We utilized a similar CD4Cre approach to delete 
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both Foxp1 and Foxp4 in T cells. Foxp1/4-deficient T cells exhibit abnormal thymic 
development and T cell receptor signaling. Loss of Foxp1/4 results in significantly 
reduced T cell numbers, and altered T cell effector function, reminiscent of Foxp1cKO T 
cells. 
Lastly, we examined the functions of Foxp1/4 in Foxp3+ regulatory T cells 
(Tregs). Tregs are critical for prevention of autoimmunity and controlling immune 
responses during infection. While conditional deletion of either Foxp1 or Foxp4 in T cells 
has little effect on Tregs, combined deletion results in abnormal Treg generation. 
Foxp1/4-deficient Tregs exhibited significant defects in both development and 
homeostasis. Under competitive conditions, double-deficient Tregs are at a significant 
developmental disadvantage relative to wild-type competitors. Furthermore, Foxp1/4-
deficient Tregs exhibit impaired cytokine-induced STAT5 phosphorylation and reduced 
expression of Foxp3, suggesting Foxp1/4 is required for normal Treg generation. 
Together, these findings demonstrate that the FoxP family regulates multiple 
facets of T cell development and function, and actively contributes to the maintenance of 
immunological tolerance. 
  
	   vii	  
 
 
 
TABLE OF CONTENTS 
   
ABSTRACT .......................................................................................................... V 
TABLE OF CONTENTS ..................................................................................... VII 
LIST OF TABLES ................................................................................................ XI 
LIST OF FIGURES ............................................................................................. XII 
CHAPTER I: INTRODUCTION .............................................................................. 1 
A brief introduction to the adaptive immune system ................................................................ 1 
Forkhead transcription factors govern cell fate decisions ....................................................... 4 
The FoxP subfamily of transcription factors .............................................................................. 6 
FoxP family transcriptional regulation in mammalian development ....................................... 8 
FoxP transcription factors in the adaptive immune system ................................................... 11 
FoxP protein Interactions in T cells .......................................................................................... 13 
Structure of Thesis ..................................................................................................................... 15 
CHAPTER II: FOXP4 REGULATION IS DISPENSABLE FOR T CELL 
DEVELOPMENT, BUT ESSENTIAL FOR MEMORY RECALL RESPONSES. . 18 
Introduction ................................................................................................................................. 18 
Results ......................................................................................................................................... 21 
       Foxp4 is expressed in T lymphocytes ............................................................................... 21 
	   viii	  
       Foxp4 can be efficiently deleted in thymocytes ............................................................... 24 
       Foxp4 is not required for T cell development and peripheral homeostasis .................. 26 
       Normal Regulatory T cell generation in Foxp4 cKO CD4 T cells. .................................... 30 
       Foxp4 is not necessary for T cell proliferation or activation. .......................................... 31 
       Foxp4 does not regulate T helper cell commitment ......................................................... 34 
       Foxp4-deficient T cells control chronic infection ............................................................. 37 
       Foxp4 is not required for acute viral clearance. ............................................................... 43 
Discussion ................................................................................................................................... 47 
CHAPTER III: FOXP1 AND FOXP4 DIRECT T CELL FATES AND 
FUNCTIONS. ....................................................................................................... 52 
Introduction ................................................................................................................................. 52 
Results ......................................................................................................................................... 54 
       Generation of Foxp1/Foxp4 conditional double knockout mice. .................................... 54 
       Foxp1 and Foxp4 in thymic development. ........................................................................ 57 
       FoxP members maintain peripheral CD4 and CD8 T cell number ................................... 62 
       CD44 expression is regulated by Foxp1 but not Foxp4. .................................................. 65 
       cDKO CD4 and CD8 T cells acquire an effector memory phenotype. ............................. 66 
       Loss of Foxp1/4 results in systemic T lymphopenia. ....................................................... 67 
       Cell-intrinsic regulation of T cell development by FoxP proteins. .................................. 69 
       Cell-intrinsic regulation of T cell central and effector memory phenotype .................... 73 
       Foxp1 regulates T cell effector functions. ......................................................................... 75 
       FoxP transcription factors regulate IL-7R expression and cytokine signaling. ............ 83 
       cDKO T cells exhibit increased proximal STAT5 signals but poor survival. ................. 85 
Discussion ................................................................................................................................... 89 
CHAPTER IV: THE FOXP FAMILY REPRESSES CD4 EXPRESSION IN T 
LYMPHOCYTES. ................................................................................................ 91 
Introduction ................................................................................................................................. 91 
	   ix	  
Results ......................................................................................................................................... 93 
       cDKO CD4 and CD8 T cells express increased levels of CD4. ........................................ 93 
       CD4 is intrinsically regulated by FoxP family members. ................................................. 96 
       CD4 is a transcriptional target of FoxP family regulation. ............................................... 98 
Discussion ................................................................................................................................. 100 
CHAPTER V: FOXP1 AND FOXP4 REGULATE FOXP3+ TREG CELL 
DEVELOPMENT. .............................................................................................. 102 
Introduction ............................................................................................................................... 102 
Results ....................................................................................................................................... 106 
       Foxp1 and Foxp4 are expressed in regulatory T cells. .................................................. 106 
       Foxp1 and Foxp4 are required for normal Treg generation. .......................................... 106 
       cDKO Tregs phenotypically resemble memory Tregs ................................................... 112 
       cDKO Tregs exhibit loss of suppressive function in vitro. ............................................ 115 
       FoxP members regulate adaptive Treg development. .................................................... 116 
       Defective cDKO Treg development is cell intrinsic. ....................................................... 119 
       cDKO thymocytes signal abnormally through the T cell receptor. ............................... 123 
       STAT5 signals are dysregulated in cDKO Tregs. ........................................................... 125 
       Impaired cytokine signaling and Foxp3 induction is an intrinsic defect in cDKO 
thymocytes. ............................................................................................................................... 128 
Discussion ................................................................................................................................. 131 
CHAPTER VI: DISCUSSION ............................................................................ 134 
Introduction ............................................................................................................................... 134 
I. Foxp4 regulation in effector and memory T cells ............................................................... 135 
       Future Directions: Foxp4 regulation in lymphocyte development ................................ 138 
II. Foxp1 and Foxp4 in the regulation of lymphocyte development. .................................... 140 
       cDKO thymocytes exhibit altered T cell receptor signaling. ......................................... 140 
       Defects in cDKO T cells suggest Akt/Foxo1 dysregulation. .......................................... 141 
	   x	  
       Foxp1 and Foxp4 regulation of IL-7 receptor signaling and survival. .......................... 144 
       Future Directions: Foxp1 and Foxp4 regulation of immune responses in vivo. ......... 145 
III. Foxp1 and Foxp4 regulation of Foxp3+ Treg generation ................................................. 146 
       Future Directions: Rescuing cDKO Treg development .................................................. 147 
       Future Directions: Investigation of Foxp1/4 regulation of Treg maintenance ............. 149 
       Future Directions: Runx:FoxP family interactions ......................................................... 150 
The relationship between Foxp1 and Foxp4 in T cells .......................................................... 154 
CHAPTER VII: MATERIALS AND METHODS ................................................. 158 
CHAPTER VIII: BIBLIOGRAPHY ..................................................................... 167 
 
	    
	   xi	  
LIST OF TABLES 
	  
Table 3.1. Generation of cDKO mice and littermate controls.           54 
Table 3.2. Summary of cDKO CD4 and CD8 T cell cytokine production in vitro.            83 
	   	  
	   xii	  
	  
 
LIST OF FIGURES 
 
Chapter II. 
Figure 2.1. Foxp4 is expressed in lymphoid tissues and T cell subsets         23 
Figure 2.2. Generation of Foxp4 cKO mice             25 
Figure 2.3. Deletion of Foxp4 at the DP stage does not alter thymocyte development   27 
Figure 2.4. Foxp4 is not required for the generation of peripheral CD4 and CD8  
 T cells                 29 
Figure 2.5. Foxp3+ Regulatory T cell development does not require Foxp4 
 expression                 31 
Figure 2.6. T cell activation induces normal proliferation and effector T cell 
 differentiation in the absence of Foxp4            33 
Figure 2.7. Foxp4 is not required for .T helper cell differentiation.           36 
Figure 2.8. Toxoplasma gondii infection does not lead to wasting or lymphopenia in 
  Foxp4 cKO mice               39 
Figure 2.9. Foxp4 deletion alters recall responses to Toxoplasma gondii in the  
 spleen and brain.                42 
Figure 2.10. Antigen specific Foxp4 cKO T cells persist after antigen clearance        45 
Figure 2.11. Foxp4 deficient CD4 T cells exhibit reduced memory recall responses 
following LCMV infection.                47 
 
Chapter III. 
Figure 3.1. Generation of cDKO mice             57 
Figure 3.2. Reduced thymic cellularity in Foxp1cKO and cDKO mice          58 
Figure 3.3. Foxp1/4 deletion alters CD5 expression and DP cellularity but not SP 
polyclonality                 60 
Figure 3.4. Normal numbers of SP thymocytes develop in cDKO mice         62 
Figure 3.5. Reduced cDKO CD4 and CD8 T cells contribute to significant T 
lymphopenia.                  65 
	   xiii	  
Figure 3.6. cDKO SP thymocytes and splenic T cells express T cell signaling 
 proteins and markers of activation.             67 
Figure 3.7. Reduced cDKO CD4 and CD8 T cells were detected in multiple tissues      69 
Figure 3.8. Schematic of generation of competitive bone marrow chimeras.        71 
Figure 3.9. Competitive development of cDKO DP and SP thymocytes in mixed  
 bone marrow chimeras.              72 
Figure 3.10. Foxp1cKO- or cDKO-derived CD4 and CD8 T cells have a developmental 
disadvantage in peripheral lymphoid tissues.            74 
Figure 3.11. Expression of effector memory cell surface markers are intrinsically 
regulated by Foxp1 and Foxp4.              76 
Figure 3.12. Foxp1, but not Foxp4, regulates IL-2 and IFNγ production by CD4  
 T cells.                 79 
Figure 3.13. Altered CD4 T cell cytokine production reflects cell-intrinsic Foxp1-
dependent regulation of IFNγ and IL-2.             81 
Figure 3.14. Decreased frequencies of cDKO CD8 T cells produce IFNγ.         82 
Figure 3.15. Competitive chimeras reveal comparable frequencies of cDKO CD8 T cells 
produce IFNγ.                 83 
Figure 3.16. cDKO CD4 T cells exhibit increased STAT5 phosphorylation but decreased 
survival                 89 
 
Chapter IV. 
Figure 4.1. cDKO CD4 and CD8 T cells express increased levels of CD4   
 co-receptor                96 
Figure 4.2. Increased CD4 expression is cell-intrinsically regulated by FoxP proteins.  98 
Figure 4.3. Total CD4 protein level and cd4 transcript is increased in cDKO CD4  
 T cells               100 
 
Chapter V. 
Figure 5.1. Conditional deletion of Foxp1 and Foxp4 alters thymic Foxp3+ tTreg
 frequencies.               108 
Figure 5.2. Foxp1/4 deletion results in significantly reduced numbers of  
 peripheral Tregs.             110 
Figure 5.3. Frequencies of cDKO Tregs are significantly increased in spleen  
 and LN.              112 
	   xiv	  
Figure 5.4 cDKO Tregs express an altered cell surface phenotype.        115 
Figure 5.5. cDKO Tregs exhibit reduced suppressive ability in vitro.       117 
Figure 5.6. Inducible Treg differentiation requires Foxp1 expression.       119 
Figure 5.7. Foxp1 or Foxp4 expression is necessary for normal tTreg generation.      121 
Figure 5.8. CD45.2+ cDKO Tregs are nearly absent in peripheral lymphoid tissues 
 of competitive chimera mice.             123 
Figure 5.9. cDKO CD4SP T cells display increased signaling to anti-CD3   
 and anti-CD28 stimulation in vitro.            125 
Figure 5.10. cDKO tTregs express increased cytokine receptors but   
 exhibit impaired survival.             128 
Figure 5.11. cDKO thymocytes have intrinsic cytokine signaling defects.       131 
 
Chapter VI. 
Figure 6.1. Model of TCR signaling defects in cDKO T cells.         144 
Figure 6.2. Schematic of Runx1-regulated gene targets in the CD4 T lineage.       152 
Figure 6.3. Models of Foxp1/4 and Runx regulation of selected gene targets     
 in CD4 T cells.             154 
 
	  
 
1	  
 
	  
CHAPTER I 
 Introduction 
 
	  
A brief introduction to the adaptive immune system 
The purpose of the immune system is to protect the host from infection with 
pathogens, including bacteria, viruses, fungi, and parasites. There are two branches of 
the immune system: innate and adaptive. The innate immune system exists in different 
forms in all multicellular organisms, whereas the adaptive immune system evolved in 
vertebrates in the animal kingdom. While innate immune mechanisms provide initial 
protection to the host, adaptive mechanisms mount specific responses to control and 
clear foreign substances and pathogens.  
The primary cellular components of the adaptive branch of the immune system 
are a type of white blood cell called lymphocytes, which are further divided into T cells 
and B cells. Compared to cells of the innate system, T and B lymphocytes are uniquely 
suited to initiate specialized soluble and cellular responses and to conduct a systemic 
response upon exposure to a pathogen. For instance, activated lymphocytes undergo 
clonal expansion in which rapid cellular division produces an exponential increase in 
identical daughter cells poised for further activation and effector differentiation.  
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Because of the potent functions of lymphocytes, activation of these cells is tightly 
regulated from the early stages of development. During lymphocyte maturation, somatic 
rearrangement of antigen receptor genes causes each cell to express a unique antigen 
receptor complex on the cell surface. In the T lineage, this antigen receptor is called the 
T cell receptor (TCR). A successfully rearranged TCR complex licenses a single 
specificity to each cell. A large percentage of developing lymphocytes are selectively 
culled, to ensure that each antigen receptor rearrangement signals appropriately and 
that clones with self-reactive antigen receptors are eliminated. Similar processes occur 
in B cells to restrict the survival of potentially autoreactive lymphocytes.  
During development, lymphocytes are further committed to distinct subsets that 
best suit their antigen receptor specificity. Within the T lineage, cells are divided into two 
main T cell subsets. CD4+ TCR+ lymphocytes (CD4 T cells) respond to immunologic 
challenges originating outside host cells, such as bacterial infections and allergenic 
antigens. CD8+ TCR+ cells (CD8 T cells) are cytotoxic lymphocytes that clear 
intracelullar pathogens, like viruses, by killing infected host cells. Signals specific for 
each kind of immunologic insult activate the correct cell type and induce effector cell 
differentiation, proliferation, and expression of gene programs encoding lymphocyte 
functions. 
Mature lymphocytes circulate through blood and lymphatic vessels to patrol host 
tissues for pathogens. To ensure inflammatory lymphocyte reactions occur only when 
warranted, layers of transcriptional regulation prevent non-specific initiation of effector 
programs. Naïve, or antigen-inexperienced, lymphocytes remain functionally silent until 
they encounter cognate antigen. Activation of T and B cells requires antigen receptor 
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ligation, which triggers a cascade of intracellular signaling and initiation of an adaptive 
immune response.  
Successful clearance of infection requires expansion of lymphocytes expressing 
antigen receptor complexes specific for epitopes unique to the pathogen. Of the millions 
of lymphocytes circulating in the body, only a fraction will be specific to any one 
pathogen. Upon activation, these pathogen-specific T cells and B cells expand 
exponentially to produce significant numbers of identical daughter cells, equally reactive 
to pathogenic epitopes. B cell clones become activated and produce soluble antibodies 
against the pathogen, which aid in detection and killing of extracellular pathogens. T 
cells orchestrate responses by secreting cytokines that recruit other immune cells to 
infected tissues. CD8 T cells can also participate by mounting cytotoxic responses 
against cells harboring intracellular pathogens. This process of clonal expansion and 
activation affords the host access to an army of effector T or B cells to control the spread 
of bacterial, fungal, viral or parasitic pathogens at the time of infection, while maintaining 
fewer lymphocytes at steady-state.   
Following pathogen clearance, there is no need for the large numbers of 
daughter effector cells; further, prolonged maintenance of these cells can harm the host. 
Effector cells undergo apoptosis during the contraction phase, which occurs after an 
infection is controlled. However, a population of pathogen-specific lymphocytes is 
retained and persists in the host to guard against repeated infection. These cells allow 
the host to mount more rapid and larger immune responses upon re-exposure to a 
specific pathogen. A cardinal feature of adaptive immunity is the provision of this 
immunological memory, which benefits the longevity of the host by preventing chronic 
illness. 
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The protective benefits of adaptive immunity described above are offset by the 
potential damage caused by dysregulated immune reactions. At every point in the life 
cycle of lymphocytes, both environmental and intracellular signals direct cell fate 
decisions to maintain a diverse repertoire of quiescent antigen-specific T and B cells in a 
healthy host. Unprovoked expansion and activation of T or B cell clones commonly 
results in non-specific immune responses and damage to host tissues. Therefore, the 
selective activation of pathogen-specific cells is tightly regulated. Lymphocyte specificity, 
controlled activation, and restrictions on self-reactive lymphocyte development are 
examples of regulatory mechanisms in the adaptive immune system. These precautions 
provide protection for vertebrate organisms against foreign pathogens, while minimizing 
the risk of uncontrolled cytotoxic and inflammatory responses. 
 
Forkhead transcription factors govern cell fate decisions 
In every nucleated cell in the body, cell fate decisions are regulated by both 
extrinsic and intrinsic mechanisms. Environmental cues such as soluble growth factors 
support cell metabolism, migration, and survival. Intrinsic processes include cell cycle 
checkpoints and manipulation of genomic DNA to express proteins necessary for 
proliferation and differentiation. Successful execution of gene expression requires both 
temporal and contextual specificity. In eukaryotic cells, regulatory mechanisms have 
evolved to correctly interpret extrinsic and intrinsic signals to prevent unproductive gene 
expression. A fundamental source of regulation is a class of proteins called transcription 
factors that translate extracellular signals and control the expression or silencing of gene 
programs. 
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One family of transcription factors is the forkhead family. Members of this family 
are expressed in all eukaryotic cells except plant cells (Jonsson and Peng, 2005). All 
forkhead box (Fox) proteins possess a highly conserved sequence of 80-100 amino 
acids, originally identified in Drosophila in 1990 (Kaufmann and Knochel, 1996). X-ray 
crystallography and nuclear magnetic resonance (NMR) studies of the forkhead domain 
determined this sequence forms three alpha helices and three beta sheets flanked with 
two loops or wings, giving the three-dimensional structure a butterfly-like appearance 
(Hannenhalli and Kaestner, 2009). This winged-helix structure facilitates binding of Fox 
proteins to the major groove of DNA sequences containing consensus binding sites 
(Myatt and Lam, 2007). Fox proteins recognize sites with the core sequence 5’ 
(A/G)(C/T)(A/C)AA(C/T)A 3’ (Carlsson and Mahlapuu, 2002; Myatt and Lam, 2007).  
More than 100 genes in the human genome encode forkhead proteins that are 
organized into 27 subfamilies based on phylogenetic hierarchy and sequence homology 
(Hannenhalli and Kaestner, 2009; Uhlenhaut and Treier, 2011). In humans, expression 
of forkhead proteins has been implicated in the generation of most tissues in the body. 
Forkhead family members are required to orchestrate organogenesis throughout 
embryonic development, and mutations in forkhead proteins can result in embryonic 
lethality. Defective Fox regulation in children and adults is associated with pathological 
disorders and increased incidence of cancer (Myatt and Lam, 2007).  
Forkhead proteins are required for normal hematopoiesis and the maintenance of 
both innate and adaptive immunity. In both myeloid and lymphocyte blood cell lineages, 
expression of forkhead proteins is essential for normal development and function (Coffer 
and Burgering, 2004; Myatt and Lam, 2007). Fox transcription factors directly regulate 
thymic organogenesis (Foxn1), lymphocyte proliferation and survival (FoxO family 
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proteins), and differentiation of multiple blood cell lineages (Foxj1) (Coffer and 
Burgering, 2004). Therefore, forkhead proteins play a crucial role in maintaining adaptive 
immunity by dictating cell fate decisions in the hematopoietic lineage. 
 
The FoxP subfamily of transcription factors 
The FoxP subfamily is comprised of four proteins, Foxp1-Foxp4, which generally 
act as transcriptional repressors (Lopes et al., 2006; Teufel et al., 2003). FoxP family 
proteins share common characteristics including a conserved leucine zipper domain, a 
zinc finger motif, a long glutamine repeat, and the forkhead box DNA-binding domain 
(Teufel et al., 2003; Wang et al., 2003). The sequences of FoxP member genes foxp1, 
foxp2 and foxp4 are more closely related, while foxp3 is least like its family members (Lu 
et al., 2002; Uhlenhaut and Treier, 2011). While FoxP proteins recognize the nucleotide 
sequence unique to forkhead DNA binding, sequence variation among the family 
members is thought to license each protein to recognize independent targets and 
assume distinct regulatory roles. For example, Foxp3 binds the nucleotide sequence 5’ 
(G/a)TAAACA 3’, while Foxp1 binds the sequence 5’ AA(C/t)A(C/t)AAATA 3’ (Koh et al., 
2009; Wang et al., 2003). Each contains the core sequence recognized by forkhead 
transcription factors, but also illustrates variable specificity in gene targets of the FoxP 
family. Furthermore, the flanking sequences around the forkhead domain in FoxP 
proteins are all unique, which may affect how these proteins bind DNA targets and other 
proteins. 
The FoxP proteins are unique from all other forkhead subfamilies because of the 
way these proteins dimerize to bind DNA. The leucine zipper domain is required for 
protein-protein dimerization and for regulation of gene targets (Chokas et al., 2010). 
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FoxP family members can also heterodimerize with one another via the leucine zipper 
motif. Mutation of the highly conserved leucine residues within the leucine zipper domain 
disrupts protein-protein interactions and inhibits transcriptional regulation by FoxP 
dimers (Li et al., 2004a; Liu et al., 2012; Zhou et al., 2009). Heterodimerization provides 
for regulation of specific combinations of gene sequences, depending on which proteins 
participate in the FoxP complexes. Ectopic overexpression studies have demonstrated 
that Foxp1, Foxp2, and Foxp4 can homo- and heterodimerize, and that Foxp3 can form 
heterodimers with Foxp1. FoxP family heterodimerization may offer another level of DNA 
site recognition, elegantly controlled by the expression or availability of different FoxP 
partners.  
 
 
Schematic 1. The FoxP family. Representation of the features and relative length of 
the four members of the FoxP family of transcription factors.  
 
More complexity of FoxP protein regulation is provided by interactions with other 
transcription factors and enzymes that regulate DNA architecture through chromatin 
	   8	  
remodeling. Conformational changes in FoxP proteins as they bind partners may also 
expose different sites involved in protein-protein interactions. Competition for FoxP 
protein binding sites by potential partners and the stability of multi-protein complexes 
may affect transcription factor function. Therefore, the conserved FoxP family 
characteristics support complex protein interactions, and highly specific regulation of 
gene programs.  
 
FoxP family transcriptional regulation in mammalian development 
Each member of the FoxP family regulates diverse tissue-specific cell fate 
decisions throughout development (Carlsson and Mahlapuu, 2002; Kaufmann and 
Knochel, 1996; Shu et al., 2001). Although Foxp1, Foxp2, and Foxp4 are detected in 
adult tissues, expression of these transcription factors is highest during embryonic 
development of neural, intestinal, pulmonary, and cardiovascular tissues. Foxp3 
expression is detected during development in the embryonic neuronal tissues, but is 
otherwise limited to immune cells, which will be discussed later.  
The function and regulation of FoxP proteins have been characterized through 
germline deletion, overexpression, and gene mutation. Initial studies demonstrated that 
germline deletion of Foxp1, Foxp2, or Foxp4 blocks development, resulting in embryonic 
lethality (French et al., 2007; Li et al., 2004a; Wang et al., 2004). However, more recent 
studies describe the effects of lineage-specific FoxP family deletion, which bypass 
blocks in embryonic development. This growing body of literature illustrates the 
versatility of FoxP transcription factor functions, including regulation of cellular 
proliferation, differentiation, localization, and survival. 
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Studies of cardiopulmonary development offer excellent examples of the ways 
FoxP proteins regulate cell fate decisions. Foxp1 expression is highest in developing 
lung tissue and is required for the normal development of the distal pulmonary 
epithelium. Foxp4 is co-expressed with Foxp1—together, these proteins repress 
abnormal cell differentiation of pulmonary epithelium throughout development. Deletion 
of either Foxp1 or Foxp4 does not alter differentiation of epithelial cells, but Foxp1/Foxp4 
double deficiency has profound effects on secretory cell development in the pulmonary 
airway that cause neonatal morbidity. Co-regulation of pulmonary development by Foxp1 
and Foxp4 highlights the ability of these homologous Fox proteins to compensate for 
one another to preserve cell fate potential. In contrast, Foxp2 is also required for normal 
lung development, but regulates the development of proximal-distal epithelium 
independently of Foxp1 and Foxp4. The expression patterns and regulatory functions of 
Foxp1/Foxp2/Foxp4 neatly demonstrate the roles FoxP members can play 
independently and in combination to direct cell fate decisions. 
In addition to directing tissue differentiation, FoxP family proteins regulate cell 
survival and proliferation. The FoxP family is essential for normal cardiac development, 
both in the formation of vasculature and cardiomyocyte development. Foxp1 and Foxp2 
are implicated in cardio vasculogenesis. Germline deletion of Foxp1 causes defects in 
heart valve and ventricle formation, resulting in death by day 16.5 of embryogenesis 
(E16.5) (Wang et al., 2004). This defect is further characterized by dysregulated 
myocardium maturation, which is dependent on Foxp1 regulation. Foxp1-/- 
cardiomyocytes exhibit hypertrophy, increased proliferation, and failure to differentiate 
normally (Bai and Kerppola, 2011). These findings suggest Foxp1 is required for 
repression of abnormal cell division and growth in cardiac tissues as well as in the lung. 
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Like Foxp1 and Foxp2, Foxp4 is expressed in and required for development of 
cardiopulmonary tissues. Foxp4 expression in the developing embryo programs 
localization of cardiac tissues and proper heart development. Foxp4-deficient mice 
exhibit embryonic lethal cardia bifida (Li et al., 2004b). Foxp4-deficient precardiac 
tissues fail to migrate toward the midline of the fetus, resulting in two symmetrical hearts, 
bilateral to the midline (Li et al., 2004b). Defects in the developing foregut of embryonic 
Foxp4-/- mice also suggest Foxp4 not only directs localization, but also directs the 
survival of critical tissues during embryogenesis. 
Defects observed in cardiopulmonary development demonstrate transcriptional 
regulation by Foxp1 and Foxp2 represses cellular proliferation. Dysregulation of cellular 
proliferation is a hallmark of cancer, and FoxP family members have been implicated in 
tumor repression. Oncogenic cell growth occurs with loss of Foxp1 and Foxp2 
transcriptional regulation in multiple tissues (Myatt and Lam, 2007). FoxP family member 
Foxp3 also protects against tumor development (Heinze et al., 2011; Li et al., 2011; 
Wang et al., 2010). Mutations that perturb Foxp3 regulation lead to cancer development 
in the breast, brain and intestine (Hannenhalli and Kaestner, 2009; Myatt and Lam, 
2007; Triulzi et al., 2013).  
Together, these studies demonstrate how FoxP family proteins regulate multiple 
kinds of cell fate decisions across a variety of tissues. FoxP-mediated regulation of 
target genes affects development, survival, and differentiation. FoxP proteins direct 
these processes individually and through cooperation with other transcription factors. 
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FoxP transcription factors in the adaptive immune system 
All members of the FoxP family are expressed in blood cells, except Foxp2. 
Previous studies in lymphocytes demonstrate how Foxp1 and Foxp3 regulate cell fate 
decisions and impact adaptive immunity. In B cells, Foxp1 initiates B lymphopoiesis, and 
controls antigen receptor gene recombination later in development (Hu et al., 2006). 
Expression of the enzyme RAG (recombination activating gene) is required for normal B 
cell receptor rearrangement and B cell selection (Hu et al., 2006). Deletion of Foxp1 
impairs RAG expression and blocks B cell development. Humoral immunity may also 
rely on expression of Foxp4. Preliminary data from our work suggest Foxp4 deficiency 
causes abnormal B cell development. In contrast, loss of FoxP family proteins does not 
block T cell development. FoxP members do not regulate somatic rearrangement of 
TCR genes, but instead regulate cell fate decisions during differentiation and 
commitment to T cell subsets. 
Of the FoxP proteins, the function of Foxp3 transcriptional regulation is best 
defined. Expression of Foxp3 in T lymphocytes is critical for the maintenance of self-
tolerance (Brunkow et al., 2001; Hori et al., 2003; Ramsdell and Ziegler, 2003). Foxp3 
was first identified in mouse models of autoimmunity, and later associated with IPEX 
(Immunodysregulation polyendocrinopathy enteropathy X-linked) syndrome (Bennett et 
al., 2001; Gambineri et al., 2003). Patients with IPEX inherit gene mutations in Foxp3 
that cause dysregulation of immune cells, manifesting in symptoms of severe 
autoimmunity (Bennett et al., 2001; Gambineri et al., 2003).  
The mechanism of Foxp3-dependent tolerance was traced to a subset of CD4+ T 
cells, called regulatory T cells, or Tregs (Hori et al., 2003; Rudensky, 2011; Sakaguchi et 
al., 2006). This population of CD4 T cells is required to suppress self-reactive immune 
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responses, and to return balance to immune cell homeostasis following infection (Khattri 
et al., 2001). Foxp3 is regarded as a master regulator of Treg commitment among the 
scores of transcription factors expressed in T cells, since it is necessary to initiate Treg-
associated gene programs. In both animal models and humans, Tregs normally develop 
during thymic selection, but conversion of conventional CD4 T cells during immune 
responses also occurs upon Foxp3 induction (Chen et al., 2003; Fu et al., 2004; Zheng 
et al., 2004). In addition to Foxp3 expression, Tregs are identified by cell surface 
expression of the high affinity IL-2 receptor alpha chain (CD25), GITR (a member of the 
tumor necrosis factor receptor family) (Cuzzocrea et al., 2005; Gavin and Rudensky, 
2003). Several groups have determined Foxp3 regulates transcription of these cell 
surface proteins and other gene programs required for tolerance, although the precise 
mechanisms of Treg suppression are not well understood. 
Initial studies in Foxp1-deficient T cells determined Foxp3+ Treg differentiation 
does not require Foxp1 expression (Feng et al., 2010). Instead, Foxp1 is necessary for 
normal development of conventional T cells (Feng et al., 2010; Feng et al., 2011). 
Deletion of Foxp1 in the T lineage demonstrated that Foxp1 normally represses 
activation-induced gene programs in both CD4 and CD8 T cells. Foxp1-deficient T cells 
acquired an activated phenotype, including upregulation of the cell surface marker CD44 
(Feng et al., 2010). Furthermore, T cells lacking Foxp1 expression exhibited effector 
functions, including increased proliferation and cytokine production. Experiments in 
which Foxp1 was temporally deleted after normal T cell development demonstrated that 
loss of Foxp1 immediately resulted in abnormal activation (Feng et al., 2010). Therefore, 
sustained Foxp1 expression is required to repress effector T cell fate and to maintain the 
repertoire of naïve T lymphocytes. 
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As observed in other cell types, Foxp1 also regulates survival and proliferation of 
T lymphocytes. The survival of both B and T lymphocytes is impaired without Foxp1 
expression despite increased expression of the interleukin-7 receptor (IL-7R) (Feng et 
al., 2011). Foxp1 acts as a transcriptional repressor of the il7r gene, which encodes the 
alpha chain of the Interleukin-7 receptor (IL-7R) (Feng et al., 2010; Hu et al., 2006). 
Foxp1 and forkhead factor Foxo1 compete for a forkhead binding site in the il7r 
promoter. In the absence of Foxp1, T cells express increased levels of IL-7R, and CD8 T 
cells proliferate abnormally to IL-7 stimulation (Feng et al., 2011). However, despite 
increased sensitivity to anti-apoptotic IL-7 signals, survival is impaired. Loss of Foxp1 
causes T lymphopenia, which becomes more severe with age. Therefore, Foxp1 
regulation maintains the quality and quantity of the T lymphocyte repertoire. 
Preliminary work has demonstrated Foxp4 expression in lymphoid tissues (Teufel 
et al., 2003). However, the function of Foxp4 in lymphocytes had not been described. 
Like all FoxP family members, Foxp4 forms homodimers, and can heterodimerize with 
Foxp1 and Foxp2 in non-lymphoid cells (Li et al., 2004a). Examples of Foxp4 regulation 
in other cell types indicate this transcription factor also directs cell differentiation and 
survival. Yet it was unclear what processes Foxp4 regulates in adaptive immune cells, 
and whether Foxp4 expression is required to the same degree as its FoxP family 
members for normal T cell development.  
 
FoxP protein Interactions in T cells 
FoxP transcription factors regulate gene expression by participating in multi-
protein complexes. Multiple domains, including the conserved FoxP forkhead domain, 
mediate interactions between FoxP proteins and a variety of protein partners, leading to 
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functional alterations in gene transcription. Foxp3 binding partners include other 
transcription factors: Foxp1, NFAT, NFκB, Runx family members, retinoic acid-related 
orphan receptor (ROR). FoxP proteins also interact with chromatin remodeling proteins 
such as histone deacetylases (HDACs), which are proteins capable of altering DNA 
accessibility (Bettelli et al., 2005; Du et al., 2008; Li et al., 2006; Li et al., 2007; Ono et 
al., 2007; Wu et al., 2006). Direct interaction between Foxp4 and HDACs has also been 
reported in transfected fibroblasts, but not yet in lymphocytes (Chokas et al., 2010). The 
ability of FoxP proteins to work with a variety of partners ostensibly increases the variety 
of potential gene targets.  
Interactions with different binding partners rely on conserved motifs within the 
FoxP protein sequence. Models of Foxp3 dimerization indicate this protein changes 
conformation as it binds another Foxp3 protein, other partners, or target genes. For 
example, homodimerization of Foxp3 exposes a number of hydrophobic amino acid 
residues encoded in sequences flanking the leucine zipper domain (Zhou et al., 2009). 
Normally, these residues would provide better stability for dimerization if aligned along 
the axis of protein-protein interaction. Instead these residues are interspersed around 
and throughout the leucine zipper domain. Such unusual placement suggests these 
sequences provide a scaffold for other proteins to bind to Foxp3 dimers. Furthermore, 
Foxp3 binds different target sequences along the major or minor groove of DNA, which 
also changes the availability of motifs (Myatt and Lam, 2007; Song et al., 2012; Zhou et 
al., 2009). FoxP platforms may be fundamental for the recruitment of transcriptional 
machinery or for binding of chromatin remodeling proteins. Sequence variability around 
conserved motifs in each FoxP member may shape protein-protein interactions, or 
generate unique conformational landscapes.  
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Structure of Thesis 
 This thesis begins by specifically addressing how Foxp4 regulates T cell 
development and function. Preliminary evidence of Foxp4 expression in lymphoid 
tissues suggested this FoxP protein plays a role in adaptive immunity. Requirements for 
related proteins Foxp1 and Foxp3 for normal immune regulation, as well as the high 
degree of homology with the Foxp1 gene sequence, suggested Foxp4 could participate 
in similar regulation of lymphocyte development. These findings raised several 
hypotheses that provoked investigation of Foxp4 regulation in lymphocytes.  
Studies described in Chapter II of this thesis assessed the effects of Foxp4 
deletion on the development and function of the T lineage. Unlike its FoxP relatives, 
deletion of Foxp4 does not affect T cell development. Foxp4 does not appear to 
cooperatively regulate Treg and conventional T cell gene programs with Foxp1 or Foxp3. 
Instead, our data demonstrate Foxp4 regulates memory T cell recall responses and may 
be important for maintaining long-term immunity. 
Although our work suggested Foxp1 and Foxp4 have independent functions in T 
cells, we had not formally ruled out the possibility that Foxp1 also compensates for loss 
of Foxp4, and can assume the roles normally filled by Foxp4. In Chapter III, we 
expanded our studies to examine how loss of both Foxp1 and Foxp4 affected T cell 
development. Combined deletion of FoxP proteins provides the first characterization of 
Foxp1- and Foxp4- deficient T cells. Double-deficient T cells were compared to T cells in 
which Foxp1 or Foxp4 were deleted. Without Foxp1/4, many Foxp1-associated defects 
were exaggerated in both CD4 and CD8 T cells.  
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Deletion of both Foxp1 and Foxp4 altered the expression of the CD4 co-receptor 
on both CD4 and CD8 T cells. In Chapter IV, we examine the defect in CD4 expression 
in depth, and demonstrate cell-intrinsic dysregulation of this critical co-receptor at the 
transcriptional level. Furthermore, the expression patterns of CD4 were significantly 
dysregulated in double-deficient T cells, but not in Foxp1- or Foxp4-deficient 
conventional T cells or in the Treg subset of CD4 T cells that express Foxp3. These data 
suggest FoxP members can compensate for one another in select gene programs, and 
expression of at least one FoxP protein is sufficient to regulate levels of CD4. 
Chapter V addresses how Foxp1, Foxp3, and Foxp4 regulate peripheral 
tolerance. Deletion of Foxp1 and Foxp4 revealed a critical role for FoxP family members 
in Foxp3+ Treg development. Defects appeared in double-deficient Treg differentiation, 
but not in Foxp1 or Foxp4 knockout T cells, suggesting expression of Foxp3 with at least 
one FoxP family member was sufficient for normal generation of regulatory T cells. 
Signaling pathways downstream of cytokine and TCR stimulation are dysregulated in 
Foxp1/4-deficient cells, resulting in abnormal Treg development, survival, and function.  
Together, this work expands the model of FoxP family transcriptional regulation 
in T lymphocytes to include Foxp4-specific functions. Unlike Foxp1 and Foxp3, Foxp4 
regulation is limited to memory T cell responses. With few exceptions, our studies 
indicate Foxp4 otherwise serves as a redundant regulator of Treg development under 
steady-state conditions. Combined deletion of Foxp1 and Foxp4 causes a unique set of 
developmental and survival defects, which are exacerbated under competitive 
conditions. Studies of double knockout T cells demonstrate some cases in which Foxp1 
and Foxp4 may compensate for one another to support T cell survival and generation of 
regulatory T cells. This thesis concludes with discussion of these results, and 
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implications for Foxp4 regulation of adaptive immune cell effector and memory 
responses. 
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CHAPTER II. 
Foxp4 regulation is dispensable for T cell development, but 
essential for memory recall responses.  
 
	  
Introduction 
In the immune system, members of the FoxP family of transcription factors 
regulate gene programs important for normal development and function. FoxP family 
member Foxp4 regulates developmental programs in heart and lung tissues, and shares 
a high degree of homology with Foxp1 (Li et al., 2004b). Preliminary work has 
demonstrated expression of Foxp4 in lymphoid tissues (Teufel et al., 2003). However, 
the function and role of Foxp4 in T cells has not been described.  
FoxP family members regulate gene expression by forming homo- and 
heterodimers (Li et al., 2007). The FoxP protein Foxp3 also interacts with other 
transcription factors through participation in multi-protein complexes. Multiple domains, 
including the conserved DNA-binding forkhead domain, mediate interactions between 
Foxp3 and a variety of partners (Bettelli et al., 2005; Li et al., 2006; Ono et al., 2007; Wu 
et al., 2006). Studies in transfected fibroblasts indicate Foxp4 forms homo- and 
heterodimers. In non-lymphoid cells, Foxp4 has been shown to heterodimerize with 
Foxp1 and Foxp2 (Li et al., 2004a). Foxp4 protein-protein interactions with members of 
other transcription factor families and chromatin remodeling proteins have also been 
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demonstrated. Direct interaction of Foxp4 with histone deacetylases (HDAC) has also 
been reported in transfected fibroblasts, but not in lymphocytes (Chokas et al., 2010). 
This is the first study of Foxp4 expression and function in T lymphocytes. Foxp4 
is expressed in immature thymocytes and in mature T lymphocyte subsets. In contrast to 
previously reported studies of FoxP family members, we find Foxp4-deficient thymocytes 
undergo normal development to become naïve, quiescent peripheral T cells. Foxp4 
expression has no effect on development of Foxp3+ T regulatory cells, induction of 
Foxp3 in naïve CD4 T cells in vitro, or Treg function. T cell-specific deletion of Foxp4 
does not immediately suggest functional disruption of gene programs required for 
adaptive immunity.  
To further investigate the role of Foxp4 in T cell responses, mice lacking Foxp4 
expression in the T lineage were challenged in vivo and assessed for normal adaptive 
immune responses. In this study, we utilized two model pathogens: Toxoplasma gondii 
and lymphocytic choriomeningitis virus (LCMV).  
Toxoplasma gondii is an obligate intracellular protozoan parasite that can infect 
both humans and mice through contaminated food or water (Dubey, 2008; Dupont et al., 
2012). In immunocompetent hosts, innate and adaptive responses control infection and 
pathogen replication, but fail to clear the parasites from the body completely. (Dubey, 
2008; Johnson, 1992; Weiss and Dubey, 2009) Immune pathology declines during 
transition to chronic toxoplasmosis when immune responses contain T. gondii to tissue 
cysts in muscle and neural tissues. However, the parasite remains in the host in the form 
of dormant bradyzoites (Dupont et al., 2012; Johnson, 1992). 
Previous studies have highlighted the importance of regulating T cells responses 
during T. gondii infection, as depletion of T cells in infected mice results in uncontrolled 
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disease in the brain and increased immune pathology (Araujo, 1992). Regulation by T 
helper Th1 (Th1) and Tregs are important to orchestrate immune cell responses (Hall et 
al., 2012; Stumhofer et al., 2006). Loss of either pro-inflammatory or suppressive signals 
causes mice to succumb to infection, indicating that a balance of lymphocyte function is 
required to maintain effective immune control over parasite replication. 
LCMV is a rodent-borne arenavirus, originally isolated after an outbreak in St. 
Louis, Missouri more than 80 years ago . Models of classic antiviral immune responses 
and immunological memory have emerged from extensive studies of LCMV infection. 
Additionally, an impressive array of reagents has been developed to examine both acute 
and chronic LCMV-specific responses, enabling researchers to observe and study 
lymphocyte activation, expansion, contraction and memory T cell development. In this 
study, we utilized the Armstrong strain of LCMV, which is cleared 7-8 days post 
infection; a population LCMV-specific memory cells capable of mounting recall 
responses develop and reach stasis approximately 30 days after infection. 
Infection of Foxp4-deficient mice demonstrated Foxp4 was not required to control 
infection with either T. gondii or LCMV. However, the capacity to produce effector 
cytokines was reduced in peripheral T cells generated by either pathogen. Rechallenge 
with cognate antigen revealed reduced memory recall responses in the absence of 
Foxp4 regulation. Therefore, Foxp4 appears to be unnecessary for T cell development, 
but necessary for the maintenance of long-term host immunity.  
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Results 
Foxp4 is expressed in T lymphocytes 
foxp4 transcript expression was detected by northern blot in multiple tissues, 
including the spleen (Teufel et al., 2003). We extended these studies to assess Foxp4 
expression in developing thymi. In collaboration with Drs. Ed Morrisey and Shanru Li, 
protein was detected by immunohistochemistry in thymic tissues of fetal E18.5 day-old 
mice. Immunostaining of transverse sections with Foxp4 polysera revealed Foxp4 
protein expression in the thymus, particularly in cortical regions (Figure 2.1A, right 
panel). Foxp4 expression in the thymus was compared to other FoxP family members. 
Staining with Foxp1-specific polysera of embryonic thymi appeared a darker brown 
color, denoting Foxp1 protein expression (Figure 2.1A, left panel). In contrast, Foxp2 
staining of the thymi exhibited reduced expression, which correlates with previous 
reports that Foxp2 is not expressed in the hematopoietic lineage (Figure 2.1A center 
panel) (Shu et al., 2001). These data are consistent with published findings, and 
demonstrate Foxp4 protein expression in the thymus. 
Next, we examined Foxp4 expression in developing T lymphocyte populations 
using highly purified T lymphocyte subsets isolated from wild-type thymi (Figure 2.1B). 
Steady-state Foxp4 mRNA levels were assessed using a TaqMan-based real-time 
polymerase chain reaction (PCR) PCR assay. Thymocytes were sorted from 8-week-old 
C57Bl/6 wild-type mice using flow cytometry, based on expression of CD4 and CD8. 
Lineage markers were used to exclude CD11c, CD11b, and F4/80 expressing non-T 
cells. CD4-CD8- double negative (DN) thymocytes were further separated based on 
CD25 and c-Kit expression. In all thymocytes populations, Foxp4 mRNA was expressed 
at detectable levels, with the highest expression found in the CD4-CD8-CD25+c-Kit- 
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(DN3) subset. Following β-selection, we observed that Foxp4 expression declined but 
remained constitutively expressed in both CD4 and CD8 single positive T cell subsets.  
Previously, studies have demonstrated Foxp4 expression in peripheral lymphoid 
tissues. However, these studies did not determine the specific cell types expressing 
Foxp4. Real-time PCR was used to determine relative Foxp4 levels in various sorted T 
cell populations. Foxp4 mRNA was expressed in both peripheral mature CD4 and CD8 T 
cells (Figure 2.1C). Based on CD44 and CD62L expression, CD4 and CD8 T cells can 
be further divided into CD44loCD62Lhi naïve, CD44hiCD62Llo effector memory (EM), and 
CD44hiCD62Lhi central memory (CM) populations. While Foxp4 was expressed in sorted 
sub-populations, no statistically significant differences in Foxp4 levels were detected in 
naive, EM, or CM T cells of both the CD4 and CD8 T lineage. Therefore, Foxp4 
expression is dynamically regulated throughout thymic development but decreased in 
mature cells. In peripheral T cells, Foxp4 is constitutively expressed. 
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Figure 2.1. Foxp4 is expressed in lymphoid tissues and T cell subsets. A) 
Expression of Foxp1, Foxp2 and Foxp4 in wild-type embryonic thymi by immunostaining 
with FoxP member antisera. 10µm cryosections of E18.5 mice were mounted and fixed 
with formaldehyde and H&E stained. Frames are magnified 40X. Representative of two 
independent experiments. L=lung, SC=spinal cord, AO=aortic arch, Tr=trachea, 
Thy=thymus. B) Thymocytes from C57BL/6 mice were stained with a lineage cocktail, 
CD4, CD8, CD44 and CD25, and HSA. Stained cells were collected using flow 
cytometric cell sorting. Steady state mRNA levels of Foxp4 and ß-actin were determined 
by TaqMan PCR. Foxp4 levels were normalized to ß-actin.  Double positive thymocytes 
were given a relative value of 1. All isolated populations were lineage negative.  DN1: 
CD4-CD8-CD25-CD44+; DN2: CD4-CD8-CD25+CD44+; DN3:CD4-CD8-CD25+CD44-; 
DN4: CD4-CD8-CD25-CD44-; ISP: CD4-CD8+HSA+CD5-; DP: CD4+CD8+; CD4: 
CD4+CD8-; CD8: CD4-CD8+HSA-CD5+. C) C57BL/6 splenocytes were stained with 
CD4, CD8, CD44, CD62L and CD25 and collected by flow cytometry.  Relative levels of 
Foxp4 were determined as in (A).  Total CD8+ were given a normalized value of 1. 
Naive: CD44loCD62Lhi, EM: CD44hiCD62Llo; CM: CD44hiCD62Lhi.  Error bars represent 
standard deviation among triplicate wells from TacMan assay.  Data is representative of 
two independent experiments.  
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Foxp4 can be efficiently deleted in thymocytes 
To investigate the role of Foxp4 in T lymphocyte development and function, we 
sought to generate Foxp4-deficient thymocytes. Germline deletion of Foxp4 results in 
embryonic lethality at day E12.5 due to cardiac defects (Li et al., 2004b), necessitating a 
conditional deletion approach. To study the effect of Foxp4 deletion specifically in the T 
lineage, we used mice with LoxP/LoxP sites flanking exons 12-13 of foxp4 that encode 
the forkhead domain (Figure 2.1A). Foxp4FLOX mice were then crossed with CD4Cre mice 
in which Cre recombinase expression is under transcriptional control of the cd4 promoter 
(Lee et al., 2001). Under cd4 promoter regulation, Cre is first expressed at the transition 
from the double negative to double positive stage in the thymus. Gene deletion is 
observed in DP, mature SP thymocytes, and peripheral T cells. To increase likelihood of 
generating Foxp4 null cells, we used mice carrying one germline null allele and one 
floxed allele (Foxp4Flox/null CD4Cre+, henceforth referred to as cKO). Throughout this 
study, cKO animals were compared to conditional heterozygous (Foxp4Flox/+CD4Cre+, 
henceforth referred to as cHET) littermates that expressed one wild-type allele and one 
floxed allele. Thus, cHET T cells express one allele of Foxp4, while cKO mice lack both 
genomic Foxp4 alleles following Cre-mediated deletion.  
To confirm efficient deletion of Foxp4, we first isolated total thymocytes (>95% 
DP and SP cells) and evaluated deletion in genomic DNA using a PCR-based assay. 
Deletion of Foxp4 was verified by detection of a wild-type Foxp4 PCR product at 412 kb, 
a Foxp4FLOX product including the inserted flanking LoxP sites at 508 kb, or the deleted 
Foxp4Δ product at 475kb in total thymocytes and purified peripheral CD4 T cells from 
cKO mice (Figure 2.2A and data not shown). In RNA isolated from Foxp4 cKO purified 
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splenic CD4 T cells the level of Foxp4 message was undetectable, as determined by 
real-time PCR (Figure 2.2B). Taken together, CD4Cre-mediated deletion results in 
Foxp4 deficient thymocytes and peripheral T cells, and allows for further investigation of 
the role of Foxp4 in the T lineage. 
Figure 2.2. Generation of Foxp4 cKO mice. A) Schematic of conditional deletion of 
Foxp4 in cHET and cKO mice. LoxP sites (red triangles) were cloned into genomic DNA 
flanking exons 12 and 13 sequences, to generate the Foxp4FLOX mutant allele. cHET 
mice express one Foxp4FLOX allele and one wild-type Foxp4 allele.  cKO mice were bred 
to express one Foxp4FLOX allele and a Foxp4 mutant allele. Cre recombinase under the 
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cd4 promoter results in excised DNA between LoxP sites. B) DNA isolated from cHET 
and cKO thymocytes was amplified using primers to detect wild-type, floxed, and deleted 
allelic sequences. Band sizes and identities are indicated. Representative of ten 
experiments.  C) RNA isolated from WT (C57BL/6) and cKO thymocytes was assessed 
for Foxp4 by real time PCR.  ND=not detectable.  Representative of three experiments.   
 
Foxp4 is not required for T cell development and peripheral homeostasis 
To determine if thymocyte development was normal in the absence of Foxp4, the 
phenotype and cellularity of thymic populations from cHET and cKO animals were 
compared. From initial observation, the size and cellularity of Foxp4 cKO thymi was 
comparable to cHET and Cre control thymi (Figure 2.3A, and data not shown). 
Throughout these studies, there were no changes observed between cHET and Cre 
control mice, suggesting loss of one allele of Foxp4 had no impact on T cell 
development. The relative frequency of DP, and SP populations, and absolute numbers 
were similar between both cohorts of mice (Figure 2.3B, C). ISP, DP and SP populations 
were stained for phenotypic expression of markers of development (Figure 2.3D). Loss 
of Foxp4 resulted in comparable expression of CD5 or the TCRβ chain between cHET 
and cKO mice. CD44 levels on Foxp4 cKO cells were also evaluated, as Foxp1 
conditionally deficient CD4SP and CD8SP T cells acquire a CD44hi phenotype. In Foxp4 
cKO mice, however, CD4SP and CD8SP cells maintain low levels of CD44 expression, 
providing the first evidence that Foxp1 and Foxp4 have non-overlapping roles in 
thymocyte development. Furthermore, these data suggest that deletion of Foxp4 during 
transition from DN to DP has no effect on the development of single positive thymocytes.  
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Figure 2.3. Deletion of Foxp4 at the DP stage does not alter thymocyte 
development. A) Total cellularity was assessed in both cHET and cKO thymi from four-
week-old littermates.  Each point represents a single mouse. Mean and standard 
deviation are indicated. B) Thymocytes were stained for CD4 and CD8 and analyzed by 
polychromatic flow. Contour plots shown are previously gated on live, singlet-gated cells, 
negative for myeloid lineage markers (CD11b, CD11C, CD19, B220). Gated frequencies 
are indicated. Representative of 12 cHET and 12 cKO mice. C) Absolute numbers of 
thymocyte populations were determined.  Each point represents an individual mouse. D) 
Thymocytes were stained with CD4, CD8, CD5 and HSA.  Cells are gated on 
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populations as indicated at the top of each column and assessed for CD5, TCRβ, and 
CD44 expression. Solid histograms are from cHET and bold lines are from cKO mice.  
Representative of 12 cHET and 12 cKO mice. 
 
Because thymocytes appear to develop normally, we were able to assess the 
effect of Foxp4 deficiency in peripheral T cell populations. Splenic cellularity in cKO mice 
was similar to that seen in cHET mice (Figure 2.4A, left panel).  Similarly, the frequency 
and absolute number of cKO CD4 and CD8 T cells was comparable to controls (Figure 
2.4A, center and right panels, Figure 2.4B).  As observed in developing Foxp4 cKO 
thymocytes, the majority of Foxp4 cKO splenic T cells remain phenotypically naïve, 
expressing low levels of CD44 and high levels of CD62L (Figure 2.4B). Similar 
frequencies of CD44hi endogenous memory T cells were present in Foxp4 cHET and 
cKO mice. This is in contrast to Foxp1 cKO T cells, which are uniformly CD44hi.  We 
assessed other markers of activation for any indication of aberrant T cell development, 
but we found comparable expression of CD69 and the TCRβ chain on splenic CD4 and 
CD8 T cells (Figure 2.4C, D). Similarly, Foxp4 deletion does not affect levels of the IL-2 
or IL-7 receptor on either CD4 or CD8 T cells (Figure 2.4E), suggesting Foxp4 does not 
regulate mechanisms of T cell commitment or homeostasis. Foxp4 cKO mice were 
observed for more than 12 months, and did not develop any sign of abnormal immune 
activation or overt pathology (data not shown). Thus, Foxp4 deficiency does not result in 
abnormal activation or lead to overt autoimmune pathology, allowing for interpretation of 
function studies. 
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Figure 2.4. Foxp4 is not required for the generation of peripheral CD4 and CD8 T 
cells. A) Absolute numbers from spleens from four-week-old cHET and cKO mice, 
including total spleen cellularity (top panel), numbers of CD4+ T cells (middle panel) and 
CD8+ T cells (bottom panel). B-E) Splenocytes cells from 6-8 week-old cHET and cKO 
mice were stained for expression of CD4, CD8 and CD44 and CD62L, or CD25, CD69, 
TCRβ, and IL-7 receptor (CD127) for immunophenotyping by polychromatic flow 
cytometry on LSRII. Histograms are gated on live, singlet CD4+ T cells. Representative 
of 4 independent experiments. 
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Normal Regulatory T cell generation in Foxp4 cKO CD4 T cells. 
Interaction of FoxP family members in homo- and heterodimers suggested 
Foxp3+ regulatory T cells (Tregs) could be affected by Foxp4 deletion. Foxp4-deficient 
mice were assessed for normal Foxp3+ regulatory T cell development (Treg) (Figure 
2.5). The frequency of CD4 T cells expressing the high affinity interleukin-2 receptor 
alpha chain (CD25) and Foxp3 was similar between cHET and cKO mice (Figure 2.5A, 
and data not shown). There was no difference in the total cell number of this population, 
or in expression of Foxp3 protein, as indicated by the mean fluorescence intensity of 
Foxp3 staining (Figure 2.5A-B).  
Induced regulatory T cells (iTreg) develop when naïve CD4 cells are activated in 
the presence of exogenous IL-2 and transforming growth factor β (TGFβ) in vitro. To 
assess whether Foxp4 is necessary for the induction of Foxp3 expression in mature CD4 
T cells, sorted naïve CD44low CD4 cHET or cKO T cells were cultured in vitro with TGFβ 
and IL-2. After four days under polarizing conditions with or without TGFβ, cells were 
assessed for Foxp3 and CD25 co-expression (Figure 2.5C). In the presence of TGFβ 
and IL-2, similar frequencies of cHET and cKO CD4 cells acquire a regulatory T cell 
phenotype, and Foxp3 induction is normal. Culture of Foxp4 cKO CD4 cells with IL-2 but 
not TGFβ did not result in Foxp3 expression (Figure 2.5C, left panels).  Thus, Foxp4 is 
not necessary for the development of nTreg or generation of iTreg cells.   
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Figure 2.5. Foxp3+ Regulatory T cell development does not require Foxp4 
expression. A) Splenic Foxp3+ nTreg cells were identified by flow cytometry based on 
expression of CD4, CD25 and intracellular staining for Foxp3 protein. Gated frequencies 
are indicated.  Representative of 7 cHET and 7 cKO mice.  B) Frequencies of Treg were 
calculated using the splenic cellularity and relative frequency.  Each point represents an 
individual mouse.  Mean and standard deviation are indicated.   C) Naïve CD4 T cells 
from cHET or cKO mice were polarized to induce iTreg differentiation for four days in 
vitro in the presence of anti-CD3 and IL-2 with (left) or without (right) TGFβ. Wells were 
harvested and cells were assessed for expression of CD25 and Foxp3.  Plots are gated 
on live, CD4+ cells.  Representative of 4 experiments.  
 
Foxp4 is not necessary for T cell proliferation or activation. 
We next assessed how Foxp4 levels are regulated in response to T cell receptor 
stimulation and activation.  CD4 T cells from wild-type C57BL/6 mice were stimulated 
with anti-CD3 and anti-CD28, and harvested 24 or 48 hours later. foxp4 transcript levels 
were measured using real-time PCR.  foxp4 message is increased three-fold 24 hours 
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after TCR stimulation and returns to pre-activation levels by 48 hours (Figure 2.6A).  The 
change in Foxp4 expression in response to TCR and CD28 costimulation suggests that 
Foxp4 regulation may be involved in transcriptional programs of activation.  
To determine whether Foxp4 upregulation is necessary for normal T cell 
activation, Foxp4 cKO T cells were stimulated in vitro. T cell stimulation induces 
activation of several fundamental signaling pathways, resulting in upregulation of cell 
surface proteins associated with T cell activation and proliferation. T cell proliferation 
was assessed by stimulating CFSE-labeled T cells in vitro with anti-CD3 and anti-CD28. 
Foxp4 cKO CD4 and CD8 T cells dilute CFSE comparably to cHET T cells (Figure 2.6B 
and data not shown). Proliferation of cKO cells was equivalent to cHET cells regardless 
of the concentration of anti-CD3 used. Activated cKO T cells were stained for expression 
of cell surface effector markers typically induced during effector responses. Overnight 
stimulation of CD4 and CD8 T cells resulted in equivalent induction of CD69 and 
decreased levels of IL-7R (Figure 2.6C), suggesting Foxp4 does not regulate Foxp1 
targets, IL-7R. Similarly, splenocytes stimulated for four days exhibited increased CD44 
expression and concomitant downregulation of CD62L expression similar to control 
cHET cells (Figure 2.6D).  Together, these data suggest that the loss of Foxp4 does not 
alter the proliferative response or the profile of cell surface receptors that accompanies T 
cell activation. 
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Figure 2.6. T cell activation induces normal proliferation and effector T cell 
differentiation in the absence of Foxp4. A) C57BL/6 CD4+ T cells were isolated and 
plated in wells coated with 1μg/mL anti-CD3 and 5μg/mL soluble anti-CD28. Wells were 
harvested on the indicated days.  RNA was isolated and cDNA was generated as 
described in Materials and Methods. Foxp4 relative to β-actin transcript levels were 
normalized to day 0. Representative of 2 experiments.  B) CD4+ T cells were labeled with 
CFSE, and cultured 4 days with indicated concentrations of aCD3 and soluble anti-
CD28. Dilution of CFSE was assessed on day 4. Representative of 4 cHET and cKO 
mice. C) CD4 T cells from cHET and cKO mice were stimulated overnight in wells coated 
with anti-CD3 plus soluble anti-CD28. Harvested cells were stained for CD69 and IL-7R. 
Histograms are gated on CD4 or CD8 TCRβ+ cells.  Representative of 2 experiments.  
D) cHET and cKO CD4+ T cells were stained for expression of CD44 and CD62L after 4 
days in culture with anti-CD3 and anti-CD28. Representative of 4 cHET and 5 cKO mice. 
A 
Phenotype Activation 
 
CD69 
CD44 
CD28 
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
CFSE 
cKO 
cHET 
2 1 0.5 0.25 0.1 0.01 0 CD3 (µg/mL) 
B 
C 
CD69 
CD8 
CD4 
IL-7R 
cHET 
 
cKO 
 
Unstim 
CD44 
D 
CD62L 
4 
3 
2 
1 
0 
0 1 2 
Days 
fo
xp
4
 R
el
at
iv
e 
m
R
N
A 
	   34	  
Foxp4 does not regulate T helper cell commitment 
Effector CD4 T cell differentiation induces commitment to a T helper subset and 
specific regulation of cytokine production. Preliminary experiments demonstrated that 
CD4 and CD8 cKO T cells were capable of producing interferon gamma (IFNγ), tumor 
necrosis factor (TNFα), and IL-2 during a short restimulation immediately ex vivo (data 
not shown). To determine how Foxp4 might regulate effector T cell development, we 
exploited the T helper cell model of in vitro polarization. Naïve CD4 T cells can commit to 
several different lineages, depending on environmental signals during activation. To 
assess whether Foxp4 deficiency affects T helper cell commitment, CD4 T cells were 
enriched from spleens of cHET and cKO mice by MACS column and stimulated in vitro 
in cytokine cocktails. Committed T helper cells produce lineage-specific cytokines upon 
restimulation. To demonstrate T helper lineage commitment, cultured cells were 
restimulated with phorbol myristate acetate and ionomycin. Cytokine export was 
inhibited with addition of monensin. After 4 hours, cells were stained intracellularly for 
production of IL-2, IFNγ, and interleukin-17 (IL-17), indicating Th0, Th1, and Th17 
differentiation, respectively.  
cHET and cKO T cells were able to commit to specific T helper lineages and 
produce prototypical cytokines in response to restimulation (Figure 2.7A). Both cHET 
and cKO CD4 T cells cultured with IL-12 under Th1 lineage conditions produced IFNγ, 
but not the Th17 lineage-specific cytokine IL-17. Conversely, T cells cultured with TGFβ 
and interleukin-6 (IL-6) to induce Th17 commitment produced IL-17, but not IFNγ. T cell 
activation in the presence of IL-2 resulted in expected production of IL-2 and IFNγ. 
Specific T helper lineage cytokine production demonstrates intact regulation of T helper 
gene programs in Foxp4-deficient CD4 T cells. 
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To investigate Foxp4 expression in T helper lineages, expression of Foxp4 was 
determined in wild-type polarized CD4 T cells. Wild-type cells were cultured in vitro to 
induce Th0, Th1, or Th17 polarization. After four days, wells were harvested to assess 
foxp4 transcript by real-time PCR. Foxp4 expression is increased in Th17, relative to 
starting levels in naïve T cells, and to other T helper subsets (Figure 2.7C). Together, 
these data suggest Foxp4 expression is induced after T cell activation and remains 
elevated under Th17 conditions,  
Foxp4 cKO T cells exhibited a trend toward increased IL-17 production in vitro.  
As Foxp4 is thought to be a transcriptional repressor (Li et al., 2004a), this led us to 
investigate additional anomalous cytokine expression by polarized cKO T cells.  
Interestingly, a higher frequency of Th17 skewed Foxp4 cKO cells produced IL-2, 
relative to identically stimulated cHET cells (Figure 2.7A, bottom left panel, and 2.7B). To 
quantitate the relative percentages of IL-17 or IL-2 producing Th17 cells over a number 
of experiments, the percentages of IL-2+ or IL-17+ cKO cells were normalized to 
matched cHET controls (Figure 2.7B). Foxp4 cKO Th17 cells averaged increased 
frequencies of IL-2 or IL-17 producers, but not IFNγ. Maintenance of IFNγ repression 
indicates normal commitment to Th17 differentiation in cKO T cells. Instead, increased 
IL-2 and IL-17 production suggested Foxp4 may be necessary for repressing excessive 
cytokine responses in CD4 Th17 cells. 
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Figure 2.7. Foxp4 is not required for T helper cell differentiation. A) CD4 T cells 
were enriched from cHET or cKO spleens and cultured in wells coated 1μg/mL anti-CD3 
and 5μg/mL soluble anti-CD28. Antibody cocktails were prepared as described in 
Materials and Methods and added to induce T helper commitment. After 4 days wells 
were restimulated for 4 hours with PMA and Ionomycin. Cytokine export was inhibited by 
Brefeldin A. Wells were harvested and cells were stained for expression of CD4, TCRβ, 
CD44 and intracellularly for cytokine production of prototypic T helper cytokines IFNγ, IL-
2, and IL-17. Representative plots of eight experiments. B) CD4+ CD44hi T cells 
harvested from Th17 polarized wells and stained for cytokine production. Compiled 
frequencies of live CD4+ CD44hi T cells producing the indicated cytokines were 
normalized to frequencies of control cells in each independent experiment. Compiled 
from eight experiments. C) C57BL/6 CD4+ T cells were isolated and plated in wells 
coated with 1μg/mL anti-CD3 and 5μg/mL soluble anti-CD28. Exogenous IL-2 was 
added to cultures to induce Th0 polarization. Recombinant IL-12 was added to Th1 
wells, and TGFβ and IL-6 induced Th17 polarization. Wells were harvested after four 
days.  RNA was isolated and cDNA was generated as described in Materials and 
Methods. Foxp4 relative to β-actin transcript levels were normalized to day 0. 
Representative of 2 experiments. 
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Foxp4-deficient T cells control chronic infection 
We determined Foxp4 expression was not necessary for T cell development, and 
in vitro T helper commitment was not greatly affected. It was unclear how T cell-specific 
Foxp4 deficiency might alter the physiologic immune response to pathogenic infection. T 
helper polarization of Foxp4 cKO T cells in vitro prompted us to investigate how loss of 
Foxp4 regulation in activated cells affected the course of host immunity. Toxoplasma 
gondii infection elicits a systemic Th1 type immune response but establishes a chronic 
infection approximately 30-40 days after infection.  
To assess the response to chronic toxoplasmosis, Me49 T. gondii cysts were 
injected intraperitoneally to cHET and cKO cohorts, and Foxp4FLOX Cre-negative 
littermates. Immune dysregulation during onset of toxoplasmosis resulted in weight loss 
and increased morbidity in other systems (Stumhofer et al., 2006). No differences were 
observed between Foxp4 cHET and Cre control mice, suggesting Foxp4 haplo-
insufficiency had no effect on pathogen control. Body weight of experimental cohorts 
was monitored throughout the course of infection. Weights were then normalized as a 
percentage relative to starting weight, and averaged across cohorts (Figure 2.8A). No 
differences were observed in the weight or morbidity between groups of CreNEG, cHET 
and cKO mice, and no overt immune pathology developed (data not shown). 
We sought to determine if the infection was controlled normally in Foxp4 cKO 
mice. To assess parasite clearance, brain tissues were harvested for 
immunohistopathology, and for determination of parasite burden by quantitative PCR. 
Foxp4 cKO tissues and littermate controls were assessed in a blinded fashion for cyst 
counts, with no appreciable difference across the cohorts (data not shown). Parasite 
burden in the brain and liver was measured by real-time PCR and normalized to a 
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standard curve to calculate parasite DNA remaining forty days post-infection (Figure 
2.8B, C). Parasite load by DNA amplification indicated similar degrees of chronic 
toxoplasmosis in typical sites of parasite maintenance in cHET and cKO animals. No 
additional effects on tissue histology or animal survival were observed. These data 
suggest that T cell-specific loss of Foxp4 does not alter the overall ability to control T. 
gondii infection. 
To further characterize the immune response again T. gondii, T cells from 
spleen, lymph node and CNS were analyzed. Overall splenic cellularity, CD4 and CD8 T 
cell numbers were comparable between cKO and control mice (Figure 2.8D, E). 
Additionally, brain mononuclear cells (BMNCs) were isolated from perfused brain 
tissues. Total numbers were comparable, which suggests Foxp4 cKO T cells were not 
trafficking into the CNS abnormally (Figure 2.8F). Frequencies and relative numbers of 
CD4 and CD8 T cells were also comparable in cHET and cKO cohorts (Figure 2.8G, and 
data not shown).  
Activation and proliferation of Foxp4 cKO BMNCs and splenocytes appeared 
normal (data not shown). We assessed proliferation by Ki-67 staining of lymphocytes.  
Similar numbers of cHET and cKO T cells stained positively for Ki-67, suggesting cKO T 
cell numbers were maintained by normal turnover in response to T. gondii in both CNS 
and peripheral lymphoid tissues (data not shown).  Furthermore, CD4 and CD8 T cells 
from spleens and lymph nodes of cHET and cKO mice showed comparable expression 
of activation markers CD44 and CD62L (data not shown), which demonstrates that 
Foxp4 is not necessary for the maintenance of peripheral T cells during chronic 
toxoplasmosis.  
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Figure 2.8. Toxoplasma gondii infection does not lead to wasting or lymphopenia 
in Foxp4 cKO mice. Eight-week-old Foxp4FLOX/FLOX CreNEG, cHET and cKO mice were 
infected with T. gondii by intraperitoneal injection of 20 Me49 cysts. A) Weights of mice 
were assessed longitudinally and plotted relative to the percentage of each respective 
mouse’s starting weight at d0. Mean and s.d. from 9 CreNEG, 12 cHET, and 15 cKO mice. 
B-C) Parasite DNA was quantitated using SYBR probes specific for T. gondii. B) Brain 
tissue was perfused and harvested at day 40 post infection. C) Whole liver was 
homogenized for detection of parasite DNA. Levels of T. gondii DNA were normalized to 
a standard curve. Each point represents an individual mouse. Mean and standard 
deviation are shown.  Representative of 3 individual experiments. D) Spleens were 
harvested at 40 days post infection and total spleen cellularity was determined. E) Total 
CD4 and CD8 T cell numbers were determined by staining splenocytes from mice in 
infected cohorts for analysis by multichromatic flow cytometry. F) Brain mononuclear 
cells were isolated via Percoll gradient and enumerated. G) Frequencies of TCR+ CD4 
and CD8 lymphocytes in the brain were identified by multichromatic flow cytometry. D-G) 
Each point represents an individual mouse. Mean and standard deviation are shown. 
Representative of 3 experiments.  
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We next assessed the differentiation and functionality of Foxp4 cKO effector T 
cells that had been generated in response to T. gondii infection. During chronic infection 
with T. gondii, Th1 CD4 T cells are an important source of IFNγ, and are required for 
control of the parasite (Araujo, 1992; Gazzinelli et al., 1992). Cytokine production in 
cHET and cKO T cells was first assessed by enzyme-linked immunoassay (ELISA). 
Whole splenocytes were cultured for 24 hours in the presence of anti-CD3 or soluble 
tachyzoite antigen (STAg), or left unstimulated in media (Figure 2.6A).  Culture 
supernatants were assessed for levels of IFNγ, an effector cytokine critical in controlling 
T. gondii infection and preventing cyst reactivation (Denkers, 1999; Yap and Sher, 
1999). STAg stimulation, which restimulates those cells specific for T. gondii, resulted in 
statistically lower levels of soluble IFNγ detectable in cKO versus CreNEG control. A trend 
toward lower IFNγ was seen when comparing CreNEG to cHET and cHET to cKO cells, 
but the difference did not reach statistical significance. Conversely, supernatants from 
splenocyte cultures stimulated with anti-CD3 contain equivalent levels of IFNγ.  These 
results suggest that Foxp4 may regulate the induction of IFNγ in an antigen-specific 
manner. IL-17 production in response to ant-CD3 and STAg stimulation was also 
measured, to determine if IFNγ responses were uniquely regulated. However, we found 
IL-17 production was also reduced in Foxp4 cKO cultures, demonstrating that Foxp4 
deletion appears to impact the overall responsiveness of antigen specific cells to 
rechallenge. 
The difference seen in cytokine production could be caused by several defects: a 
reduced number of cytokine-producing T cells, a decrease in the per cell production, or 
increased consumption of the cytokine. To determine if cKO T cells had altered cytokine 
generation on a per cell basis, unfractionated splenocytes were stimulated. Intracellular 
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cytokine staining (ICS) was used to measure single-cell production of IFNγ, IL-2, IL-17, 
and tumor necrosis factor alpha (TNFα). Cells were stimulated with PMA and ionomycin 
for four hours to determine whether cKO T cells were capable of producing cytokines. 
Analysis by flow cytometry indicated no difference in the frequency or absolute number 
of splenic CD4 or CD8 T cells capable of producing the cytokines assayed (Figure 2.9B, 
and data not shown). Furthermore, the MFI of these cytokines also suggests these cells 
are capable of producing similar amounts of cytokine, but does not address how antigen 
specific TCR stimulation elicits cytokine production.  
The brain is a site of constant antigen presentation during toxoplasmosis. We 
isolated mononuclear cells from the brain (BMNCs) and assessed cytokine production 
by ELISA and ICS (Figure 2.9C, D). Similar to splenic T cells, there was no difference in 
the levels of IFNγ in response to anti-CD3 (Figure 2.9C). In wells stimulated with STAg, 
IFNγ levels are statistically decreased in cKO BMNCs, relative to BMNC responses from 
cHET and CreNEG mice. Foxp4 cKO BMNCs were further assessed by ICS in a four-hour 
recall response. Cells isolated from the brain tissues are capable of producing IFNγ, IL-
2, IL-17, and TNFα at similar frequencies to controls, despite the lower quantity detected 
by ELISA (Figure 2.9D, and data not shown).  
Predicted T helper responses to restimulation suggest Foxp4 is not necessary for 
differentiation or commitment to T helper lineages during infection. Therefore, the 
decreased cytokine response by chronically infected Foxp4 cKO cells is not caused by 
reduced IFNγ production on a per cell basis, deficient Th1 CD4 effector function, or a 
striking lack of lymphocytes. Rather, Foxp4-deficient cells demonstrated decreased IFNγ 
responses to STAg stimulation by ELISA regardless of tissue, suggesting a systemic 
defect in antigen-specific immunity. 
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Figure 2.9. Foxp4 deletion alters recall responses to Toxoplasma gondii in the 
spleen and brain. A and C) Splenocytes and BMNC from mice infected with T. gondii 
40 days earlier were cultured with anti-CD3, soluble tachyzoite antigen (STAg), or left 
unstimulated for twenty-four hours. Supernatants were analyzed for levels of IFNγ by 
ELISA, and normalized to a standard curve.  Representative of 3 independent 
experiments. B and D) Splenocytes and BMNC were stimulated for four hours with PMA 
and Ionomycin in the presence of Brefeldin A, and assessed for intracellular IL-2 and 
IFNγ. Contour plots are gated on CD4+ or CD8+CD3+ cells. Relative percentage is shown 
within each gate.  Splenocytes are representative of 9 CreNEG, 12 cHET and 15 cKO.  
BMNC are representative of 5 CreNEG, 7 cHET, and 7 cKO mice.  E) CD8-depleted 
splenocytes from cHET and cKO mice were cultured in Th0 (left) or Th1 (right) polarizing 
conditions. Cells were restimulated in the presence of monensin. Histograms are gated 
on CD4+ T cells. cHET (filled histogram); cKO (black solid line); unstimulated (dashed 
line). Representative of 6 experiments. 
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Foxp4 is not required for acute viral clearance. 
Host immunity and pathogen control and clearance differs greatly depending on 
the nature of the pathogen and the characteristics of the infection. Chronic infection with 
T. gondii results in sustained inflammatory conditions and presence of antigen, which 
may result in exhaustion and/or dysfunctional T cell responses. It was unclear whether 
Foxp4 was necessary during the chronic disease setting of T. gondii and whether 
constant antigen caused exhaustion and poor cytokine production by Foxp4 cKO T cells. 
Therefore, we investigated whether Foxp4 cKO memory cells would mount normal recall 
responses following an acute infection. We utilized the LCMV model of viral infection.  
CreNEG, cHET and cKO mice were infected with the Armstrong strain of LCMV at 
day 0. To differentiate CD44hi endogenous memory T cells from LCMV-specific CD4 
memory cells, cells were stained with MHC Class II tetramer:peptide conjugated to 
phycoerythrin. Additional staining for cell surface levels of CD44 determined antigen-
experienced LCMV-specific T cells. For detection of LCMV-specific CD8 T cells we 
employed MHC Class I tetramer:peptide conjugated to allophycocyanin. CD4 
splenocytes bearing the TCR specific for the LCMV epitope gp61 were identified by 
positive staining with I-Ab:gp61 tetramer, and CD8 T cells specific for LCMV epitope 
gp33 were identified by staining with H2-Db:gp33 tetramer. Mice were bled weekly, to 
assess expansion and contraction of LCMV-specific CD4 and CD8 T cells. Gp61-specific 
or gp33-specific T cells were normalized per million lymphocytes. Foxp4 expression was 
not necessary in effector CD4 or CD8 T cell expansion or contraction after viral 
clearance (Figure 2.10A, B).  
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At day 30 post-infection, cohorts were sacrificed and assessed for maintenance 
and function of memory CD4 and CD8 T cells. Comparable frequencies of gp61-specific 
CD4 T cells and gp33-specific CD8 T cells were found in CreNEG, cHET and cKO mice 
(Figure 2.10C). Total numbers of I-Ab:gp61 tetramer+ cells or H2-Db:gp33+ cells were 
calculated from spleen cellularity and demonstrated similar numbers across all cohorts 
(Figure 2.10D, and data not shown).  
	  
Figure 2.10. Antigen specific Foxp4 cKO T cells persist after antigen clearance. 
Foxp4FLOX/FLOX CreNEG, cHET and cKO mice were infected with the Armstrong strain of 
LCMV by intraperitoneal injection at day 0, allowed to clear infection, and to generate 
memory T cells. A-B) Peripheral blood was taken weekly from infected mice and 
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peripheral lymphocytes isolated using a Ficoll gradient. Frequencies of A) I-Ab:gp61+ 
CD44hi antigen specific CD4 T cells and B) H2-Db:gp33+ CD44hi LCMV specific CD8 T 
cells were determined by tetramer staining and flow cytometric analysis. Representative 
of 3 CreNEG, 5 cHET and 5 cKO mice across two independent infections. C-D) At day 30 
post-infection mice were sacrificed and spleens were harvested. C) Frequencies of I-
Ab:gp61+ CD44hi CD4 T cells (left panels) and H2-Db:gp33 CD44hi CD8 T cells (right 
panels) at day 30. Representative of 3 CreNEG, 5 cHET and 5 cKO mice across two 
independent infections. D) Numbers of I-Ab:gp61+ CD44hi CD4 T cells were calculated 
from whole spleen numbers. Each point represents one mouse. Mean and standard 
deviation are indicated. 
 
To assess whether Foxp4 was necessary to mount recall responses following 
acute viral infection, single-cell cytokine production was assessed following a short recall 
response. Splenocytes were challenged ex vivo with gp61 peptide or left unstimulated, in 
the presence of Brefeldin A, to test CD4 cytokine responses (Figure 2.11A, and data not 
shown). Wells were harvested after 4 hours and cells were stained intracellularly for 
IFNγ, IL-2 and TNFα.  Representative plots show comparable percentages of CreNEG 
and cHET splenocytes produce IFNγ and TNFα in response to gp61 peptide stimulation 
(Figure 2.11A and data not shown). However, Foxp4 cKO spleens contained fewer 
responders to gp61 restimulation. Cytokine production of all three cytokines is reduced 
in cKO mice, relative to cHET and CreNEG mice (Figure 2.11C). Frequencies of 
polyfunctional gp61-specific memory cells also reveal a distinct reduction in cKO 
splenocytes that produce IFNγ, TNFα, and IL-2, suggesting Foxp4 expression is 
important in CD4 memory recall responses following acute infections (Figure 2.11D). 
Polyclonal restimulation with PMA and ionomycin revealed an decreased percentage of 
CD4 T cells are capable of producing cytokine (Figure 2.11B), suggesting the total cKO 
CD4 population may exhibit decreased functional cytokine responses. 
In contrast, when whole splenocytes were rechallenged with gp33 peptide, 
LCMV-specific responses by CD8 T cells appeared to be relatively similar between 
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cHET and cKO mice (Figure 2.11E and data not shown). Furthermore, total CD8 cells 
were stimulated with PMA and ionomycin and produced cytokine normally, suggesting 
polyclonal CD8 recall responses were intact.  Therefore, Foxp4 may be important for 
CD4 memory recall responses, but not CD8, in the setting of acute infection. 
 
	  
Figure 2.11. Foxp4 deficient CD4 T cells exhibit reduced memory recall responses 
following LCMV infection. Foxp4FLOX/FLOX CreNEG, cHET and cKO mice were infected 
with the Armstrong strain of LCMV by intraperitoneal injection at day 0, allowed to clear 
infection, and to generate memory T cells. At day 30 post-infection mice were sacrificed 
and spleens were harvested. A) Splenocytes harvested at day 30 were restimulated with 
gp61 peptide for four hours in vitro, in the presence of Brefeldin A. Cells were assessed 
for cell surface expression of CD4, CD8, CD44, and stained intracellularly for IFNγ, 
TNFα, and IL-2. Representative plots of 3 CreNEG, 5 cHET and cKO across two 
independent infections. B) Splenocytes from infected cohorts were stimulated with PMA 
and Ionomycin in the presence of Brefeldin A, and similarly stained for cytokine 
production as in B. C) Compiled frequencies of cells producing IFNγ, TNFα, or IL-2 (left), 
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or polyfunctional cells producing all three cytokines (right). D) Frequencies of 
polyfunctional CD4 T cells from gp61 peptide stimulation. E) Splenocytes stimulated with 
gp33 peptide (left panels) or PMA and Ionomycin (right panels) in the presence of 
Brefeldin A were assessed for IFNγ, TNFα, and IL-2. Events are previously gated on 
live, CD8+ CD44hi T cells. Representative plots of 3 CreNEG, 5 cHET and cKO across 
two independent infections. 
 
Discussion 
In this chapter, we detail exclusive requirements for Foxp4 regulation in the T 
lineage. We show that Foxp4 is expressed in T cells and plays a role in effector T cell 
cytokine responses in vitro and in vivo. We also present evidence of unique Foxp4 
regulation in memory recall responses. Due to the high degree of homology between 
Foxp1 and Foxp4, and known heterodimerization in other cell types, Foxp4 cKO T cells 
might have developed an activated phenotype. Surprisingly, naïve Foxp4 deficient T 
cells develop normally, indicating Foxp4 is not necessary to maintain T cell quiescence. 
More recent studies have shown Foxp1 represses il7ra transcription and regulates 
homeostasis in T cells (Feng et al., 2011). Whether repression of IL-7R transcription is 
due to Foxp1:Foxp1 homodimers or Foxp1:Foxp4 heterodimers was not directly 
addressed. However, deletion of Foxp4 has no effect on either IL-7R levels or on 
peripheral homeostasis based on steady-state lymphocyte numbers and in vivo 
bromodeoxyuridine labeling (data not shown), suggesting that repression of IL-7R 
transcription and maintenance of a naïve phenotype is likely Foxp4-independent.  
Similarly, Foxp3 expression in regulatory CD4 cells is not affected by Foxp4 
deletion. Normal Treg development in Foxp4 cKO mice suggests Foxp4-specific 
regulation is not necessary for the generation or maintenance of natural Tregs in vivo. 
These data also indicate Foxp3:Foxp4 protein interaction is not important for Treg 
development. In addition, we did not find alterations in the frequency or number of Tregs 
	   48	  
in acutely or chronically infected mice (data not shown), suggesting that Foxp4 deletion 
does not have an impact on the survival or maintenance of Tregs under homeostatic or 
infectious conditions. 
Because Foxp4 expression is not necessary for normal generation of peripheral 
T cells, we were able to evaluate how Foxp4 deletion affected cell fate commitment of 
effector CD4 T cells. We expected Foxp4 expression to be important for T cell activation, 
and possibly differentiation, given the three-fold increase in expression following 
stimulation. However, Foxp4 cKO effector cells did not appear defective when evaluated 
by in vitro assays. Foxp4-deficient CD4 T cells are able to differentiate into Th1 and 
Th17 lineages, and to convert into Foxp3+ Tregs in vitro. Furthermore, proliferation and 
upregulation of known markers of activation appears normal in activated CD4 and CD8 
populations. Thus, despite increased expression of Foxp4 after TCR stimulation, we 
have found no substantial effect of Foxp4 deletion on T cell activation or differentiation.  
To more thoroughly evaluate effector function, we examined Foxp4-deficient T 
cell responses following pathogenic infection. During chronic infection with T. gondii, 
Foxp4 cKO mice controlled the infection similarly to controls as evidenced by similar 
numbers of cysts and quantitatively equal parasite burden. Total cellularity and 
phenotype of T cells in infected cKO mice were comparable to cHET animals. Trafficking 
to inflamed tissues appeared normal, although we cannot exclude the possibility that 
Foxp4 cKO T cells migrate abnormally to the CNS where chronic antigen stimulation 
induces cell death. However, if this were the case, we would expect to find signs of 
increased immunopathology and lymphocyte infiltration in brain tissue, which was not 
characteristic of cKO immunohistopathology. Lack of overt pathology or increased 
morbidity of Foxp4 cKO animals suggests T cell responses were largely intact. 
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Given the robust responses of CD4 and CD8 T cells stimulated in vitro, we 
expected Foxp4 deletion may cause increased cytokine production. Previous reports 
have demonstrated that Tregs and suppressive signals, including IL-10 and IL-27, are 
important for host survival during infection with T. gondii. Extraneous Th1 responses 
lead to increased host fatality, and aberrant Th17 responses, in IL-27-deficient animals, 
lead to increased inflammation in the CNS. However, Foxp4 cKO antigen specific 
lymphocytes exhibited reduced cytokine responses upon rechallenge. While stimulation 
with anti-CD3 generated similar quantities of cytokine detected, stimulation with STAg 
resulted in lower IFNγ and IL-17 responses. On an individual cell basis, Foxp4 cKO CD4 
and CD8 T cells were capable of producing cytokine following short-term 
pharmacological stimulation. However, lower quantities of cytokine from 24-hour 
stimulation with STAg suggest Foxp4 deficient cells are less responsive to T. gondii 
antigen. Moreover, we found a dose-dependent effect of Foxp4 expression in STAg 
responses. Foxp4 cHET mice exhibited an intermediate defect in cytokine production, 
suggesting wild-type Foxp4 expression is required for normal memory recall responses. 
We reasoned chronic infection could lead to fewer T. gondii specific effector and 
memory T cells, but limitations of antigen specific reagents in T. gondii responses 
prevented further investigation. The LCMV model of infection provides identification of 
antigen specific T cells by tetramer binding of LCMV-specific T cell clones. We found 
normal numbers of LCMV-specific CD4 and CD8 T cells in Foxp4 cKO mice after acute 
infection. However, lower frequencies of Foxp4-deficient memory CD4 T cells also 
produced cytokines during antigen specific recall responses. These data suggest Foxp4 
may not be important for maintaining the quantity of memory T cells, but rather the 
quality. 
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Foxp4 cKO studies described defects that only appear in activated T cells. 
Previous evidence supports Foxp1-dependent regulation is important for naïve T cell 
maintenance, cell survival, and IL-7R expression. Gene array data demonstrates effector 
T cells express lower levels of Foxp1 (Heng and Painter, 2008; Rudra et al., 2012), 
presumably to release Foxp1-mediated repression of effector programs. Given the high 
degree of homology between Foxp1 and Foxp4, perhaps Foxp1 is able to compensate 
for Foxp4 deletion, until Foxp1 is downregulated in effector T cells. Reduced expression 
of both FoxP members then results in dysregulation of normal T cell function. 
Binding of FoxP proteins to forkhead family members and to other transcription 
factors affords Foxp4 the opportunity to participate in a broader range of gene 
regulation. Some clues about Foxp4 regulation come from in vitro polarization studies, 
which indicate Th17 differentiation may be subtly dysregulated without Foxp4 
expression. It is particularly interesting that comparison of polarized cells with and 
without CD28 signals indicated costimulation was required to induce abnormal cytokine 
responses (data not shown), and that the resulting cKO Th17 cells produce more IL-2. 
These data suggest Foxp4 may interact with NFκB or NFAT, primary regulators of IL-2 
gene transcription. FoxP family members have been shown to directly bind both of these 
transcription factors. Therefore, Foxp4 may be important in repressing NFκB or NFAT 
gene targets. Foxp4 regulation appears to be central to Th17 programs, which suggests 
RORγT may be another factor that co-regulates with Foxp4. Alternatively, Foxp4 gene 
targets may be most accessible in the chromatin conformation of RORγT regulated loci. 
Taken together, these subtle defects invite future work to describe the Foxp4 binding 
partners and regulatory mechanisms.  
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While decreased memory responses indicate Foxp4 is important for maintaining 
T cell function, it does not exclude a role for antigen presenting cells (APCs) or natural 
killer cells. Control of chronic toxoplasmosis requires several immune cell types, and 
CD4 T cells orchestrate much of the cooperation of innate and adaptive components 
during immune responses. Expression of CD4Cre generates T lineage-specific deletion 
of Foxp4, but does not rule out a model in which the ability of CD4 T cells to influence 
the maturation and activation of accessory cell types is dependent on Foxp4 expression. 
These studies are the first to characterize expression of Foxp4 in T cells and 
report diminished effector T cell responses in infected Foxp4 cKO mice. Development of 
naïve T cells and regulatory T cells is normal in Foxp4 cKO mice, indicating Foxp4 may 
not regulate the same gene programs as FoxP family members, Foxp1 or Foxp3. 
Instead, Foxp4 expression is increased in activated T cells, and in vivo studies suggest a 
role for Foxp4 in the regulation of cytokine responses. These findings differentiate Foxp4 
from its family members, and offer another prospective area of immune regulation by 
FoxP proteins. While Foxp1 and Foxp3 are both necessary to maintain a dormant 
immune environment, Foxp4 appears to have a supportive role in maintaining protective 
immune responses. 
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CHAPTER III. 
Foxp1 and Foxp4 direct T cell fates and functions. 
 
 
Introduction  
Forkhead transcription factors of the FoxP family regulate cell fate decisions in 
immune cells. Foxp3 regulates the balance between suppressive and inflammatory Th17 
T helper lineages and provides maintenance of peripheral tolerance, while Foxp1 directs 
T cell subset development and differentiation (Feng et al., 2010; Ziegler, 2006; Ziegler 
and Buckner, 2009). Previous studies have demonstrated that Foxp1 maintains naïve 
CD44low T cell development by suppressing effector cell differentiation. Proliferation and 
survival is disrupted in Foxp1-deficient T cells due to altered responses to cytokine 
signaling (Feng et al., 2011).  
In contrast, development of T cell subsets does not appear to rely on the related 
FoxP family member, Foxp4; however, CD4 helper T cell differentiation may be altered 
without Foxp4-dependent regulation. Transcriptional regulation by Foxp4 supports long-
term immunity by maintaining memory T cell recall responses. Foxp4-deficient CD4 and 
CD8 memory T cells exhibit reduced effector function after rechallenge, specifically in 
cytokine responses (Wiehagen et al., 2012).  
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Characteristics of Foxp1 and Foxp4 protein sequences enable these FoxP 
proteins to interact with each other and potentially co-regulate genes (Li et al., 2004a). 
Additionally, homology between Foxp1 and Foxp4 suggest these transcription factors 
can possibly compensate for one another by recognizing similar consensus binding sites 
or partnering with identical transcription factors. Additional changes in gene regulation 
may occur in single cKO mice, but expression of Foxp1 in Foxp4cKO may compensate for 
loss of Foxp4. Therefore, it was unclear how combined deletion of Foxp1 and Foxp4 in 
the T lineage would affect adaptive immunity, and whether double-deficient T cells would 
reveal additional genes under FoxP regulation. 
Mice were generated in which T cells were deficient for both Foxp1 and Foxp4. 
Characterization of Foxp1/4-deficient, or cDKO, T cells is described in this chapter, 
including an extensive description of thymic development and T cell differentiation, 
survival, and cytokine production. cDKO T cell survival and development were further 
examined in competitive bone marrow chimeras to assess how cell-intrinsic Foxp1/4-
dependent regulation affects gene programs in the T lineage.  
Preliminary data suggest expression of either Foxp1 or Foxp4 is required for 
maintenance of adaptive immunity and control of infection. These data indicate Foxp1 
has exclusive gene targets important for naïve T cell maintenance, and that Foxp4 can 
partially compensate for loss of Foxp1. Additionally, expression of one allele of Foxp1 is 
sufficient for normal lymphocyte development and function. Together, these findings 
inform models of Foxp1 and Foxp4 regulation in T cells. 
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Results 
Generation of Foxp1/Foxp4 conditional double knockout mice.  
To generate mice in which the T lineage is selectively deleted for Foxp1 and 
Foxp4, we crossed Foxp1FLOX/FLOX, previously described (Feng et al., 2010; Li et al., 
2012), and Foxp4FLOX/FLOX mice to generate Foxp1FLOXFoxp4FLOX mice, which express all 
four mutant alleles (Figure 3.1A). Foxp1FLOXFoxp4FLOX offspring were crossed with 
transgenic mice expressing Cre on the cd4 promoter, as discussed in Chapter 2, to 
produce CD4Cre+ Foxp1FLOXFoxp4FLOX (cDKO) mice. Throughout these studies, deletion 
of Foxp1 and Foxp4 in cDKO mice was compared to deletion of Foxp1 or Foxp4 in 
single cKO mice (Foxp1cKO and Foxp4cKO, respectively). Wild-type mice expressing 
CD4Cre (CrePOS) served as Cre controls.  
 
 
Table 3.1. Generation of cDKO mice and littermate controls. Solid boxes represent 
expression of Foxp1 (blue) or Foxp4 (green) wild-type alleles. Hatched boxes represent 
deletion after Cre-mediated recombination. Each row represents Foxp1/4 expression 
patterns in one genotype, specified in the left column. The remaining FoxP genes 
expressed after deletion are included in the right column. 
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Our breeding strategy also generated littermates in which combinations of floxed 
or wild-type Foxp1 and Foxp4 genes were expressed. We examined littermates in which 
one allele of each FoxP member was deleted (Foxp1FLOX/+Foxp4FLOX/+CD4Cre+; 
conditional double heterozygote, or cDHET). Offspring also included mice with one allele 
of Foxp1 and two alleles of Foxp4 (Foxp1FLOX/+Foxp4FLOX/FLOX, or 1H4K), and mice 
expressing both alleles of Foxp1 and one allele of Foxp4 (Foxp1FLOX/FLOXFoxp4FLOX/+, or 
1K4H). Inclusion of 1H4K and 1K4H mice, in which three of the four genes are deleted, 
enabled evaluation of allelic series of Foxp1 and Foxp4 expression, and definition of the 
contribution of both genes in dose-dependent settings. Unless otherwise stated, the 
studies described in this chapter included four- to eight- week-old cDKO mice with 
littermate controls. 
Deletion of FoxP family members was verified by quantitative real-time PCR. 
CD4+ TCR+ mature single positive thymocytes were sorted from cDKO or wild-type 
thymi. Transcript levels of Foxp1 and Foxp4 were determined in wild-type and cDKO T 
cells and normalized to internal β-actin levels. In cDKO thymocytes, relative expression 
Foxp1 and Foxp4 was at least ten-fold less than wild-type thymocytes, and in some 
experiments, below the limits of detection (Figure 3.1B-C, and data not shown). 
Successful deletion of Foxp1 and Foxp4 was satisfactory, and allowed further work to 
survey the effects of FoxP deletion in the T lineage.  
	  
	   56	  
	  
Figure 3.1. Generation of cDKO mice. A) Schematic of breeding strategy to produce 
offspring expressing engineered Foxp1FLOX and Foxp4FLOX alleles, and CD4-Cre. 
Foxp1FLOX and Foxp4FLOX alleles are similarly designed to eliminate DNA encoding the 
forkhead DNA-binding domain (FOX). Exons are denoted by black rectangles. Exons 11 
and 12 in the Foxp1 gene encode the FOX domain and are flanked with LoxP sites (red 
triangles). The Foxp4 FOX domain is eliminated by excising exons 12 and 13. Cre 
expression begins at the DP stage of thymocyte development. B-C) Relative expression 
of Foxp1 (B) and Foxp4 (C) mRNA transcript detected in highly-purified CD4SP 
thymocytes by real-time PCR. Expression is relative to wild-type C57Bl/6 CD4SP cells. 
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Foxp1 and Foxp4 in thymic development.  
To assess the effect of Foxp1/4 deletion on T cell development, we initially 
characterized thymocyte development, where Cre expression is induced. DP and SP 
thymocytes were detected in all cohorts but total thymic cellularity was reduced in cDKO 
mice compared to Foxp4 and CrePOS mice (Figure 3.2A). On average, cDKO thymi were 
one-third smaller than CrePOS thymi (Figure 3.2B). Less significant differences were 
observed between cDKO and other littermate cohorts, although both Foxp1cKO and 
cDKO trended toward reduced numbers in comparison to cDHET and Foxp4cKO. 
Importantly, cDHET thymi were comparable to Foxp4 and CrePOS numbers, indicating 
haploinsufficiency of Foxp1 and Foxp4 did not affect thymic development.  
	  
Figure 3.2. Reduced thymic cellularity in Foxp1cKO and cDKO mice. A) 
Representative plots of developing DP, CD4SP and CD8SP thymocytes in CrePOS, 
Foxp1cKO, Foxp4cKO or cDKO mice. B) Abolute cell numbers of total thymi compiled from 
16 experiments, comparing multiple mouse cohorts. CrePOS thymic cellularity was 
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compared to littermates expressing four, two, or one wild-type copy of either Foxp1 or 
Foxp4. Each point represents an individual mouse. Statistical analyses were determined 
by one-way ANOVA with Dunnett post-test. p values are denoted above. All other 
comparisons were not statistically significant. 
 
In wild-type thymi, 75%-85% of the thymus consists of CD4+CD8+ DP cells. In 
cDKO mice, the reduced frequency and number of DP accounted for the decreased 
thymic cellularity (Figure 3.3A-B). Foxp1 deletion resulted in similarly reduced numbers 
of DP in Foxp1cKO and 1K4H thymi, suggesting that Foxp1 deletion in these cohorts 
affected DP development. Expression of at least one allele of Foxp1 was sufficient for 
normal DP numbers, as the number of DP cells in thymi from cDHET, Foxp4cKO, and 
1H4K mice were comparable to thymi from CrePOS mice (data not shown). 
Further characterization of DP thymocytes indicated developmental differences 
between CrePOS, Foxp1cKO, and cDKO mice, suggesting altered TCR signaling. DP 
thymocytes can be divided into immature and mature populations based on the 
expression of TCRβ, CD69, and CD5. Relatively normal frequencies of immature and 
mature DP thymocytes were detected in Foxp1cKO and cDKO thymi (data not shown). 
However, significantly increased expression of CD5 was consistently detected in DP 
thymocytes from cDKO mice compared to other cohorts (Figure 3.3C-D).  
CD5 is a cell surface protein that associates with TCR complexes containing 
TCRβ, CD3, and CD28 (Raman, 2002). Expression of CD5 typically correlates with TCR 
signaling strength, which has important implications for the negative selection of 
developing thymocytes (Kishimoto and Sprent, 2000). CD5 inhibits TCR signaling, and 
earlier reports suggested CD5 regulates TCR tuning during thymocytes maturation. 
Increased levels of CD5 expression denoted altered thymic selection. (Azzam et al., 
2001). To determine whether thymic selection was dysregulated in cDKO mice, the Vβ 
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usage of CD4SP and CD8SP cDKO thymocytes was compared in cDKO, single cKO, 
and Cre control mice (Figure 3.3E). Thymic selection was not grossly affected in cDKO 
mice, as the usage of Vβ families in both CD4SP and CD8SP populations was 
comparable to that observed in CrePOS mice. The development of polyclonal SP cells 
allowed us to assess T cell development in Foxp1 and Foxp4 mutants more thoroughly. 
 
	  
Figure 3.3. Foxp1/4 deletion alters CD5 expression and DP cellularity but not SP 
polyclonality. A-B) Absolute number (A) and frequency (B) of DP thymocytes compiled 
from 16 experiments. Compared to CrePOS littermate controls, number and frequency of 
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cDKO DP are significantly reduced. Each point represents an individual mouse. C) 
Representative staining of cell surface expression of CD5 on DP from CrePOS (gray 
histogram), Foxp1cKO (black line) Foxp4cKO (dotted black line), or cDKO (red line). D) 
Relative fold change in mean fluorescence intensity of CD5 staining compiled from 5 
experiments. Black dotted line represents average of CrePOS littermate controls to which 
all cohorts were relative. A-D) Statistical analyses by one-way ANOVA with Dunnett 
post-test. *p<0.05; Significant p values are shown, all other comparisons were not 
statistically significant. E) TCR Vβ usage across eight Vβ families by CD4SP thymocytes 
in Cre control (gray), Foxp1cKO (white) or cDKO (red) thymocytes. Frequencies 
calculated from percentage of cells expressing individual Vβ+ chains as a fraction of the 
total CD4SP population. 
 
Our findings show that thymic development generally remained intact in the 
absence of Foxp1 and Foxp4 expression. CD4SP and CD8SP thymocytes develop in 
cDKO thymi, demonstrating that Foxp1/4 deletion in DP thymocytes did not cause a 
block in SP thymocyte generation (Figure 3.1A). Mature cDKO TCRβ+ CD4+ SP and 
CD8+ SP thymocytes were present at typical ratios of CD4SP to CD8SP thymocytes 
observed in wild-type and CrePOS mice (data not shown). Similarly, CD4SP and CD8SP 
thymocytes were detected in thymi from CrePOS, cDHET, 1H4K, and 1K4H mice (data 
not shown), indicating that Foxp1 or Foxp4 expression is not required for CD4 and CD8 
SP thymocyte generation.  
Numbers of CD4SP or CD8SP thymocytes were comparable regardless of the 
expression of various combinations of Foxp1 and Foxp4 (Figure 3.4A-B). Therefore, our 
data demonstrate that Foxp1 and Foxp4 were not required individually or together for 
generation of TCRβ+ CD4 or CD8 SP. However, an increased percentage of total cDKO 
thymocytes were CD4SP (Figure 3.4C). On average, cDKO CD4SP comprised 11% of 
total thymocytes, compared to approximately 7% of total thymocytes in control thymi. In 
contrast, frequencies of CD8SP and DN were not significantly different in cDKO thymi 
(data not shown). While this increase in relative CD4SP frequency correlated to 
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decreased DP frequency, relative frequencies of CD8SP were unchanged, indicating 
that Foxp1 and Foxp4 expression may function differently in CD4 and CD8 SP lineages. 
 
	  
Figure 3.4. Normal numbers of SP thymocytes develop in cDKO mice. A-B) 
Absolute number of A) CD4SP and B) CD8SP thymocytes across CrePOS, Foxp1 cKO or 
Foxp4cKO, cDKO, and littermate control cohorts compiled from 16 experiments. C) 
Compiled frequency of CD4+CD8- SP thymocytes of total thymi. Cells expressing 
CD11b, CD11c, Mac-1 Gr-1, or B220 were gated out prior to CD4SP frequency 
determination. Each point represents an individual mouse. Statistical analysis by one-
way ANOVA with Dunnett post-test. 
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FoxP members maintain peripheral CD4 and CD8 T cell number 
We next assessed how deletion of Foxp1 and Foxp4 affected peripheral T cells. 
No differences in spleen cellularity were observed across any of the littermate cohorts, 
and no overt signs of pathology were detected (data not shown). However, frequencies 
of TCRβ and B220+ cells were altered in cDKO mice. Significantly fewer TCRβ+ 
lymphocytes were found in the spleens of cDKO mice, compared to age-matched 
CrePOS, single cKO, and littermate controls (data not shown). In cDKO mice, the 
frequency of TCRβ+ splenocytes averaged 5%-10%, while the frequency of TCRβ+ 
averaged 30%-40% in littermate controls. Total T cell numbers were reduced in other 
peripheral tissues as well. Peripheral blood, bone marrow, and pooled lymph nodes (LN) 
contained reduced frequencies and numbers of TCRβ+ cells in cDKO mice, suggesting 
T lymphopenia extended to other peripheral lymphoid tissues (data not shown).  
To determine which populations within the T compartment are affected by FoxP 
protein deletion, the frequency and numbers of CD4 and CD8 T cells in peripheral 
lymphoid tissues were compared across all cohorts (Figure 3.5). Foxp1 deletion alone 
resulted in reduced CD8 T cells in peripheral tissues (Figure 3.5B, D). In both lymph 
nodes and spleen tissues, the relative percentage and total number of CD8 T cells were 
significantly reduced compared to CrePOS controls. In contrast, CD4 T cells in Foxp1cKO 
spleen and LN were comparable to control mice. Together, these data suggest Foxp1 is 
not necessary to maintain CD4 T cells. However, expression of at least one allele of 
Foxp1 is necessary for CD8 T cell maintenance. 
Combined deletion of both Foxp1 and Foxp4 resulted in more severe T 
lymphopenia in both LN and spleen compared to Foxp1cKO mice. Although SP thymocyte 
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numbers in the cDKO thymus were comparable to SP thymocyte numbers in control 
thymi, the total number and frequency of CD4 and CD8 T cells in cDKO peripheral 
tissues were significantly lower compared to littermate controls. (Figure 3.5A, C, and 
data not shown). 1K4H mice exhibited an intermediate defect with CD4 and CD8 T cell 
numbers falling between the average cellularity in Foxp1cKO and cDKO mice.  This gene 
dosage effect of Foxp4 deletion suggests that T cells require FoxP members for normal 
peripheral homeostasis. Additionally, in the absence of Foxp1, Foxp4 expression may 
play a role in maintaining the T lymphocyte compartment. 
In cDKO mice, T cell numbers were more diminished in LN than in the spleen 
(Figure 3.5A-B). Numbers of cDKO CD4 T cells in pooled LN were a 100-fold lower than 
CrePOS mice. On average, we observed less than one million CD8+ T cells in the pooled 
LN of cDKO mice—almost ten times lower than the average number of CD8 T cells in 
the pooled LN from Cre control mice. In the spleen, however, cell numbers are less than 
one fold lower than littermate controls. Thus, there are more striking differences between 
cDKO and littermate controls in lymph nodes than in the spleen, indicating that anatomic 
location may also play a role in cDKO T cell maintenance.  
In comparison, littermate controls, including cDHET, Foxp4cKO, and 1H4K mice 
had similar numbers and frequencies of peripheral CD4 and CD8 T cells in the LN and 
spleen. Expression of one allele of Foxp1 was sufficient to provide normal T cell 
development. Together, these data demonstrate that the deletion of Foxp1 in the T 
lineage results in overall decreased T cell numbers in peripheral lymphoid tissues, 
affecting CD8 T cell cellularity. Combined deletion of Foxp1 and Foxp4 significantly 
exacerbates T lymphopenia and affects both CD4 and CD8 T cell numbers. 
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Figure 3.5. Reduced cDKO CD4 and CD8 T cells contribute to significant T 
lymphopenia. A, C) Representative plots of CD4 and CD8 T cells from pooled lymph 
nodes (A) or spleen (C) from CrePOS, Foxp1cKO, Foxp4cKO, cDKO mice. Frequencies 
correspond to CD4+ or CD8+ T cells. B, D) Absolute numbers of CD4 (left) or CD8 
(right) T cells. Each point represents an individual mouse. B) LN numbers compiled from 
6 experiments. **p<0.005 ***p<0.0001. D) Spleen numbers compiled from 16 
experiments. **p<0.05 ***p<0.001. 
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CD44 expression is regulated by Foxp1 but not Foxp4.  
In Chapter 2, we demonstrated Foxp4 deletion does not affect the phenotype of 
developing SP thymocytes. In contrast, previous studies have shown that Foxp1cKO 
thymocytes develop abnormally and acquire CD44 expression upon SP maturation 
(Feng et al., 2010). Therefore, we sought to determine whether deletion of both Foxp1 
and Foxp4 altered expression of CD44 or other cell surface markers.  
Compared to CrePOS or Foxp4-deficient T cells, cDKO T cells express altered 
levels of cell surface markers. In the thymus, CD44 expression by cDKO CD4SP and 
CD8SP thymocytes was similar to Foxp1cKO SP thymocytes, indicating Foxp1 expression 
is necessary to repress CD44 upregulation (Figure 3.6A). Comparison of CD44 profiles 
across all littermates clearly showed that expression of at least one allele of Foxp1 is 
sufficient for repressing CD44 expression. These results indicate that Foxp4 expression 
has no effect on aberrant expression of CD44 on SP thymocytes in Foxp1cKO or cDKO 
mice. Thus, regulation of CD44 expression in thymocytes represents a non-overlapping 
role of Foxp1 and Foxp4 in thymic development. 
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Figure 3.6. cDKO SP thymocytes and splenic T cells express T cell signaling 
proteins and markers of activation. A) CD4SP (top panels) and CD8SP (bottom) 
thymocytes from CrePOS (solid histograms), Foxp1cKO (black line), Foxp4cKO (black dotted 
line), cDKO (red line) express comparable levels of TCRβ, CD28 (left panels). Foxp1cKO 
and cDKO SP thymocytes express abnormal levels of CD44. B) Representative plots of 
CrePOS, cDKO, and single cKO CD4 (top) and CD8 (bottom) T cell expression of markers 
of activation: CD44 and CD62L.  
 
cDKO CD4 and CD8 T cells acquire an effector memory phenotype. 
As observed in the thymus, Foxp1cKO and cDKO T cells are CD44hi in both spleen 
and LN. In addition to CD44, expression of CD62L is altered in both CD4 and CD8 
cDKO T cells. In CrePOS and Foxp4cKO mice, 75%-90% of CD4 and CD8 T cells are 
CD62Lhi naïve lymphocytes. In general, we observed that 70%-85% of Foxp1cKO CD4 
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and CD8 T cells are 70%-85% CD62Lhi, resembling a central memory (CM) phenotype. 
In contrast, approximately 10% of cDKO CD4 T cells are CD62Lhi CM, and 90%-95% 
CD4 T cells are CD62Llow (Figure 3.6B, top panels). CD62L expression in cDKO CD8 T 
cells is slightly different than CD4 T cells. CD8 T cells isolated from the spleen and LN of 
cDKO mice are 50%-70% CD62Llow (Figure 3.6B bottom panels, and data not shown). 
Taken together with the CD44hi phenotype, the vast majority of CD4 and CD8 cDKO T 
cells exhibit an effector memory CD44hiCD62Llow phenotype.  
 
Loss of Foxp1/4 results in systemic T lymphopenia. 
We reasoned it was possible the T lymphopenia we perceived in lymphoid 
tissues was actually due to changes in T cell migration. CD62L, or L-selectin, is 
responsible for trafficking of T cells into spleen and LN (Arbones et al., 1994). We 
investigated whether the total cDKO T cell population were intact but CD62Llow T cells 
were merely retained in peripheral tissues and excluded from total T cell numbers. To 
test this hypothesis, the frequency and numbers of T cells were calculated in multiple 
tissues in cDKO mice. An extensive systemic evaluation revealed reduced frequencies 
and numbers of T cells throughout cDKO tissues. T cells numbers in the lung, liver, 
peritoneal cavity, Peyers patches, mesenteric lymph nodes, the lamina propria of the 
small intestine and large intestine, blood, bone marrow, and skin were detected. Greater 
differences were found in the fold change and number of cDKO CD4 T cells than in CD8 
(Figure 3.7). Compared to CrePOS controls, frequencies and numbers of cDKO CD4 and 
CD8 T cell were significantly reduced. However, no tissues resembled a specific cDKO 
CD4 or CD8 T cell reservoir, to which peripheral lymphocytes migrate in cDKO mice. 
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Therefore, T cells are not selectively trafficking to extra-lymphoid tissues due to 
dysregulated CD62L expression; instead, cDKO mice exhibit systemic T lymphopenia. 
 
Figure 3.7. Reduced cDKO CD4 and CD8 T cells were detected in multiple tissues 
A-B) Percentage of conventional Foxp3- CD4 T cells (A) or (B) CD8 T cells, portrayed as 
fold change relative to CrePOS littermate controls. Fold changes of CD4 or CD8 T cells 
were assessed in bone marrow (BM), thymus (Thy), spleen (Spl), pooled axillary, 
cervical and inguinal lymph nodes (LN), peripheral blood, liver, lung, peritoneal exudate 
cells (PECs), skin, pooled mesenteric lymph nodes (mLN), pooled Peyers patches (PP), 
small intestine lamina propria (SI), or lamina propria of large intestine (colon). Mean and 
standard deviation calculated from three independent experiments.  
 
Lymphopenia can induce T cell proliferation and differentiation due to excess 
cytokine availability, which can stimulate the expansion of both CD4 and CD8 T cells. 
Expanded T cells assume a memory-like phenotype, including increased CD44 
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whether cDKO lymphocytes exhibited lymphopenia-induced proliferation and were 
proliferating abnormally in vivo, we assessed turnover using Ki-67, a cytoplasmic marker 
of cell cycle. Frequencies of Ki-67+ CD4 and CD8 splenocytes were comparable 
between cDKO and Cre control mice; importantly, there was also no difference when 
comparing CD44hi populations, which typically include expanding cells (data not shown). 
Because CrePOS mice are not lymphopenic, these data suggest CD44hi cDKO T cells are 
circulating in lymphopenic physiologic conditions, but do not exhibit increased 
lymphopenia-induced proliferation. However, we have not excluded other explanations 
for normal Ki-67 staining, such as cell-extrinsic effects or simply increased death of 
dividing cDKO cells. Taken together, these data indicated cDKO T cells were detected in 
reduced numbers and acquired altered expression of cell surface proteins associated 
with activation. However, double knockout cells failed to proliferate as would be 
expected of lymphocytes in lymphopenic conditions. 
 
Cell-intrinsic regulation of T cell development by FoxP proteins. 
In cDKO mice, young mice exhibited substantial T lymphopenia, and the 
remaining T cells exhibited an effector memory CD44hiCD62Llow phenotype. To assess 
whether the T cell phenotype in cDKO mice is caused by loss of Foxp1/4 expression, or 
an effect of increased lymphopenia, we generated competitive bone marrow chimeras. 
Briefly, bone marrow from cDKO mice and from congenically marked wild-type mice was 
mixed in a 90:10 ratio, respectively, to give cDKO progenitors an advantage during 
reconstitution of lethally irradiated congenically unique host mice (Figure 3.8A). 
cDKO:WT chimeras were compared to similarly generated chimeras given CrePOS, 
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Foxp1cKO, or Foxp4cKO bone marrow. Eight weeks after reconstitution, T cell generation 
in the chimera cohorts was examined.  
After reconstitution, the frequency of wild-type CD45.1+ and donor-derived 
CD45.2+ B cells in bone marrow was determined (Figure 3.8B and data not shown). B 
cells are not affected by CD4Cre, and therefore should represent wild-type- and donor-
derived populations from grafted bone marrow progenitors. Across three independent 
experiments the ratio of CD45.1+ and CD45.2+ B cells and other myeloid populations in 
bone marrow and spleen were approximately 90:10, allowing further examination of the 
effects of Foxp1 and Foxp4 deletion on T cell development in a competitive system. 
 
Figure 3.8. Schematic of generation of competitive bone marrow chimeras. A) 
Schematic diagram of mixed bone marrow chimera generation. B) Chimerism of 
CD45.2+ (white) and CD45.1+ (gray) cells gated from CD19+ B cells in bone marrow of 
host mice reconstituted with CrePOS, Foxp1cKO, Foxp4cKO, or cDKO bone marrow in 
Compiled from five mice in each cohort. 
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Deletion of FoxP proteins did not inhibit T cell generation, as mature DP and SP 
thymocytes develop at approximately the expected ratio in competitive chimeras (Figure 
3.9A). The relative contribution of cDKO and wild-type progenitors to DP, CD4SP and 
CD8SP thymocyte populations was calculated from the ratio of CD45.2+ and CD45.1+ 
cells in each population (Figure 3.9B). Chimerism of developing thymocyte populations 
was approximately the expected 90:10 ratio across all mixed bone marrow chimera 
cohorts.  
 
Figure 3.9. Competitive development of cDKO DP and SP thymocytes in mixed 
bone marrow chimeras. A) Representative plots of thymocytes gated on CD45.2+ or 
CD45.1+ expression, then for CD4 and CD8 expression to determine DP, CD4SP and 
CD8SP populations. Numbers indicate frequency of gated cells. B) Compiled chimerism 
of indicated populations. Average and standard deviation of the frequency of CD45.2+ 
and CD45.1+ thymocytes comprising total DP, CD4SP or CD8SP populations.  
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Although SP thymocytes exhibited comparable chimerism, Foxp1 or Foxp4 
deletion conferred competitive disadvantages in peripheral lymphoid tissues of mixed 
chimeras.  CD45.2+ CD4 and CD8 T cells were detected in peripheral tissues of single  
(Foxp1- or Foxp4-deficient) and double knockout mixed chimeras. However loss of 
Foxp1 or Foxp4 resulted in significantly reduced frequencies compared to CrePOS 
controls (Figure 3.10A, B). CrePOS CD4 and CD8 splenic T cells develop normally, but 
loss of either Foxp1 or Foxp4 resulted in decreased competitive chimerism from 9:1 to a 
1:1 ratio of CD45.2+ Foxp1cKO or Foxp4cKO to CD45.1+ WT. Combined deletion of Foxp1 
and Foxp4 resulted in the greatest disadvantage. CrePOS chimeras exhibited 
approximately 3:1 CrePOS:WT T cells in splenic populations, perhaps due to the effects of 
Cre expression, which can become toxic. In contrast, cDKO chimeric splenic ratios were 
inverted, and averaged approximately 1:3 cDKO:WT T cells.  
Similar to findings in non-chimeric mice, CD45.2+ cDKO T cells are found in 
lower frequencies in chimeric LN than in spleen. (Figure 3.10C, D). Inguinal, axillary, and 
brachial lymph nodes were pooled to assess the contribution of cDKO T cells in LN from 
cDKO:WT chimeras. cDKO CD4 T cells were vastly outnumbered by WT lymphocytes. 
In contrast to the 3:1 ratio of CD45.2+:CD45.1+ T cells in control chimeric LN, CD4 T 
cells averaged 1:12 cDKO:WT (Figure 3.7C). Similarly, cDKO CD8 T cells constitute 
only 10%-12% (or ~1:10) of all LN CD8s, while CrePOS controls averaged >70% 
chimerism (Figure 3.10D). Therefore, CD4 and CD8 cDKO T cells are not only reduced 
compared to endogenous WT populations, but also compared to cDKO T cells in 
chimeric spleens. These data recapitulate reduced cDKO cell numbers in the LN and 
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spleen of non-chimeric mice, and demonstrate cell-intrinsic FoxP-protein regulation of 
competitive T cell development and maintenance. 
 
Figure 3.10. Foxp1cKO- or cDKO-derived CD4 and CD8 T cells have a 
developmental disadvantage in peripheral lymphoid tissues in competitive bone 
marrow chimeras.  A-B) Average chimerism of splenic CD4 (A) or CD8 (B) T cells. 
Frequency of CD45.2+ and CD45.1+ cells gated comprising chimeric populations was 
averaged from 15 CrePOS, 10 Foxp1cKO, 10 Foxp4cKO, and 15 cDKO bone marrow 
chimeras. Standard deviation denoted by +/- error bars. C-D) Average chimerism was 
similarly calculated as A-B) from T cell populations in pooled axillary, brachial, and 
inguinal lymph nodes from mixed bone marrow chimeras. Mean and standard deviation 
is shown. 
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Foxp1cKO:WT and cDKO:WT chimeras, endogenous wild-type-derived thymocytes 
remained CD44low, which demonstrates the dysregulation of CD44 in Foxp1cKO and 
cDKO mice is specific to T cells lacking Foxp1. Therefore, dysregulated CD44 
expression is a cell-intrinsic finding in Foxp1-deficient cells, which occurs independently 
of Foxp4 expression. 
In competitive bone marrow chimeras, lymphopenia does not develop. 
Developing wild-type cells simultaneously fill the homeostatic niche in peripheral 
lymphoid tissues, which prevents the development of lymphopenia. Generation of 
cDKO:WT bone marrow chimeras allowed us to assess whether the CD62Llo effector 
memory T cell phenotype observed in non-chimeric cDKO mice was caused by T 
lymphopenia and lymphopenia-induced proliferation. The cell surface phenotype of 
peripheral T cells in mixed bone marrow chimeras was compared to endogenous WT 
competitor cells and to CD45.2+ cells in other cohorts.  
Like non-chimeric mice, Foxp1cKO and cDKO T cells in the spleens and LN of 
chimeric mice are CD44hi. These data demonstrated that cDKO T cells are not merely 
lymphopenia-induced memory-like cells, but maintain the CD44hi phenotype observed in 
non-chimeric mice. Furthermore, cDKO CD4 and CD8 T cells express reduced CD62L, 
as observed in non-chimeric cDKO mice (Figure 3.11B). cDKO-derived CD4 T cells are 
consistently 90-95% CD44hiCD62Llow in cDKO:WT chimeras, and 40-60% of chimeric 
cDKO CD8 T cells are CD62Llow. Moreover, T cells in peripheral LN, blood, bone marrow 
and mesenteric LN retained an EM phenotype (data not shown). Therefore, combined 
deletion of Foxp1 and Foxp4 results in an effector memory T cell phenotype, and 
significant defects in peripheral lymphocyte competition. The phenotypic and competitive 
	   75	  
defects described in this section are caused by cell intrinsic dysregulation and by loss of 
transcriptional regulation by Foxp1 and Foxp4. 
 
Figure 3.11. Expression of effector memory cell surface markers are intrinsically 
regulated by Foxp1 and Foxp4. A) Representative staining of CD44 expression on 
CD4SP (left) and CD8SP (right) from CD45.2+ CrePOS (gray histogram), Foxp1cKO (black 
line), Foxp4cKO (dotted line), or cDKO (red line). Representative of at least 5 chimeras in 
each cohort. B) Representative staining of CD44 and CD62L expression on CD4 (top 
panels) or CD8 (bottom) splenic T cells from CrePOS:WT, Foxp1cKO:WT, Foxp4C+:WT or 
cDKO:WT competitive bone marrow chimeras. CD45.2+ experimental CD4 or CD8 T 
cells were gated and overlaid with respective endogenous CD45.1+ wild-type T cells 
from each mouse. Flow plots representative of 15 CrePOS:WT, 9 Foxp1cKO:WT, 10 
Foxp4cKO:WT, and 15 cDKO:WT chimeras. 
 
Foxp1 regulates T cell effector functions. 
The CD44hi memory phenotype is associated with increased effector activity in T 
cells (Goldrath et al., 2000; van Leeuwen et al., 2009). Cytokine production is a key 
effector function of the adaptive immune system. To investigate how Foxp1 and Foxp4 
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regulate cytokine production in CD44hi CD4 and CD8 T cells, splenocytes from cDKO 
mice and littermate controls were stimulated with phorbol myristate acetate (PMA) and 
ionomycin immediately ex vivo. Monensin was added to prevent cytokine export. After a 
four-hour stimulation, cells were stained intracellularly for production of interferon 
gamma (IFNγ), tumor necrosis factor alpha (TNFα), interleukin-2 (IL-2), and interleukin-
17 (IL-17). 
 
Foxp1 regulates cytokine responses in CD4 T cells. 
We first assessed cytokine production in stimulated T cells. To control for 
frequencies of CD44hi T cells in Foxp1cKO and cDKO mice, all samples were previously 
gated on CD44hi T cells. Foxp1cKO CD4 T cells exhibited significantly decreased IFNγ 
production, and three-fold increased frequencies of IL-2-producing CD4 T cells (Figure 
3.12A-C). These findings agree with the initial studies of Foxp1, which demonstrated this 
forkhead protein represses IL-2 gene expression by directly binding the il2 promoter 
(Wang et al., 2003). Subsequent work by Feng, et al, first demonstrated IFNγ production 
was dysregulated in Foxp1-deficient CD4 T cells (Feng et al., 2010). Abnormal IFNγ and 
IL-2 production by Foxp1cKO CD4 T cells was also observed throughout our studies. 
These findings were extended to include TNFα and IL-17 production. The 
frequency of TNFα-producing CD4 T cells from Foxp1cKO mice is also increased two-fold 
relative to CrePOS and Foxp4cKO CD4 T cells (Figure 3.12A, compiled data not shown). 
Additionally, the frequency of TNFα+IL2+ T cells is increased compared to Cre controls 
(Figure 3.14A bottom panels, and data not shown), suggesting Foxp1cKO T cells exhibit 
increased polyfunctionality. 
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Production of IFNγ and IL-17 is regulated by independent transcription factors, 
which antagonize one another. We reasoned loss of IFNγ production in Foxp1cKO T cells 
could be caused by dysregulated differentiation into IL-17-producing T helper 17 (Th17) 
CD4 T cells. In Th17 cells, RORγT silences Th1 transcription factors responsible for 
IFNγ production. To test whether the majority of Foxp1cKO CD4 T cells have acquired 
Th17 function, we assessed IL-17 production immediately ex vivo. Similar to IFNγ 
production, IL-17 responses are significantly reduced in Foxp1cKO mice. Therefore, 
Foxp1 does not appear to suppress Th17 differentiation in CD4 T cells, and loss of IFNγ 
production is not a result of aberrant T helper differentiation. 
In contrast, Foxp4 deletion alone did not produce the same defects. CD44hi 
Foxp4cKO CD4 T cell cytokine responses were similar to CrePOS controls, indicating initial 
regulation of effector functions does not require Foxp4-dependent transcriptional 
regulation (Figure 3.12A-B). Furthermore, there were no significant differences between 
CD44hi CD4 T cell responses from CrePOS, cDHET, or 1H4K mice (data not shown).  
Reduced IL-17 production in Foxp4cKO T cells relative to CrePOS controls was also 
observed (Figure 3.12D). In Chapter 2 we assessed Th17 lineage commitment in 
polarized Foxp4cKO T cells, and found indications that Foxp4 may repress IL-17 and IL-2 
production. In contrast, these experiments represent the frequency of natural Th17 cells 
immediately ex vivo. Together, these data indicate FoxP members may be important for 
generation of natural Th17 cells as well as Th17 differentiation of effector cells in vitro. 
Whether Foxp4 contributed to effector gene regulation in Foxp1-deficient T cells 
remained unclear. To assess the effects of Foxp4 gene dosage on Foxp1cKO T cell 
effector functions, stimulated splenocytes from Foxp1cKO, 1K4H, and cDKO mice were 
compared (Figure 3.12B-D).  Deletion of Foxp1 in combination with loss of one or both 
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alleles of Foxp4 does not alter the Foxp1cKO profile of cytokine production. cDKO T cell 
cytokine responses resemble Foxp1cKO patterns. 1K4H cells reiterated the same 
dysfunctional cytokine profile as Foxp1cKO and cDKO cells. These data suggest that 
Foxp4 does not compensate for loss of Foxp1 in the regulation of cytokine programs. 
Foxp1 deletion elicits a dominant effector phenotype, regardless of Foxp4 expression.  
 
Figure 3.12. Foxp1, but not Foxp4, regulates IL-2 and IFNγ production by CD4 T 
cells. A) Representative plots of splenic CD4 T cells from cDKO and littermate controls. 
Splenocytes were stimulated in vitro with PMA and Ionomycin and stained intracellularly 
for cytokine production. B-D) Compiled frequencies of CD4 T cells producing B) IFNγ, C) 
IL-2, or D) IL-17 immediately ex vivo. Results from three independent experiments. 
 
To determine whether altered cytokine production is caused by cell intrinsic 
defects in Foxp1-deficient lymphocytes, splenocytes from mixed bone marrow chimeras 
were stimulated ex vivo as described above. In competitive chimeras, nearly the same 
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pattern of cytokine expression develops. A higher frequency of CD45.2+ CD4 Foxp1- or 
cDKO-derived T cells produced TNFα, while IFNγ+ cells were essentially undetected 
(Figure 3.13A, and data not shown). Frequencies of IFNγ-producing CD4 T cells were 
comparable in CD45.2+ CrePOS, Foxp4cKO, and respective CD45.1+ wild-type controls 
(Figure 3.13B and data not shown). These findings indicate Foxp1 regulation of IFNγ is 
part of a cell-intrinsic program. IL-2 regulation is also an intrinsic effect of Foxp1 
regulation. The frequency of IL-2-producing cDKO-derived CD4 T cells was increased 
two-fold compared to CrePOS wild-type endogenous CD4 T cells. (Figure 15C, and data 
not shown).  
Interestingly, TNFα expression may reflect cytokine regulation by extrinsic 
pressure in non-chimeric cDKO mice. In mixed chimeras, the proportion of TNFα+ cDKO 
T cells was increased compared to endogenous wild-type cells, but not as strikingly as 
observed in non-chimeric responses. Moreover, CD45.2+ cDKO TNFα production was 
relatively comparable to that of CrePOS cells in CrePOS:WT chimeras (Figure 3.13D and 
data not shown). Therefore, TNFα production may be regulated by non-cell-autonomous 
mechanisms in Foxp1cKO and cDKO mice. 
Therefore, these data suggest Foxp1 normally represses IL-2 production, and 
induces IFNγ and IL-17. Together with non-chimeric cDKO CD4 T cell responses, we 
can conclude that loss of Foxp1, and not Foxp4, is responsible for dysregulation of 
several cytokine genes in CD4 effector cells.  
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Figure 3.13. Altered CD4 T cell cytokine production reflects cell-intrinsic Foxp1-
dependent regulation of IFNγ and IL-2. A) A) Representative plots of chimeric 
splenocytes stimulated immediately ex vivo and stained intracellularly for IFNγ and TNFα 
production. Plots are gated on CD45.2+ cells from a representative CrePOS:WT or 
cDKO:WT competitive chimera. Numbers in each quadrant represent relative frequency. 
B) Relative frequency of IFNγ-producing CD4 T cells from CrePOS:WT or cDKO:WT 
chimeras, compiled from two independent experiments. Each point represents cells 
gated on CD45.2+ (CrePOS or cDKO) or CD45.1+ (endogenous wild-type cells) from each 
chimera. C-D) Compiled relative frequencies of C) IL-2-producing or D) TNFα-producing 
CD45.2+ cDKO or CrePOS CD4 splenic T cells from chimeric mice. Each point represents 
one competitive chimera. Combined from two independent experiments.  
 
Effects of Foxp1 and Foxp4 deletion on cytokine responses in CD8 T cells.  
We next determined how Foxp1 and Foxp4 deletion affected CD8 T cell cytokine 
production. Stimulation of CD8 T cells reveals substantial differences in FoxP family 
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member regulation, compared to CD4 T cell function. In CrePOS, Foxp4cKO, 1H4K, and 
cDHET controls CD44hi CD8 T cells exhibited similar production of IFNγ, IL-2, TNFα, or 
IL-17 (Figure 16A and data not shown). Unlike Foxp1cKO responses in CD4 T cells, IFNγ 
and IL-2 production by Foxp1cKO CD8 T cells is comparable to controls (Figure 3.14A, 
C). Lastly, Foxp1- or Foxp4-deficient CD8 T cells are not IL-17 producers, demonstrating 
that Th17 regulation in CD8 T cells is intact without Foxp1 or Foxp4 regulation (Figure 
3.14D). Taken together with CD4 cytokine responses, these findings emphasize the 
differences in Foxp1 regulation between CD4 and CD8 T cells. IFNγ and IL-2 gene 
regulation is vastly different in these two T cell subsets. 
 
 
Figure 3.14. Decreased frequencies of cDKO CD8 T cells produce IFNγ. A) 
Representative plots of splenic CD8 T cells from cDKO and littermate controls. 
Splenocytes were stimulated in vitro and stained as in Figure 14, and gated on CD8 T 
cells. B-D) Compiled frequencies of CD8 T cells producing B) IFNγ, C) IL-2, or D) IL-17 
immediately ex vivo. Results from three independent experiments. 
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While IL-2 and IL-17 responses did not seem grossly affected, deletion of both 
Foxp1 and Foxp4 resulted in reduced frequencies of IFNγ+ CD8 T cells. A dose-
dependent effect of Foxp4 deletion in Foxp1-deficient CD8s results in fewer IFNγ-
producing T cells in both 1K4H and cDKO mice (Figure 3.14A-B). cDKO CD8 T cell 
production of TNFα was also diminished relative to littermates. One possibility was that 
IFNγ and TNFα are gene targets of Foxp1/4 in cDKO CD8 T cells.  
To determine whether TNFα and IFNγ production was altered due to cell intrinsic 
effects of Foxp1/4 deletion, cytokine responses by CD45.2+ CrePOS, single cKO, or 
cDKO CD8 T cells from bone marrow chimeras were compared. As observed in non-
chimeric responses, IL-2 and IL-17 production were not significantly different across 
cohorts or compared to endogenous WT cells (data not shown). However, in contrast to 
non-chimeric CD8 T cell functions, TNFα and IFNγ responses were not significantly 
reduced in mixed chimeras (Figure 3.15). Frequencies of cytokine-producing CD45.2+ 
CD8 T cells and wild-type CD45.1+ cells from cDKO:WT mixed chimeras were similar 
(Figure 3.15A-B, and data not shown). Differences between non-chimeric and chimeric 
experiments may indicate selective pressure on effector CD8 T cells for survival. 
 
 
Figure 3.15. Competitive chimeras reveal comparable frequencies of cDKO CD8 T 
cells produce IFNγ. A) Representative plots of chimeric splenocytes stimulated 
immediately ex vivo and stained intracellularly for IFNγ and TNFα production. Plots are 
gated on CD45.2+ cells from each chimeric cohort. Numbers in each quadrant represent 
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relative frequency. B) Compiled relative frequencies of IFNγ-producing CD45.2+ cDKO 
or CrePOS CD8 splenic T cells from chimeric mice. Each point represents one competitive 
chimera. Combined from two independent experiments. 
 
Taken together, Foxp1cKO CD4 and CD8 T cell function indicates how Foxp1 
orchestrates a complex network of effector gene regulation. A simplified summary of 
cDKO CD4 and CD8 T cell cytokine responses is included below (Table 3.2). This 
network is significantly different in CD4 and CD8 T lineage programs, and invites several 
avenues of investigation. Foxp4 expression does not appear to be required for effector 
cytokine production, and cannot compensate for loss of Foxp1 in 1K4H or cDKO CD4 T 
cells. Thus, Foxp1 and Foxp4 maintain non-overlapping regulatory roles in CD4 and 
CD8 T cell effector function.  
 
Table 3.2. Summary of cDKO CD4 and CD8 T cell cytokine production in vitro. 
 
FoxP transcription factors regulate IL-7R expression and cytokine signaling. 
In both non-competitive and chimeric conditions, we determined cDKO mice 
possessed reduced T cell numbers. Lower numbers of T cells could be a result of 
impaired development, poor survival, or both. Decreased numbers of T cells under 
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(Relative to 
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IFNγ Decreased No 
IL-17 No change Yes 
IL-2 No change Yes 
TNFα No change Yes 
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lymphopenic conditions generally consume reduced quantities of cytokine than an intact 
T cell compartment, resulting in increased availability of pro-survival factors, including IL-
7. However it was possible that cDKO T cells not only developed abnormally, but also 
failed to detect survival and growth factors in vivo.  
Recently, elegant studies of Foxp1-deficient T cells revealed how Foxp1 and 
another forkhead transcription factor, Foxo1, regulate a common target: IL-7Rα (Feng et 
al., 2011). Competition between Foxp1 and Foxo1 for forkhead consensus binding sites 
on the IL-7Rα promoter controls a critical cytokine signaling process that participates in 
naïve T cell maintenance. Because Foxp4-deficient T cells express normal levels of IL-
7R, it appeared IL-7Rα was not a target of Foxp4 regulation (Figure 2.4E). But it was 
unclear whether increased IL-7R expression in Foxp1cKO mice required any participation 
by Foxp4. Furthermore, it was unknown what the effect of combined Foxp1/4 deletion 
would be on IL-7R expression and subsequent responses to IL-7 signals.  
To determine the combined effect of Foxp1/4 deletion on IL-7Ra expression, 
cDKO T cells from the thymus and spleen of non-chimeric mice were stained for IL-7Rα 
and compared to Foxp1cKO, Foxp4cKO and CrePOS controls. DP thymocytes in CrePOS, 
Foxp1cKO, Foxp4cKO or cDKO thymi do not express IL-7Rα, demonstrating that IL-7R is 
dysregulated only after SP development (data not shown). In agreement with published 
findings, Foxp1cKO CD8SP expressed the highest levels of IL-7R. Once Foxp1cKO CD4SP 
and CD8SP upregulate IL-7R, it remains at abnormally high levels on peripheral 
lymphocytes.  
Surprisingly, IL-7R is not as highly expressed on cDKO T cells as observed in 
Foxp1cKO controls (Figure 3.16A-B). Foxp1/4-deficient CD4SP and CD8SP thymocytes 
exhibited increased IL-7Rα, relative to CrePOS and Foxp4cKO mice. However, IL-7R 
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expression was not as increased on cDKO thymocytes as observed in Foxp1cKO thymi 
(Figure 3.16A). Peripheral cDKO CD4 T cells expressed similar levels of IL-7R 
compared to CrePOS, but CD8 T cells in cDKO mice maintained a slight increase in IL-7R 
over CrePOS CD8 T cells. Like thymic CD8SP populations, peripheral cDKO CD8 T cells 
expressed significantly less IL-7Rα protein than Foxp1cKO CD8 T cells (Figure 3.16B, 
bottom panel). 
We considered that IL-7R complexes are internalized and removed from the cell 
surface after IL-7 ligation. We reasoned it was possible increased levels of IL-7 cytokine 
in lymphopenic cDKO mice could trigger increased IL-7R internalization, and cause the 
appearance of lower IL-7Rα expression. Initially, expression of another member of the 
IL-7R complex was examined to investigate whether total IL-7R complexes were 
internalized. Expression of the common gamma chain (γc chain) is necessary for IL-7R 
complex formation and IL-7 signaling (Figure 3.16B right panels, and data not shown). 
cDKO, single cKO, and CrePOS T cells expressed normal levels of γc chain on the cell 
surface. It appeared altered IL-7Rα expression was not necessarily due to significantly 
increased internalization of the entire IL-7R complex.  
 
cDKO T cells exhibit increased proximal STAT5 signals but poor survival. 
IL-7R signaling is paramount to naïve T cell survival and maintenance. Early 
onset of lymphopenia in young cDKO mice, as well as failure to compete for survival in 
mixed chimeras, suggests poor maintenance of cDKO T cells. Like Foxp1cKO mice, 
cDKO mice do not develop naïve T cells, and exhibit dysregulated IL-7R expression 
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compared to WT controls, but it was unclear whether cytokine signaling was intact in 
cDKO T lymphocytes. 
Following IL-7:IL-7R ligation, intracellular signaling events initiate Janus kinase 
(JAK) and Signal Transducer and Activator of Transcription (STAT) phosphorylation. The 
JAK/STAT pathway is activated by γc chain signaling cytokines, including IL-7. Trans-
phosphorylation of STAT5 protein dimers results in nuclear translocation and 
transcriptional regulation of STAT5 gene targets. In lymphocytes, STAT5 
phosphorylation is measured to assess proximal IL-7 signaling. Other signaling events 
downstream of IL-7R ligation include kinase activity of PI-3K and downstream effects on 
both the Erk and Akt pathways; however, the studies described here focused on 
JAK/STAT signals. 
To assess whether IL-7 cytokine signals were intact in cDKO T cells, we 
measured levels of phosphorylated STAT5 (pSTAT5) in thymocytes and splenocytes 
stimulated in vitro. pSTAT5 was compared Cre control cells treated similarly, as well as 
unstimulated cDKO T cells. Frequencies of pSTAT5+ cells were significantly increased 
in cDKO conventional CD4 and CD8 T cells stimulated with IL-7, but not in IL-7RNEG DP 
(Figure 3.16C-D, and data not shown). Additionally, pSTAT5 levels on a per cell basis 
were also increased, suggesting more cDKO T cells responded to IL-7 stimulation and 
each cell exhibited increased levels of pSTAT5. Therefore, IL-7R and pSTAT5 
responses are intact in cDKO T cells. Furthermore, increased pSTAT5 signaling is 
maintained in stimulated T cells from mixed chimeras (Figure 3.16E). IL-7 signaling in 
mixed cDKO and wild-type cells demonstrated increased intracellular levels of pSTAT5 
in cDKO CD4 and CD8 T cells over endogenous WT control cells (data not shown). 
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Therefore, cDKO T cells exhibit increased proximal signaling to IL-7 stimulation, 
compared to Cre control cells. 
IL-7 signals support lymphocyte survival by inducing anti-apoptotic proteins and 
protecting T cells from cell death. Theoretically, increased STAT5 signaling in cDKO T 
cells should induce increased Bcl-2 expression, and inhibit cell death.  We assessed the 
ability of cDKO T cells to survive for 72 hours in vitro with either IL-7 or in 
unsupplemented media.  
Increased STAT5 responses to γc chain cytokines did not protect cDKO T cells 
from cell death. In fact, cDKO T cells demonstrated poor survival after 24 hours in 
culture, and total live lymphocytes were dramatically reduced after 48 and 72 hours 
(Figure 3.16F). Precipitous loss of live T cell numbers indicated increased incidence of 
apoptosis. Levels of intracellular Bcl-2 protein in harvested cDKO T cells after 24 or 72 
hours in culture were measured. cDKO T cells expressed substantially reduced Bcl-2, 
even though cDKO pSTAT5 levels were increased in previous studies (Figure 3.16G). 
These data suggest FoxP proteins may be important for linking STAT5 signals to Bcl-2 
gene regulation, or possibly to stabilize expression of Bcl-2 protein.  
Together these data suggest Foxp1 is required for normal IL-7Rα expression, but 
loss of Foxp1 and Foxp4 results in expression of relatively lower levels of IL-7Rα. 
However, cDKO T cells maintain higher IL-7Rα expression compared to CrePOS controls. 
Responses to IL-7 stimulation indicate a proportionately increased pSTAT5 response, 
but failure to induce or maintain Bcl-2 expression leaves cDKO T cells vulnerable to 
apoptosis.  
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Figure 3.16. cDKO CD4 T cells exhibit increased STAT5 phosphorylation but 
decreased survival. A) Representative staining of IL-7Rα expression by CD4SP  and 
CD8SP T cells. B) IL-7Rα expression by splenic CD4 and CD8 T cells (left panels). Right 
panels: Common gamma chain expression on splenic CD4 (top) and CD8 (bottom) T 
cells. C-D) Levels of phosphorylated STAT5 in thymocytes from CrePOS (dotted line) or 
cDKO (black line) stimulated with IL-7 in vitro, or left unstimulated (gray histogram. C) 
Plots depict pSTAT5 responses by DP and CD4SP. D) pSTAT5 levels in CD4 
splenocytes stimulated as in C). E) Levels of phosphorylated STAT5 in CD4SP 
thymocytes from CrePOS:WT or cDKO:WT competitive chimera thymi. Whole 
unfractionated thymocytes were stimulated in vitro with IL-7, and stained intracellularly 
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for pSTAT5. CD4SP were gated out to compare to unstimulated, rested cells (gray 
histogram). F) Survival of live TCRβ+ CD4+ T cells from CrePOS (black) or cDKO (red) 
mice cultured with IL-2, IL-7 or media alone for up to 72 hours. Each point represents 
one well harvested at indicated time points. G) Averaged mean fluorescence intensity of 
intracellular staining for Bcl-2 protein in live CrePOS or cDKO CD4 T cells cultured for 72 
hours. 
 
 
Discussion 
In Chapter III, the effects of combined deletion of Foxp1 and Foxp4 in T cells 
were investigated. In most cases, we found defects in cDKO T cells resembled the 
Foxp1cKO phenotype. Combined deletion of Foxp1/4 resulted in a slight but consistent 
reduction in thymic cellularity, which correlated with decreased numbers of DP 
thymocytes. Thymic development of cDKO SP is similar to Foxp1cKO thymocytes, and 
the CD44hi phenotype is observed in all cDKO SP and peripheral T cells.  
Some features of the cDKO phenotype differed from Foxp1cKO mice. Cell-intrinsic 
differences in cell surface patterns of CD62L and IL-7R indicate Foxp1/4 combined 
deletion affects additional gene targets. T lymphopenia is significantly worse in cDKO 
mice compared to age-matched Foxp1cKO mice. In the periphery, cDKO T cells fail to 
maintain normal numbers in peripheral lymphoid tissues. Considering altered IL-7R and 
in vitro survival, reduced cell numbers in non-chimeric mice or competitive chimeras may 
be due at least partially to altered IL-7 signals and failure to induce Bcl-2 expression. 
These data indicate cDKO T cell development is significantly impaired relative to 
single cKO T cells. The difference between cDKO and Foxp1cKO T cell numbers 
suggests that expression of Foxp4 in Foxp1cKO T cells partially rescues dysregulation of 
peripheral T cell development and maintenance. These studies indicate Foxp4 may be 
able to stabilize T cell populations in the absence of Foxp1 regulation. Further studies 
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are required to determine whether direct or indirect Foxp4 regulation of gene targets 
such as IL-7R or Bcl-2 occurs in Foxp1cKO T cells.  
From the data described here, several trends in Foxp1/4 regulation in T cells 
became apparent. First, CD4 and CD8 T cell requirements for FoxP family members 
suggests these two T cell subsets utilize Foxp1/4 to regulate different gene programs. 
cDKO CD4 T cells expressed lower levels of CD62L and IL-7R than CD8 T cells in the 
same mice. In contrast, CD8 T cells require Foxp1 expression for normal cell numbers, 
and total cDKO CD8 numbers illustrate more severe defects than in CD4 T cells. In 
mixed chimeras, however, competition by both CD4 and CD8 cDKO T cells was equally 
impaired. Together with increased frequencies of CD4SP cDKO thymocytes but not 
CD8SP, these data suggest FoxP members may have different roles in the CD4 and 
CD8 lineages.  
Foxp1 and Foxp4 individually appear to regulate non-redundant gene programs 
in T cells. Importantly, cDKO findings support conclusions from Foxp1cKO and Foxp4cKO 
studies. As described in Chapter 2, the effects of Foxp4 deletion made no difference in T 
cell numbers in the periphery, but here we demonstrate Foxp1/4 combined deletion 
resulted in reduced CD8 T cells in peripheral tissues and an abnormal T cell phenotype. 
From these data, it is clear that Foxp1-dependent defects produce a dominant 
phenotype. Comparing cDKO and Foxp1cKO mice reveals Foxp4 only partially 
compensates for Foxp1 deletion. Inclusion of 1H4K mice throughout these studies has 
demonstrated that expression of one allele of Foxp1 is sufficient to rescue control of 
effector gene programs and suppress effector T cell differentiation. Together these data 
underscore the importance of non-redundant roles for Foxp1 and Foxp4 regulation in T 
cells. 
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CHAPTER IV. 
The FoxP family represses CD4 expression in T lymphocytes. 
 
	  
	  
Introduction 
The CD4 co-receptor is a transmembrane protein expressed in developing 
thymocytes and, later, exclusively on T cells restricted to recognize antigen presented on 
major histocompatibility complex Class II (MHC II) complexes (reviewed in (Bosselut, 
2004; Singer et al., 2008). CD4 expression defines the subset of MHC II-restricted T 
cells called T helper cells, which differentiate to produce specialized cytokines in 
response to ongoing infection. The other major T cell subset of T cells expresses a 
different co-receptor, CD8, and recognizes MHC Class I antigen presentation. These 
CD8+ T cells do not express CD4 and acquire cytotoxic effector functions.  
Several transcription factors interact to control commitment to CD4+CD8- T 
helper cell lineage or CD4-CD8+ cytotoxic T lineage. The network of transcription factors 
that dictates CD4 expression includes ThPok, Gata3, and Runx family proteins 
(Bosselut, 2004; Wang and Bosselut, 2009). These transcription factors interpret 
cytokine and TCR signals to allow CD4 helper T cells to maintain CD4 expression and to 
repress CD4 expression on CD8 T cells (Tani-ichi et al., 2013). Modulation of cd4 by 
transcription factors requires access to the cd4 promoter, and two other known 
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regulatory elements built into the cd4 gene sequence. An upstream enhancer element 
promotes CD4, while a silencer motif downstream of the promoter is essential for CD8 T 
cell development (Xiong and Bosselut, 2012; Zou et al., 2001).  
CD4 itself participates in T cell development and commitment through a complex 
feedback system. CD4 co-receptor is embedded in the plasma membrane and 
participates in signaling events both inside and outside of CD4+ T cells. Extracellular 
domains of the CD4 protein interact with MHC II complexes expressed by antigen-
presenting cells to stabilize TCR:MHC II ligation (Gratton et al., 2000; Janeway, 1991). 
The intracellular tail of CD4 associates with protein kinases that initiate proximal signals 
necessary for T cell activation (Gascoigne and Palmer, 2011; Veillette et al., 1989; Wiest 
et al., 1993). Localization of proximal kinase Lck to the plasma membrane, near 
intracellular signaling domains of the TCR complex, shortens the interval between TCR 
ligation and initiation of T cell activation (Gascoigne and Palmer, 2011; Janeway, 1991). 
These CD4 functions shape the TCR signals that ultimately determine whether a T cell 
becomes a CD4+ T helper or CD8+ cytotoxic cell, or succumbs to cell death. 
While characterizing cDKO T cells (described in Chapter 3), we noted a 
significant change in CD4 protein levels. Known transcription factor networks do not 
include FoxP family members, but our data suggest these proteins participate in the 
regulation of the cd4 gene in both CD4 and CD8 T cells.  
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Results 
cDKO CD4 and CD8 T cells express increased levels of CD4. 
Increased CD4 expression was detected on cDKO thymocytes early in 
development, concomitant with Cre-mediated deletion. DP thymocytes express higher 
CD4 levels compared to CrePOS, Foxp1cKO, and Foxp4cKO controls (Figure 4.1A left 
panel). Mature CD4SP thymocytes also express increased CD4 expression, relative to 
CrePOS and Foxp1cKO or Foxp4cKO cells. Moreover, cDKO CD4SP express increased 
levels of CD4 compared to DP in the same thymi, suggesting CD4 expression is 
dysregulated after deletion of Foxp1 and Foxp4, and increases with SP maturation of 
cDKO thymocytes (Figure 4.1A right panel, Figure 3.4A, C, and data not shown). 
Foxp1cKO CD4SP thymocytes express slightly increased levels of CD4, relative to CrePOS 
and Foxp4cKO cells, but this trend did not reach statistical significance. CD4 protein levels 
were assessed by mean fluorescence intensity, and normalized to matched CrePOS 
controls. CD4 was significantly upregulated on DP and CD4SP thymic populations  
(Figure 4.1B-C, and data not shown).  
Peripheral CD4 T cells in cDKO mice also expressed increased levels of CD4 
(Figure 4.1D). The majority (85-90%) of cDKO CD4 T cells expressed higher levels of 
CD4, relative to CrePOS and littermate controls. The fraction of cDKO CD4 T cells 
expressing CD4 at control levels mostly consisted of Foxp3+ Tregs (data not shown). 
Mean fluorescence intensity of CD4 on cDKO CD4 T cells was increased compared to 
CrePOS and littermate controls (Figure 4.1E). As observed in the thymus, loss of Foxp1 
also led to increased levels of CD4 on CD4 T cells; however, cDKO thymocytes 
exhibited significantly more CD4 expression relative to Foxp1cKO T cells. 
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In contrast to CD4 T cells, most cDKO CD8 T cells were CD8+CD4-. However, 
approximately 15-20% of total peripheral CD8 T cells expressed higher levels of CD4 
than control CD8 T cells (Figure 4.1C). We also noted a small percentage (5-10%) of 
CD8 T cells in Foxp1cKO mice were also CD4dimCD8 T cells. These CD4dimCD8 T cells 
were consistently observed in CD8 populations throughout Foxp1cKO and cDKO mice 
(data not shown). It was unclear whether this population was a stable subset of CD8 T 
cells, or whether CD4dimCD8 T cells were associated with lymphopenia induced 
proliferation in T lymphopenic cDKO mice. Alternatively, this population of CD8 T cells 
may have escaped normal thymic selection, and were in fact MHC class II-restricted. To 
determine whether CD4 expression on both CD4 and CD8 T cells was a cell-
autonomous occurrence, we investigated CD4 levels on T cells generated under 
competitive conditions in mixed bone marrow chimeras. 
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Figure 4.1. cDKO CD4 and CD8 T cells express increased levels of CD4 co-
receptor. A) Representative histograms of CD4 expression on DP and CD4SP 
thymocytes from cDKO mice and littermate controls. Representative of 16 experiments. 
B-C) Mean fluorescence intensity (MFI) of CD4 staining on cDHET, Foxp1cKO, Foxp4cKO, 
and cDKO B) DP or C) CD4SP. CD4 MFI is relative to matched CrePOS controls in every 
experiment. Data compiled from 16 independent experiments. Each point represents 
one mouse. D) Representative plots of CD4 expression on splenocytes from indicated 
mice. Relative frequency of CD4, CD8 and CD4dim CD8 T cells of total, live splenocytes 
is indicated. E) Representative CD4 MFI from staining of CD4 splenic T cells from cDKO 
mice and littermate controls in one experiment. Mean and standard error of the mean is 
shown. Representative of 4 experiments. B-E) Statistical analyses by one-way ANOVA 
and Dunnett post-test. *p<0.05, **p<0.01. 
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CD4 is intrinsically regulated by FoxP family members. 
CD4 regulation in both T lineage subsets proved to be a cell-autonomous 
phenomenon (Figure 4.2). Mixed bone marrow chimeras revealed significantly increased 
CD4 expression on Foxp1cKO- and cDKO-derived DP and CD4SP (Figure 4.2A). Mean 
fluorescence intensity of CD4 staining illustrates specific dysregulation of CD4 
expression on Foxp1-deficient thymocytes. Defects observed in cDKO-derived 
thymocytes were larger than in Foxp1cKO-derived cells. In contrast, endogenous wild-
type cells, wild-type CrePOS and Foxp4cKO controls expressed similar levels of CD4.  
CD4 profiles of splenic cDKO-derived T cells resembled that of CD4 and CD8 T 
cells in non-chimeric cDKO mice. CD4hi T cells and CD4dimCD8 T cells were observed in 
CD45.2+ populations in cDKO:WT chimeras, but not in CrePOS:WT or single cKO:WT 
chimeras, or in any CD45.1+ WT T cells (Figure 4.2C). CD4hi and CD4dimCD8 T cells 
were also observed in LN, peripheral blood, mesenteric LN, and bone marrow of 
cDKO:WT chimeric mice (data not shown). Together these data indicate increased CD4 
is a cell-intrinsic defect caused by deletion of Foxp1 and Foxp4. 
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Figure 4.2. Increased CD4 expression is cell-intrinsically regulated by FoxP 
proteins. A) Representative histograms of CD4 expression on CD45.1+ WT (gray 
histogram) and CD45.2+ (red line) DP and CD4SP from mixed bone marrow chimeras. 
Representative of 5-10 chimeric mice in each cohort generated in 3 separate sets. B-C) 
Mean fluorescence intensity (MFI) of CD4 staining on CD45.2+ CrePOS, Foxp1cKO, 
Foxp4cKO, or cDKO B) DP or C) CD4SP. CD4 MFI is normalized to endogenous 
CD45.1+ WT MFI in every chimeric mouse. Data is compiled from one experiment with 
2-3 chimeras in each cohort. Mean and s.e.m. is shown. Each point represents one 
chimeric mouse. D) Representative plots of CD4 expression on splenocytes from 
chimeric mice. Plots are previously gated on live, singlet, TCRβ+, CD45.2+ (top) or 
CD45.1+ (bottom) lymphocytes. Relative frequency of CD4, CD8, and CD4dim CD8 T 
cells of total TCRβ+ splenocytes is indicated. Representative of 10-15 chimeric mice in 
each cohort. 
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CD4 is a transcriptional target of FoxP family regulation. 
We next investigated whether total CD4 protein was increased in CD4hi T cells, 
or whether CD4 coreceptor was merely trafficked to the plasma membrane and 
inefficiently internalized. T cells were stained for cell surface CD4 protein, and then 
permeabilized to stain for CD4 intracellularly. Comparison of cells stained only for 
surface CD4 or for total protein indicates CD4 is not isolated to the cell surface of cDKO 
T cells. Intracellular and extracellular CD4 levels were higher than extracellular CD4 
alone. Therefore, it does not appear that CD4 is sequestered on the cell surface. 
Instead, total CD4 expression in cDKO T cells was increased (Figure 4.3A).  
To determine whether total levels of CD4 were increased due to increased cd4 
transcription, we assessed cd4 mRNA transcript levels in sorted CrePOS, Foxp1cKO, 
Foxp4cKO, and cDKO CD4 T cells. Relative quantification by real-time PCR demonstrated 
cd4 transcript was increased 50-fold in cDKO CD4 splenic T cells (Figure 4.3B). 
Expression of cd4 transcript was increased in Foxp1cKO or Foxp4cKO cells, relative to 
CrePOS controls. Foxp1cKO CD4 T cells express >20-fold higher CD4 mRNA, and 
Foxp4cKO expression is 10-fold increased. Similar quantification of cd4 transcript levels in 
CD4dimCD8 T cells showed increased mRNA in cDKO cells as well (data not shown).  
These data demonstrate that repression of cd4 requires FoxP family regulation. CD4 
expression is most dysregulated in conventional cDKO T cells, but expression of either 
Foxp1 or Foxp4 can partially function to repress CD4 transcription, suggesting direct or 
indirect cd4 transcriptional repression may be a shared target of these FoxP proteins. 
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Figure 4.3. Total CD4 protein level and cd4 transcript is increased in cDKO CD4 T 
cells. A) Representative histograms of surface CD4 expression and total (surface + 
intracellular) CD4 levels on CrePOS, Foxp1cKO, Foxp4cKO, cDKO CD4 splenic T cells. 
Representative of 2 experiments including at least two mice per group. B) Relative 
quantification of cd4 transcript levels by real-time PCR in sorted splenic CD4 t cells from 
cDKO and littermate control. CD4 mRNA levels are set relative to CrePOS samples, and 
normalized to β-actin levels. Samples were tested in triplicate, mean and standard 
deviation is shown. *p<0.05, **p<0.001. 
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Discussion 
In this chapter we have demonstrated that FoxP family members regulate cd4 
transcription in T cells. Loss of Foxp1 and Foxp4 resulted in increased CD4 levels in the 
majority of CD4 T cells, and a fraction of CD8 T cells. In CD4 T cells, deletion of Foxp1 
resulted in altered CD4 expression. Further deletion of Foxp4 in CD4 T cells 
exacerbated de-repression of CD4 expression. Because Foxp3+ Tregs did not exhibit 
increased levels of CD4 expression, it appears expression at least one FoxP protein can 
repress CD4 in MHC II-restricted T cells. Conventional T cells require expression of at 
least Foxp1 or Foxp4 to maintain relatively normal CD4 expression. 
CD4 T cells require Gata3 and ThPok to induce CD4 expression, and one 
possible cause of increased expression of CD4 in cDKO T cells is unrestricted activity of 
one or both of these factors. FoxP proteins may be required to repress expression or 
activity of factors that induce cd4 expression. Another hypothetical mechanism is 
dysregulated repression at this locus. These studies did not address whether FoxP 
proteins bind directly to the cd4 locus, so it remains unclear whether Foxp1/4 can 
antagonize cd4 expression by physically obscuring consensus binding sites. 
In contrast to CD4 T cells, only a subset of cDKO CD8 T cells exhibited 
dysregulated CD4 expression. Frequencies of CD4dimCD8 T cells were substantially 
higher in cDKO mice than in littermate controls. In cDKO:WT mixed bone marrow 
chimeras, the detection of CD4dimCD8 T cells indicated cell-intrinsic dysregulation of cd4 
silencing. However, we were unable to determine whether CD4dimCD8 cells develop in 
the thymus, as that CD4 profile resembles DP thymocytes. Furthermore, these studies 
	  101	  
did not address whether CD4dimCD8 T cells were in fact MHC I-restricted, or whether this 
population represents thymocytes that escaped normal T cell selection.  
Runx family member, Runx3, controls CD4 expression in CD8 T cells by 
regulating the silencer element in the cd4 locus (Collins et al., 2009). Runx3 recruits 
chromatin-remodeling factors that methylate histones in the cd4 locus, rendering the 
gene inaccessible to transcription factors (Taniuchi et al., 2002). Because cDKO CD8 
cells failed to silence CD4 expression, these studies suggest FoxP family members 
regulate cd4 silencer activity either directly or indirectly. Foxp3 is known to interact with 
Runx family proteins (Hu et al., 2007), so one possible mechanism of FoxP protein 
repression of cd4 is through cooperation with Runx3. Alternatively, Runx3 itself may be a 
target of FoxP family members, and downstream cd4 regulation is an effect of altered 
Runx3 levels. 
The studies described here demonstrate CD4 expression is regulated by FoxP 
family transcription factors. Dysregulated CD4 expression holds implications for thymic 
selection, MHC-restriction, and T cell signaling, but further work is required to 
understand how CD4 levels are regulated and why it may be important to maintain 
specific regulation at this locus in mature T cells. 
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CHAPTER V. 
Foxp1 and Foxp4 regulate Foxp3+ Treg cell development. 
 
 
Introduction 
Regulatory T cells (Tregs) are critical for the maintenance of self-tolerance and 
the prevention of autoimmunity (Ochs et al., 2007; Ziegler, 2006). During infection, Tregs 
are necessary for controlling immune responses and suppressing effector T cell 
responses following pathogen clearance. This subset of immunomodulatory lymphocytes 
is a subset of CD4+ T cells that express interleukin-2 receptor (IL-2R) and the forkhead 
transcription factor Foxp3 (Rudensky, 2011; Sakaguchi et al., 2006). Foxp3 governs 
transcriptional programs and modifies gene expression, enabling Tregs to acquire 
effector-like characteristics, migrate to sites of inflammation, and suppress immune 
responses (Campbell and Koch, 2011; Ding et al., 2012; Feuerer et al., 2009; 
Josefowicz et al., 2012). 
Treg development typically occurs in the thymus during thymic selection. Thymic 
Treg (tTreg) generation requires T cell receptor- and cytokine-generated signals to 
induce Foxp3 expression. How these signals cooperate to induce tTreg development 
remains unclear. Recent studies have suggested a model in which a two-step 
developmental process requires T cell receptor (TCR) signals to prime a population of 
CD4 single positive (CD4SP) thymocytes termed preTregs (Burchill et al., 2008; Lio and 
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Hsieh, 2008). This precursor population upregulates cytokine receptors, and subsequent 
STAT5 signaling induced by cytokine signals results in expression of Foxp3 (Burchill et 
al., 2008; Lio and Hsieh, 2008). A similar combination of TCR and cytokine stimulation 
can induce Foxp3 expression in conventional CD4 T cells from peripheral tissues, 
causing these lymphocytes to differentiate into inducible Tregs (iTregs) in vitro. 
Generation of preTregs requires selection of a limited repertoire of immature 
thymocytes. The quality and quantity of TCR signaling appear to be critical for Treg 
development. Weak TCR response to self-peptide is not sufficient to select Tregs 
precursors, while overpowering TCR signals result in negative selection and deletion 
(Jordan et al., 2001). Downstream cascades of TCR ligation also play an integral role in 
Treg development by inducing transcription factors AP-1, NFAT, and NFκB, which 
regulate Foxp3 expression (Huehn et al., 2009; Ruan and Chen, 2012). Conversely, 
phosphorylation of Akt by PI3K, and subsequent activation of mammalian target of 
rapamycin (mTOR) directly interferes with Foxp3 induction (Liu et al., 2009; 
Merkenschlager and von Boehmer, 2010; Sauer et al., 2008).  
Cytokine signaling is also necessary for Foxp3 induction, and homeostasis of 
Tregs. (Turka and Walsh, 2008; Vang et al., 2008; Wuest et al., 2008). Specifically, 
Tregs depend on signaling through complexes containing the common gamma chain 
(γc), which is a subunit necessary for signaling of several cytokine receptor, including IL-
2, IL-7, and IL-15. The γc chain pairs with different complementary chains that lend 
specificity to cytokine signaling. Cytokine signal transduction occurs when receptor 
complexes embedded in the cell membrane bind soluble cytokines. Extracellular ligation 
translates to intracellular signaling. Receptor-associated Janus kinase (JAK) tyrosine 
kinases inside the cell are trans-phosphorylated. Through a series of phosphorylation 
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events, transcription factors called Signal Transducer and Activator of Transcription 5 
(STAT5) are also phosphorylated. Phosphorylated STAT5 (pSTAT5) forms homodimers, 
and translocates to the nucleus. Transcriptional regulation by STAT5 dimers supports T 
cell survival by inducing expression of anti-apoptotic proteins, such as Bcl-2 (Lord et al., 
2000; Van Parijs et al., 1999). Intracellular levels of Bcl-2 protein correlate with survival 
and homeostasis of T lymphocytes. STAT5 dimers are also required to bind directly to 
the foxp3 promoter to induce Foxp3 expression (Burchill et al., 2007; Passerini et al., 
2008; Snow et al., 2003). Cytokines important for Foxp3 induction and Treg homeostasis 
include IL-2, IL-7, and IL-15 (Cheng et al., 2011; Le Campion et al., 2012).  
Forkhead-domain containing FoxP transcription factors are necessary for the 
development and function of T lineage memory cells (Feng et al., 2010; Feng et al., 
2011; Wiehagen et al., 2012). Despite similar primary sequences and expression in 
lymphocytes, T cell-specific deletion has demonstrated that Foxp1 and Foxp4 are not 
redundant in T cells. CD4-Cre mediated deletion of Foxp1 at the double positive (DP) 
stage of thymic development results in dysregulated homeostasis of peripheral T cells 
(Feng et al., 2010). In contrast, T cell-specific deletion of Foxp4 does not alter thymocyte 
development, peripheral T cell activation, or differentiation (Wiehagen et al., 2012). 
Importantly, neither CD4-Cre mediated deletion of Foxp1 nor Foxp4 alone impairs Treg 
development (Feng et al., 2010; Feng et al., 2011; Wiehagen et al., 2012). 
The FoxP family proteins dimerize to interact with target gene sequences and 
participate in protein-protein interactions. Previous studies have shown Foxp1 and 
Foxp3 bind to one another, as well as Foxp1 to Foxp4 (Li et al., 2004a; Song et al., 
2012). Furthermore, Foxp3 can occupy the promoters of Foxp1 and Foxp4, and Foxp3 
represses Foxp1 transcription (Rudra et al., 2012). Gene array data demonstrates that 
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Foxp1 expression is downregulated in peripheral wild-type Foxp3+ Tregs (Heng and 
Painter, 2008; Rudra et al., 2012). In addition to FoxP protein-protein binding, several of 
the transcription factors required for Treg generation are known to interact with FoxP 
proteins (Bettelli et al., 2005; Hu et al., 2007; Sauer et al., 2008; Wu et al., 2006; Zhang 
et al., 2008). These data generated the hypothesis that FoxP family members Foxp1 and 
Foxp4 participate in Treg development. Thus, the comparatively normal Treg generation 
in Foxp1cKO and Foxp4cKO mice may suggest Foxp1 and Foxp4 compensate for one 
another. 
To better understand the roles of Foxp1 and Foxp4 in Treg development, we 
generated mice in which both Foxp1 and Foxp4 were conditionally deleted using a CD4-
Cre transgenic. Surprisingly, while loss of either Foxp1 or Foxp4 alone did not alter 
thymic Treg (tTreg) numbers, combined loss resulted in a significant decrease in Treg 
numbers. cDKO CD4 splenocytes do not differentiate into inducible Tregs, indicating 
multiple defects in Treg development. cDKO Tregs exhibited an abnormal cell surface 
phenotype, and reduced capacity to suppress conventional CD4 T cells in vitro. 
The decrease in tTregs was a cell-intrinsic effect of loss of Foxp1 and Foxp4. 
Under competitive conditions, double-knockout Tregs exhibited impaired cytokine-
induced signaling and were at a significant developmental disadvantage relative to wild-
type competitors. These findings establish that expression of Foxp1 or Foxp4 is required 
for normal generation of tTregs, and that more than one member of the FoxP family 
contributes to immunological tolerance.  
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Results 
Foxp1 and Foxp4 are expressed in regulatory T cells. 
A defining feature of regulatory T cells is expression of FoxP family member 
Foxp3. To characterize expression of other FoxP family members, steady-state levels of 
foxp1 and foxp4 transcript were assessed in highly purified wild-type thymic Tregs using 
real-time PCR (Figure 5.1A). Similar to findings in peripheral Tregs, Foxp1 expression is 
reduced in tTregs relative to conventional Foxp3- CD4SP T cells. In contrast, Foxp4 
transcript expression was 2-3 fold increased (Figure 5.1A, right panel). These data 
indicate FoxP family members are individually regulated in Foxp3+ Tregs.  
  
Foxp1 and Foxp4 are required for normal Treg generation. 
In Chapter 3, initial characterization of cDKO mice revealed that the total 
cellularity of thymi from cDKO mice was lower compared to CrePOS, Foxp1cKO, and 
Foxp4cKO mice, due to reduced DP numbers (Figure 3.2B, 3.3A-B). Although total 
numbers of cDKO CD4SP were normal, we noted a higher frequency of CD4SP cells 
within cDKO thymi (Figure 3.4C). Increased frequencies of cDKO CD4 cells did not 
correlate with increased Foxp3+ Tregs, however. Instead, a modest but statistically 
significant reduction was observed in Foxp3+ tTregs, relative to either total thymocytes 
or total CD4SP (Figure 5.1B-C and data not shown). Despite reduced frequencies, the 
total numbers of tTregs were not significantly different across any cohorts (Figure 5.1D, 
and data not shown). 
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Figure 5.1. Conditional deletion of Foxp1 and Foxp4 alters thymic Foxp3+ tTreg 
frequencies. A) Relative levels of stead-state foxp1 or foxp4 transcript in sorted wild-
type tTregs as determined by real-time PCR. tTreg expression compared to CD4SP 
thymocytes, and normalized to β-actin levels in each population. B) Representative plots 
previously gated on CD4SP thymocytes from four-week-old Cre positive (CrePOS), single 
knockout Foxp1cKO and Foxp4cKO, and cDKO mice. Relative frequencies of Foxp3+ cells 
are indicated.  Results are representative of 12 experiments. C) Frequency of Foxp3+ 
tTreg as a percentage of CD4SP. Data is combined from twelve independent 
experiments. Each point represents an individual mouse. Statistical analysis generated 
with one-way ANOVA with Dunnett post-test. * p<0.05. n.s. = not significant. D) Absolute 
numbers of Foxp3+ tTreg in cDKO and littermate controls. Mean is shown. Each point 
represents one mouse. Compiled from 6 independent experiments. Statistical analysis 
indicates p>0.05 for all comparisons. 
 
Fo
xp
3 
CD4 
2
1.5
1
0.5
0
CD4SP CD25+
Foxp3+
 noit acifit nauq evit al e
R
fo
xp
1
4
3
2
1
0
CD4SP CD25+
Foxp3+
5
 noit acifit nauq evit al e
R
fo
xp
4
A
B
C D
CrePOS Foxp1 Foxp4 cDKO 
4.8 3.1 4.2 2.5 
6
4
2
0
8
%
 F
ox
p3
+ 
tT
re
g 
of
 C
D4
SP
CrePOS Foxp1cKO Foxp4cKO cDKO
***
* ***
Nu
m
be
r o
f F
ox
p3
+ 
tT
re
g
n.s.
	  108	  
As discussed in Chapter III, CD4SP thymocyte numbers were comparable to 
littermate controls, but CD4 T cell numbers in the spleen and LN were significantly 
diminished (Figure 3.5). When we quantified Tregs in peripheral tissues, the total 
numbers of cDKO Foxp3+ cells were significantly reduced in the spleen and LN 
compared to CrePOS, Foxp1cKO, and Foxp4cKO mice (Figure 5.2A-B). Splenic Treg 
numbers were significantly decreased only in cDKO mice, while quantification of Tregs in 
pooled LN demonstrated significantly fewer Foxp3+ cells in both cDKO and 1K4H mice 
(Figure 5.2B). These data suggest cDKO Tregs, like conventional T cells, are present in 
lower numbers in peripheral lymphoid tissues, and that defects in Treg cellularity is more 
severe in LN compared to the spleen. Quantification of the Treg population in multiple 
tissues of the cDKO mouse demonstrated that Treg numbers were diminished 
throughout the animal. Peritoneal tissues, skin, mesenteric LN, and Peyers patches 
contained reduced numbers of Tregs compared to CrePOS mice (Figure 5.2C). These 
data suggest decreased numbers of Tregs contribute to the total T lymphopenia 
observed in cDKO mice discussed in Chapter III. 
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Figure 5.2. Foxp1/4 deletion results in significantly reduced numbers of peripheral 
Tregs. A-B) Absolute numbers of Foxp3+ CD4+ T cells in the A) spleens or B) pooled 
LN of cDKO mice and littermate controls. Mean and standard deviation are shown. Each 
point represents one mouse. Compiled from 10 individual experiments. Statistics 
generated from one-way ANOVA with Bonferroni post-test. Spleen: * p<0.001. LN: ** 
p<0.001, *** p<0.0001. C) Fold change in Foxp3+ numbers in indicated tissues of cDKO 
mice, relative to CrePOS controls.  
 
In contrast to cell numbers, the relative frequency of Foxp3+ Treg of total CD4 T 
cells was significantly increased in cDKO mice. In the spleen, an average 15% of cDKO 
CD4 T cells were Foxp3+ Tregs. CrePOS mice typically maintained 10% Tregs within the 
total CD4 population (Figure 5.3A-B). Percentages of Tregs in spleens of Foxp4cKO, 
cDHET and 1H4K mice were not significantly different, but loss of Foxp1 caused a trend 
towards slightly increased frequencies. However, frequency of Tregs in cDKO LN was 
substantially increased compared to all littermate controls (Figure 5.3A,C). Almost 40% 
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of cDKO CD4 T cells in LN were Foxp3+ Tregs, compared to an average 12% of Tregs 
in CrePOS mice.  
To determine whether Tregs were selectively enriched in the spleen and LN of 
cDKO mice, we assessed the relative percentage of Foxp3+ Tregs of total CD4 T cells in 
multiple tissues. Treg frequencies were set relative to frequencies of Tregs in CrePOS 
controls to determine the fold change in cDKO Treg percentages. The frequency of 
cDKO Tregs was increased in all tissues examined except bone marrow, skin, and 
thymus (Figure 5.3D and data not shown). Together, these data indicate cDKO Tregs 
are relatively spared compared to conventional CD4 T cells throughout the cDKO mice, 
as a higher frequency of Tregs comprise total CD4 populations.  
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Figure 5.3. Frequencies of cDKO Tregs are significantly increased in spleen and 
LN. A) Representative plots of Foxp3+ tTreg in total splenic or LN CD4 T cells. Relative 
frequencies of Foxp3+ Treg and Foxp3- conventional CD4 T cells are indicated.  Results 
representative of 12 experiments. B-C) Compiled frequencies of Foxp3+ Tregs in B) 
spleen or C) pooled LN. Data combined from 12 experiments. Each point represents an 
individual mouse. Statistical analysis generated with one-way ANOVA with Dunnett post-
test to CrePOS controls. Spleen: * p<0.05. LN: *p<0.05, **p<0.001, ***p<0.0001 D) Fold 
change in Treg frequency, relative to CrePOS littermate controls, assessed in bone 
marrow (BM), thymus (Thy), spleen (Spl), pooled axillary, cervical and inguinal lymph 
nodes (LN), peripheral blood, liver, lung, peritoneal exudate cells (PECs), skin, pooled 
mesenteric lymph nodes (mLN), pooled Peyers patches (PP), small intestine lamina 
propria (SI), or lamina propria of large intestine (colon). Mean and standard deviation 
calculated from 3 experiments. 
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cDKO Tregs phenotypically resemble memory Tregs 
Analysis of cell surface marker expression of cDKO Foxp3+ tTregs revealed 
abnormal expression patterns compared to Foxp3+ Tregs from littermate control mice 
(Figure 5.4A). In the absence of Foxp1 and Foxp4 expression, Foxp3+ Tregs in the 
thymus express higher levels of CD44 and glucocorticoid-induced TNF-receptor-related 
protein (GITR), compared to Foxp1cKO, Foxp4cKO, or CrePOS tTregs. Other markers 
associated with Treg activation were also increased. PD-1, KLRG1, and α4β7 integrin 
(CD103) are highly expressed only on cDKO Tregs. L-selection (CD62L) was 
downregulated on Tregs, similar to findings in Foxp3- conventional cDKO CD4 T cells 
reviewed in Chapter III.  
Elevated expression of CD44, GITR, CD103, KLRG1 and ICOS has been 
previously reported on Tregs in the gut, sites of immunologic activity, and under 
lymphopenic conditions (Cheng et al., 2012; Feuerer et al., 2010). We reasoned 
abnormal cDKO Treg development could be a direct consequence of loss of Foxp1 and 
Foxp4 transcriptional regulation or due to recirculation of peripheral Tregs, expanding in 
lymphopenic conditions. Foxp3+ tTregs are present in two-day-old cDKO neonates (data 
not shown), a developmental time point where few if any CD4+CD25+ lymphocytes have 
exited the thymus (Asano et al., 1996; Kelly and Scollay, 1992). The presence of Foxp3+ 
cells indicates that tTregs can develop in the absence of recirculation, but does not 
formally rule out a role for recirculating Tregs under homeostatic conditions in the adult 
thymus.  
Like thymic Tregs, peripheral cDKO Tregs express phenotypic markers of 
activation and differentiation (Figure 5.4B). Expression of another TNF family receptor, 
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OX40, was slightly increased on splenic and LN cDKO Tregs, and neuropilin-1 (Nrp-1) 
was decreased. These markers correlate with expression of GITR, CD103, KLRG1, and 
PD-1 to establish a phenotype reminiscent of activated or memory Tregs. There are 
significantly reduced frequencies of CD62Lhi Tregs compared to littermate controls, 
suggesting Foxp1/4 deletion alters the expression of CD62L on Tregs as well as 
conventional T cells. However, neither CD4SP nor peripheral CD4 T cells expressed 
GITR, CD103, or other markers observed on cDKO tTregs (data not shown). Therefore, 
combined deletion of FoxP family members elicited a phenotype restricted to cDKO 
Tregs. Further, this phenotype was unique from cells in which either Foxp1 or Foxp4 
was deleted.  
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Figure 5.4 cDKO Tregs express an altered cell surface phenotype. A-B) 
Representative histograms of A) tTreg or B) splenic Treg expression of markers of 
activation. Plots are previously gated on Live, singlet, CD4SP Foxp3+ cells. 
Representative of six independent experiments. 
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cDKO Tregs exhibit loss of suppressive function in vitro. 
The cell surface phenotype of cDKO Tregs suggested these cells may have 
improved effector function. To assess whether the increased expression of cell surface 
markers associated with activation also correlated with increased suppressive function, 
sorted cDKO Tregs were assessed using an in vitro suppression assay.  Briefly, titrated 
numbers of Tregs were cultured with stimulated wild-type (WT) conventional CD4 T cells 
(Tconv). In this assay, suppressive activity correlates with how well Tregs restrain Tconv 
proliferation. Despite expression of an activated phenotype, cDKO Tregs exhibited 
reduced suppression of WT Tconv. Compared to controls, Tconv cells plated with cDKO 
Tregs demonstrated increased proliferation (Figure 5.5A). Enumeration of divided Tconv 
cells in cDKO wells also shows increased total number compared to controls (Figure 
5.5B). Numbers of live cDKO Tregs at the end of the assay were also significantly lower 
than numbers of control Tregs, despite identical starting numbers (data not shown), 
perhaps indicating cDKO Tregs do not survive in culture to suppress Tconv proliferation. 
Taken together, these data suggest cDKO Tregs exhibit reduced suppressive function, 
despite having an activated cell surface phenotype. 
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Figure 5.5. cDKO Tregs exhibit reduced suppressive ability. A) Representative plots 
of CFSE dilution of sorted WT Foxp3- CD4 cells stimulated in vitro with titrated numbers 
of cDKO or Cre control Tregs. Plots depict gray histograms of cell division of cells 
suppressed by sorted Cre control Tregs, and red histograms of cells cultured with cDKO 
Tregs. Ratio of Treg:Tconv is noted in each plot. Representative of 2 independent 
experiments. B) Numbers of expanded daughter cells calculated from CFSE dilution 
frequency of cells in each peak. Data compiled from 2 experiments.  
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Tregs. Splenic CD4 T cells were highly purified from WT, Foxp1cKO, Foxp4cKO, or cDKO 
mice, and cultured with TGFβ, IL-2, and anti-CD3 and anti-CD28 stimulation. The 
concentration of TGFβ was titrated to measure iTreg conversion at low and high doses 
of cytokine. After culture, WT and Foxp4cKO CD4 T cells converted into Foxp3+ Tregs 
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(Figure 5.6A). High levels of TGFβ drove increased frequencies of Foxp3+ Tregs in both 
WT and Foxp4-deficient cells (Figure 5.7B). In contrast, Foxp1cKO and cDKO CD4 T cells 
failed to induce Foxp3 expression in culture, even when cultured with the highest 
concentrations of TGFβ. Excess TGFβ (5ng/mL) also did not result in cDKO iTreg 
development (data not shown).  
Both Foxp1cKO and cDKO CD4 T cells are CD44hi and exhibit an activated 
phenotype. WT and Foxp4cKO CD4 T cells are >80% CD44low naïve T cells. To control for 
initial phenotype differences in the starting populations of CD4 T cells, WT CD44hi CD4 T 
cells were sorted and cultured. Similar to Foxp1cKO and cDKO results, WT CD44hi CD4 T 
cells failed to convert into iTregs, even at the highest concentrations of TGFβ (Figure 
5.6B). CD44hi Foxp4cKO T cells also did not generate frequencies of iTregs comparable 
to naïve CD4 T cell controls. Together, these data indicate that while naïve CD4 T cells 
can induce Foxp3 in vitro and convert to iTregs, CD44hi effector-like CD4 T cells from 
WT or mutant mice are unable to convert into iTregs. Therefore, both natural and 
inducible Treg development is altered in cDKO mice. 
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Figure 5.6. Inducible Treg differentiation requires Foxp1 expression. A) 
Representative plots of CD4 T cells sorted from cDKO mice and controls and cultured 
with IL-2, anti-CD3 and anti-CD28 stimulation, and 0 or 1 ng/mL TGFβ. B) Frequencies 
of Live, TCRβ+ CD4+ Foxp3+ iTregs generated in vitro as in A) with titrated 
concentrations of TGFβ. Data representative of 3 independent experiments. 
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Defective cDKO Treg development is cell intrinsic. 
To assess whether the altered phenotype and frequencies of cDKO tTregs are 
cell-intrinsic, we investigated Treg development in competitive bone marrow chimeras. 
Bone marrow from cDKO (CD45.2+) and wild-type CD45.1+ congenic mice was mixed in 
a 9:1 ratio (Figure 5.7A). We reasoned that this combination would give cDKO 
progenitors an advantage during reconstitution. cDKO:WT chimeras were compared to 
those similarly generated with CrePOS, Foxp1cKO, or Foxp4cKO bone marrow. Eight weeks 
after reconstitution, tTreg generation and cell surface phenotype were evaluated.  
DP and SP thymocyte development was grossly normal in cDKO:WT chimeras 
(Figure 3.9B, Figure 5.7B, far left panels). Chimerism in the DP compartment was also 
similar to that found in the DN and bone marrow B cell compartments (Figure 5.7C, 
Figure 3.8B, and data not shown).  Frequencies of total (CD45.1 plus CD45.2) CD4SP 
and Foxp3+ Tregs were similar across all cohorts (Figure 5.7B and data not shown). 
Within the CD4SP population, approximately 80%-90% of thymocytes were derived from 
CD45.2+ experimental progenitors, regardless of the genotype used for CD45.2+ bone 
marrow, indicating that even under competitive conditions, CD4Cre-mediated deletion 
had no adverse effect on development of this population (Figure 5.7B). In contrast, 
deletion of Foxp1 and Foxp4 resulted in a striking defect in tTreg generation. CD45.2+ 
cDKO-derived cells comprised less than 10% of the total tTreg pool (Figure 5.7B, far 
right panels, and 5.7C). Reduced chimerism of tTregs required loss of both Foxp1 and 
Foxp4, as tTreg development in Foxp1cKO or Foxp4cKO competitive chimeras was 
comparable to CrePOS controls.  These results suggest that either Foxp1 or Foxp4 is 
sufficient for tTreg generation and that expression of at least one of these transcription 
factors at the DP stage or later is required for tTreg development.  
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Previous studies have described a population of CD25+ GITR+ Foxp3- CD4SP 
thymocytes, which are precursors to thymic Tregs (Burchill et al., 2008; Lio and Hsieh, 
2008). To determine whether cDKO tTreg generation is altered at an earlier 
developmental stage or limited to maintenance of mature tTreg, we assessed chimerism 
of the CD25+GITR+Foxp3NEG preTreg population. In cDKO:WT chimeras, the frequency 
of cDKO CD4SP preTregs was approximately 60% of expected, while thymocytes in 
control chimeras exhibited normal preTreg development (Figure 5.7C). Together, these 
data demonstrate that the early stages of tTreg differentiation are dysregulated without 
expression of Foxp1 and Foxp4, but expression of either Foxp1 or Foxp4 is sufficient for 
preTreg and Treg generation.  
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Figure 5.7. Foxp1 or Foxp4 expression is necessary for normal tTreg generation. 
A) Schematic diagram of mixed bone marrow chimera generation. B) Representative 
plots of chimeric thymocytes. Total thymi (Left panel), CD4SP gated chimerism (Center 
left panel), total Foxp3+ CD25+ tTreg (Center right panel), and Foxp3+ CD25+ tTreg 
gated chimerism (Right panel). Data is representative of two individual sets of chimeras 
with 5 mice of each genotype per set. C) Summarized chimerism of developing 
thymocytes from CD45.2+ double negative (DN) cells through DP selection and tTreg 
development. Chimerism is shown as the frequency of CD45.2 (CrePOS, Foxp1cKO, 
Foxp4cKO or cDKO) cells in each given thymic population. Each point represents a mean 
+/- s.d.  
 
We next assessed Treg chimerism in the spleens of chimeric mice. Total 
numbers of splenic Tregs are consistent across chimeric cohorts, as WT cells are able to 
develop normally (data not shown). Loss of Foxp1 or Foxp4 results in decreased 
frequency of CD45.2+ Tregs in respective chimeric cohorts. We compared the relative 
percentage of CD45.2+ Tregs of total CD45.2+ CD4 T cells across cohorts (Figure 5.8A, 
top panels). The frequency of Foxp4cKO Tregs is approximately 50% lower than the 
relative frequency of CrePOS Tregs in CrePOS:WT chimeras. Foxp1 deletion results in 
nearly 75% fewer CD45.2+ Tregs in Foxp1cKO:WT spleens relative to CrePOS. 
Furthermore, the absolute number of CD45.2+ Foxp1cKO Tregs is 10-fold lower than 
numbers of CrePOS-derived Tregs (Figure 5.8B). Deletion of both Foxp1 and Foxp4 
results in the most significant defect. In cDKO:WT chimeras, less than 1% of CD45.2+ 
cDKO CD4 T cells are Foxp3+ (Figure 5.8A, far right panels). Total cDKO-derived 
splenic Treg numbers are 100-fold lower than CrePOS Tregs (Figure 5.8B). Foxp3 
staining of CD45.1+ endogenous WT cells demonstrates the majority of Tregs detected 
in Foxp1cKO:WT and cDKO:WT chimeras are WT Tregs.  
In LN of chimeric mice, the same trend was observed, with loss of Foxp4 or 
Foxp1 resulting in reduced CD45.2+ chimerism. However, cDKO-derived Tregs were 
nearly undetectable in pooled chimeric LN (data not shown). These findings reproduce 
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the same trends observed in non-chimeric mice, in which T cell maintenance in spleen 
and LN were significantly different. Taken together, these data demonstrate 
development defects and competitive disadvantages of Foxp1- or Foxp4-deficient Tregs. 
However, deletion of both Foxp1 and Foxp4 results in the most severe defects, 
suggesting that expression of at least one FoxP family member is necessary for Treg 
generation. 
 
	  
Figure 5.8. CD45.2+ cDKO Tregs are nearly absent in peripheral lymphoid tissues 
of competitive chimera mice. A) Representative plots previously gated on CD45.2+ or 
CD45.1+ CD4SP thymocytes from competitive chimeras in each cohort. Relative 
frequencies of Foxp3+ cells in each population are indicated. Results are representative 
of 10-15 chimeras in each cohort, in 3 independent experiments. B) Absolute numbers of 
CD45.2+ Tregs in the spleens of chimeric mice. Each point represents on chimeric 
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mouse. Mean +/- SD are shown. Statistical analyses generated from a one-way ANOVA, 
and Bonferroni post-test.   
 
cDKO thymocytes signal abnormally through the T cell receptor. 
To begin to address what defects in cDKO cells hinder Treg generation, our 
focus returned to the thymus, where the first defects in competitive chimerism were 
observed. We first investigated signals in the populations from which preTregs develop: 
DP and CD4SP. Because suitable TCR signals are vital for Foxp3- precursor generation, 
we determined whether maturing DP and CD4SP thymocytes expressed normal levels 
of signaling receptors. cDKO DP thymocytes expressed slightly higher levels of CD4, 
TCRβ, and CD5 immediately ex vivo, suggesting higher TCR signaling in these cells 
(Figure 3.3 and data not shown). CD4SP cells also express increased CD4 levels, but 
TCRβ, CD28 and CD5 were comparable to single cKO controls (Figure 4.1A, C, and 
data not shown).  
Next, we assessed whether cDKO thymocytes responded to stimulation 
appropriately in vitro. Resting thymocytes were stimulated with anti-CD3, or anti-CD3 
and anti-CD28 to measure phosphorylation of downstream signaling proteins, Akt and 
Erk1/2, by flow cytometry. DP and CD4SP cells from cDKO thymi responded more 
vigorously to CD3 and CD28 stimulation compared to CrePOS thymocytes (Figure 5.9A-B 
and data not shown). Erk1/2 phosphorylation was consistently reduced in CD4SP cells 
stimulated with anti-CD3 alone, but CD3 and CD28 stimulation resulted in significantly 
increased levels of phosphorylated Akt (pAkt) and phosphorylated Erk (pErk).  
To determine whether cDKO cells exhibit constitutively higher TCR signaling, 
resting levels of pAkt and pErk1/2 were measured. As determined by relative mean 
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fluorescence intensity of pAkt and pErk in cDKO and control thymocytes, resting levels 
of these signaling proteins were not significantly different in DP or CD4SP (Figure 5.9, 
and data not shown).  Therefore, these data demonstrate significantly increased activity 
of Akt and Erk1/2 pathways when cDKO thymocytes are stimulated with anti-CD3 and 
anti-CD28, but relatively normal steady-state kinase activity. 
 
Figure 5.9. cDKO CD4SP T cells display increased signaling to anti-CD3 and anti-
CD28 stimulation in vitro. A-B) Representative plots of phosphorylated A) Erk1/2 or B) 
Akt in CD4SP Foxp3- thymocytes rested for 3 hours, or rested and stimulated in vitro in 
wells coated with anti-CD3 or anti-CD3 and anti-CD28. MFI of pErk1/2 or pAKt is noted 
in each plot. C-D) Compiled MFI of C) pErk1/2 or D) pAkt levels in each culture 
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condition. Mean is indicated MFI is set relative to MFI of WT controls (at 100%) in each 
experiment. Compiled from 3 experiments. 
 
STAT5 signals are dysregulated in cDKO Tregs. 
Development of tTregs requires cytokine signals for induction of Foxp3 
expression (Burchill et al., 2007; Lio and Hsieh, 2008; Turka and Walsh, 2008; Vang et 
al., 2008; Zorn et al., 2006). We evaluated expression of cytokine receptors on the cell 
surface of cDKO preTregs and tTregs. In the thymus, cDKO Foxp3+ tTregs, but not 
Foxp3- preTregs, express higher levels of the IL-2Rα chain (CD25), IL-7Ra chain 
(CD127), and the common gamma chain (CD132) (Fig. 5.10A). These data suggested 
cDKO Tregs possess dysregulated regulation of cytokine receptor genes due to loss of 
Foxp1/4 repression. Alternatively, a selection event occurred between preTreg and Treg 
development in which Tregs expressing the highest levels of cytokine receptors were 
selectively maintained at the expense of Tregs expressing lower levels of cytokine 
receptors. 
We next assessed whether cytokine receptors on cDKO Tregs were functional. 
Levels of phosphorylated STAT5 (pSTAT5) are indicative of γc cytokine signaling 
responses in stimulated cells. We treated thymocytes from cDKO and CrePOS controls 
with individual common gamma chain cytokines to measure pSTAT5 levels. cDKO 
thymic Tregs levels of pSTAT5 after stimulation with IL-2, IL-15 and IL-7 are comparable 
to Cre controls, suggesting proximal cytokine signaling is intact (Figure 5.10B).  
As a result of pSTAT5 translocation and transcription, expression of anti-
apoptotic protein Bcl-2 is induced. To test distal signaling after cytokine treatment and 
Bcl-2 induction in Tregs, we tested survival in vitro. To guarantee a highly purified 
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population of starting Tregs, we utilized cDKO mice that had been crossed to the 
Foxp3GFP reporter mice (Bettelli et al., 2006). We sorted live GFP+ CD4 T cells from 
cDKO or CrePOS Foxp3GFP mice and cultured these cells in the presence of γc 
cytokines IL-2 or IL-7, or media alone. We compared survival and Bcl-2 levels of cDKO 
and CrePOS cells and found a striking defect in cDKO Treg survival (Figure 5.10C). 
Common gamma chain signals partially rescued viable cell numbers, but we found 
cDKO Tregs incubated with IL-2 or IL-7 did not express comparable levels of Bcl-2 after 
24 hours (data not shown). As early as 24 hours after plating, cDKO Tregs were 
detected in decreased numbers compared to controls, regardless of excess cytokine 
signals.  
STAT5 signals generated by common gamma chain (γc) cytokines IL-2, IL-7 or 
IL-15 regulate induction and steady-state protein levels of Foxp3. We examined the 
expression of Foxp3 in cDKO tTregs compared to littermate controls. Variable levels of 
Foxp3 protein was detected in cDKO tTreg compared to controls with a trend toward 
reduced levels (data not shown.) These data together suggest cDKO tTregs are selected 
for the cells expressing the highest levels of cytokine receptor, but pSTAT5 signals fail to 
induce normal levels of Foxp3 and Bcl-2 expression.  
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Figure 5.10. cDKO tTregs express increased cytokine receptors but exhibit 
impaired survival. A) Representative plots of preTreg (top) and tTreg (bottom) cytokine 
receptor expression. Representative of 6 independent experiments. B) pSTAT5 levels in 
preTreg (left) and tTreg (right) stimulated in vitro with IL-7, IL-2 or IL-15. Thymocytes 
were stimulated and stained intracellularly for pSTAT5 protein. preTreg plots are 
previously gated on Live, singlet, GITR+ CD25+ Foxp3- CD4 T cells, and tTreg are 
similarly gated on Foxp3+ cells. C) Survival of live TCRβ+ CD4+ GFP+ T cells from 
CrePOS (black) or cDKO (red) mice expressing the Foxp3-GFP reporter. Sorted GFP+ 
cells were cultured with IL-2, IL-7 or media alone for up to 72 hours. Each point 
represents one well harvested at indicated time points. 
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Impaired cytokine signaling and Foxp3 induction is an intrinsic defect in cDKO 
thymocytes. 
In contrast to normal tTreg numbers in non-chimeric cDKO, competitive chimeras 
demonstrate developmental disadvantages early in tTreg differentiation. To begin to 
understand the mechanism underlying the lack of cDKO-derived tTregs in competitive 
chimeric mice, we assessed cytokine receptor expression and function. CD45.2+ tTregs 
from competitive chimeric cohorts were compared for expression of CD25, CD127, 
CD122 (IL-15Rα/IL-2Rβ), and CD132 (γc). cDKO-derived Foxp3+ tTregs and preTregs 
expressed reduced levels of CD25 and CD127 as compared to endogenous CD45.1+ 
competitor wild-type cells (Figure 5.11A and data not shown). Expression of CD122 and 
CD132 were not significantly different in cDKO tTregs compared with endogenous wild-
type cells (Figure 5.12A bottom panels, and data not shown). Furthermore, CD25, 
CD122, CD127 and CD132 expression by preTregs and tTregs in Foxp1cKO:WT or 
Foxp4cKO:WT chimeras was comparable to CrePOS controls (data not shown). Together, 
these data demonstrate that Foxp1 or Foxp4 may be required for normal expression of 
the high affinity IL-2 and IL-7 receptors on developing tTregs. Furthermore, these 
findings support a model in which Tregs were selected for increased cytokine receptor 
expression under non-competitive conditions. 
To test whether decreased cell surface receptor levels translated to a functional 
signaling defect, we assessed whether cDKO thymocytes from bone marrow chimeras 
received normal signals in response to cytokine stimulation. Thymocytes from 
CrePOS:WT and cDKO:WT competitive chimeras were stimulated in vitro with either IL-2 
or IL-7 and pSTAT5 levels were measured (Figure 5.11C-D, and data not shown). IL-2 
stimulation elicited substantially reduced phosphorylation of STAT5 in both cDKO-
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derived Treg precursors and Tregs. Similarly, IL-7 stimulation resulted in decreased 
pSTAT5 in both pre-Tregs and Tregs compared to endogenous WT competitors and 
CrePOS thymocytes (data not shown). Titration of IL-2 or IL-7 did not rescue pSTAT5 
responses, as stimulation with higher doses failed to compensate for reduced receptor 
expression (data not shown). These data demonstrate that cDKO thymocytes have a 
defect in cytokine-induced phosphorylation of STAT5 and suggest that a defective 
response to cytokine signals is a potential mechanism for the developmental 
disadvantage observed in cDKO preTregs and tTregs. 
We next determined Foxp3 protein levels by mean fluorescence intensity (MFI) of 
Tregs from chimeras (Figure 5.11E). cDKO tTregs from cDKO:WT chimeras expressed 
significantly lower levels of Foxp3, relative to CD45.1+ wild-type tTregs. In contrast, 
Foxp4cKO Tregs and CrePOS controls expressed comparable levels of Foxp3 protein. 
Foxp1cKO tTregs express an intermediate amount of Foxp3 which is significantly lower 
than CrePOS and Foxp4cKO controls, but higher than that found in the cDKO (Figure 
5.11D). Therefore, deletion of both Foxp1 and Foxp4 under competitive conditions 
results in fewer cells expressing Foxp3 with reduced levels expressed on a per cell level. 
	  130	  
 
Figure 5.11. cDKO thymocytes have intrinsic cytokine signaling defects. A) 
Representative staining of cytokine receptor expression, gated on Foxp3+ CD4SP 
thymocytes. Gray histograms are gated on CD45.1+CD45.2-. Black lines are CD45.1-
CD45.2+ gated cells. Data are representative of 4 experiments. B) Relative MFI of 
CD132, CD127 and CD25 from CD45.2+ Foxp3+ cDKO compared with CD45.1+ 
endogenous wild-type cells from the same mouse. Each point represents an individual 
mouse. CD132 and CD127 comparison is compiled from 5 cDKO:WT chimeras from 2 
experiments, and CD25 levels are compiled from ten chimeras from four independent 
experiments.*p<0.005. C-D) Levels of phosphorylated STAT5 following stimulation with 
C) IL-2 or IL-7) in gated CD4SP GITR+CD25+Foxp3NEG (left panels), and CD4SP 
Foxp3+ tTregs (right panels). Gray histograms gated on CD45.1+CD45.2-. Black lines 
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are CD45.1-CD45.2+ cells. E) Relative levels of Foxp3 expression in CD45.2+ tTregs as 
determined by ratio of MFI of CD45.2+/CD45.1+. **p<0.01, ***p<0.0001. 
 
Discussion 
Foxp3-related forkhead family members Foxp1 and Foxp4 are transcription 
factors that homo- and heterodimerize with each other and with Foxp3. Expression 
patterns of Foxp1 and Foxp4 in Tregs demonstrate increased Foxp4 and decreased 
Foxp1 expression. These data suggest that Tregs may not rely on regulation by Foxp1 
and Foxp4 equally. However, while loss of either Foxp1 or Foxp4 transcriptional 
regulation in T cells has little effect on thymic Tregs, combined deletion results in 
abnormal Treg generation.  
Under competitive conditions, reduced frequencies and numbers of CD45.2+ 
cDKO Tregs were detected. In the thymus, single cKO Tregs constituted slightly reduced 
frequencies of total Tregs, compared to CrePOS cells. In the spleen and LN, we found 
reduced numbers of Foxp1cKO- or Foxp4cKO-derived Tregs. These data suggest Foxp1 or 
Foxp4 deletion results in subtle defects in Treg generation, potentially due to impaired 
development or competition. 
We investigated Treg generation in cDKO mice to assess the contribution of 
Foxp1 and Foxp4 expression in Foxp3 regulation. Altered development of cDKO Tregs 
is immediately evident by expression of markers of activation on tTregs. The spleen and 
LN contained significantly reduced numbers of cDKO Tregs, and these cells also 
demonstrate reduced suppressive activity and survival.  
The lack of CD45.2+ thymic Treg in cDKO-derived mixed chimeras contrasts with 
non-chimeric cDKO mice in which relatively normal numbers of tTreg develop. In cDKO 
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mice, ample “space” provided by growth factors may allow cDKO thymocytes to 
differentiate into Foxp3+ Tregs, survive, and expand to fill a Treg niche in vivo. 
Competition with wild-type thymocytes in chimeras limits available cytokine and survival 
signals required for persistence, turnover, and tTreg commitment. Our data cannot 
distinguish whether poor cytokine signaling is the cause of reduced survival of cDKO 
Treg precursors or Foxp3+ thymocytes, or both. Alternatively, impaired Foxp3 
expression may be the primary cause for reduced tTreg development. Understanding 
the precise nature of either a survival or developmental defect will specify how FoxP 
family members affect the course of Treg generation. 
This work suggests several potential molecular mechanisms of Foxp1 and Foxp4 
in tTreg development. Deletion of both genes results in decreased Foxp3 induction or 
stability, and/or tTreg survival. Altered TCR and cytokine signaling in cDKO thymocytes 
may interfere with normal Foxp3 expression or survival of tTregs. Increased pAkt 
signaling is known to hamper foxp3 induction (Haxhinasto et al., 2008; Sauer et al., 
2008), and dysfunctional downstream STAT5 regulation may prevent assembly of the 
transcriptional complex required for foxp3 expression. Alternatively, tTreg development 
may require Foxp1 and/or Foxp4 directly to bind the foxp3 locus. Known interactions 
with histone deacetylases also suggest Foxp1 and/or Foxp4 may participate in 
chromatin remodeling to permit optimal foxp3 transcription. Additionally, FoxP members 
may be required in Foxp3-complexes to preserve stability and function in maintaining a 
Treg phenotype.  Consistent with this model, recent studies have demonstrated Foxp1 
and Foxp4 in Foxp3 oligomeric complexes (Rudra et al., 2012).  
Another possibility is that Foxp1 and Foxp4 may regulate gene programs 
independently of Foxp3. Regulation by FoxP proteins may be required at multiple loci to 
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support preTreg and tTreg maturation and survival. Foxp1 and Foxp4 may have dual or 
exclusive roles in regulating chromatin remodeling and gene targets, including potentially 
CD25 and CD127. Similarly, Foxp1-dependent regulation of naïve T cell development 
may also affect normal Treg development. Loss of naïve CD4 T cells in both Foxp1cKO 
and cDKO mice appeared to impair iTreg differentiation in vitro. Failure of CD44hi 
CD4SP cDKO thymocytes to induce cytokine receptor and/or Foxp3 expression in the 
thymus may further constrict Foxp3+ Treg numbers. In this way, both Foxp1 and Foxp4 
expression impact Treg development, but as an effect of larger genomic regulation and 
histone modification that supports preTreg and tTreg differentiation. Whether FoxP 
proteins function cooperatively or autonomously, these studies demonstrate that FoxP 
family members are necessary for normal Treg development and maintenance of 
tolerance. 
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CHAPTER VI. 
Discussion 
 
 
 
 
Introduction 
The studies described in this thesis have demonstrated novel roles for FoxP 
family proteins in T cell development, differentiation, and function. Previous reports 
demonstrated the necessity for Foxp1 and Foxp3 in T cells: Foxp1 regulates 
development of naïve T cells, and Foxp3 controls development and function of 
regulatory T cells. Known roles for FoxP regulation in T cells, as well as sequence 
homology between FoxP proteins, generated our initial hypothesis that FoxP family 
member Foxp4 also regulates gene programs in the T lineage. Similarity between Foxp1 
and Foxp4 suggested these two proteins may function similarly by recognizing related 
gene targets. FoxP heterodimerization through the conserved leucine zipper domain 
implied Foxp1/3/4 proteins may co-regulate gene targets, and be required in 
combination for normal conventional and regulatory T cell development or function. A 
summary of the findings presented in this thesis, and discussion of recurring themes and 
remaining questions, will be provided in this chapter.  
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I. Foxp4 regulation in effector and memory T cells 
To investigate the hypotheses surrounding Foxp4-specific transcriptional 
regulation, we examined the effects of Foxp4 deletion on normal T cell generation and 
function. From studies of Foxp4cKO CD4Cre mice, we present evidence that Foxp4 is not 
required for development of T cells, but Foxp4 regulation is necessary for normal 
effector/memory T cell functions. Throughout these studies, we found Foxp4cKO CD4 and 
CD8 T cells develop normally, and Foxp3+ regulatory T cells were detected in normal 
numbers and frequencies. Furthermore, lack of autoimmunity suggested normal 
suppressive function of Foxp4cKO Tregs, and that Foxp4 was not necessary for the 
maintenance of self-tolerance in conventional T cells.  
The most notable changes we observed in Foxp4cKO mice were in activated 
effector CD4 T cells and antigen-experienced memory T cells. Expression of Foxp4 was 
transiently increased in activated T cells and suggested a role for Foxp4 in activation 
programs. Furthermore, Foxp4 expression was increased in wild-type Th17-polarized 
CD4 T cells. Our data suggest Foxp4-deficient CD4 T cells more readily differentiate into 
Th17 T cells, and indicate Foxp4 may normally repress Th17 programs. A connection 
between the FoxP family and Th17 differentiation was established from studies showing 
Foxp3 and Th17-lineage transcription factor RORγT antagonize one another. Given 
similarities in FoxP proteins, a similar antagonistic function of RORγT and Foxp4 is 
possible. Like Foxp3, Foxp4 may suppress RORγT regulation and moderate Th17 
responses. In the absence of Foxp4, RORγT is free to enforce Th17 gene expression.  
However, unlike normal Th17 CD4 T cells, increased frequencies of Foxp4cKO 
Th17-polarized T cells produce IL-2. IL-2 typically drives Treg differentiation and inhibits 
Th17 commitment, so Th17 production of IL-2 is counter-productive. IL-2 is a known 
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target of Foxp1 suppression, and one possible reason for unusual IL-2 production in 
Foxp4cKO Th17 cells may be a requirement for FoxP protein expression to limit il2 
transcription. Foxp4 upregulation in Th17 cells indicates this T cell population may 
require Foxp4 specifically for dual roles in moderating IL-2 and IL-17. Further studies to 
determine how Foxp4 regulation alters Th17 commitment may prove Foxp4 is another 
FoxP family member necessary for maintaining the balance between tolerogenic and 
inflammatory CD4 T cell responses. 
The second Foxp4-specific defect we observed was reduced memory T cell 
function. Infection with either viral or intracellular parasitic pathogens was initially 
controlled by Foxp4cKO T cell responses, but cytokine production was reduced following 
rechallenge of memory T cells. From these studies it was unclear which cells required 
Foxp4 expression. LCMV studies suggested CD4 T cells are primarily affected by loss of 
Foxp4 expression, but T. gondii experiments did not distinguish defects in CD4 or CD8 T 
cells, or whether all memory T cells performed poorly to rechallenge with cognate 
antigen. It is possible, therefore, that only cytokine-producing CD4 T cells are affected 
without Foxp4 expression in both models, and cripple effector immune cells that require 
CD4 T cell help. Another possibility is that different infections cause different outcomes 
for CD4 and CD8 T cells. Perhaps LCMV and T. gondii cause different effects in memory 
T cells. Setting aside for the moment whether Foxp4-specific regulation was limited to 
one T cell population or globally affects antigen-specific cells, reduced recall responses 
can be explained by several defects potentially caused by Foxp4 deletion. 
First, our data do not suggest antigen specific memory cells die in LCMV-infected 
Foxp4cKO mice, as tetramer reagents detected similar frequencies and numbers of gp61-
specific CD4 T cells after clearance of the pathogen. However, we did not determine 
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whether gp61-specific CD4 T cells were turning over to account for cell death, or 
whether T. gondii-specific cells persisted normally in chronically infected cohorts. 
Abnormal survival in either case can contribute to overall loss of effector cytokine 
responses. To determine whether cell death is increased, future experiments are needed 
to assess longevity of memory T cell populations. Pulse-chase assays with an 
intracellular marker, such as bromodeoxyuridine (BrdU), measure loss of labeled T cells 
over time. This approach may reveal a change in the rate of cell death by comparing 
changes in numbers of BrdU+ cells.  
Alternatively, Foxp4 expression may be necessary for preventing exhaustion in 
memory T cell populations. Particularly in chronic infection, continued TCR stimulation 
by antigen can cause T cells to lose effector function and transition into an anergic state. 
Reduced IFNγ production in response to STAg or to gp61 stimulation could be a 
consequence of antigen specific T cell exhaustion. It also remains unclear whether 
memory T cell functions are reduced across a spectrum of infections. These data 
suggest anti-viral and anti-parasite responses may be impaired, but challenge with 
fungal, bacterial, or chronic viral pathogens can determine whether the defect in IFNγ 
recall responses are the only affected memory functions in Foxp4cKO T cells. 
Because we assessed memory T cells in peripheral lymphoid tissues or in the 
CNS in T. gondii infection, it is also possible memory T cells simply migrated elsewhere, 
causing the appearance of overall reduced responses. Cell homing and migration 
defects can be interrogated by performing adoptive transfers of Foxp4cKO memory T cells 
into similarly infected host mice, to control for inflammatory conditions. Short-term 
homing assays will determine how transferred populations migrate to peripheral 
lymphoid tissues or sites of inflammation. These data, along with investigation of T cell 
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exhaustion and cell death, are necessary to further define the role of Foxp4 in long-term 
memory responses. 
Taken together, our findings in the Foxp4cKO mouse suggests Foxp4 expression 
is not necessary for normal T cell development, but effector and memory T cells require 
Foxp4 to preserve effector functions, including cytokine production. Expression data 
suggest Foxp4 is maintained until activation of T cells, when Foxp4 expression is 
upregulated. In activated CD4 T cells, Foxp4 regulates T helper cell differentiation. In 
memory T cells, Foxp4 is required to maintain long-term immunity against recurrent 
infections. 
 
Future Directions: Foxp4 regulation in lymphocyte development  
In Chapter II, we demonstrated Foxp4 expression in developing thymocytes, 
peripheral T cells, recently activated T cells, and in polarized CD4 T cells. 
Immunohistochemistry indicated increased Foxp4 expression in cortical regions of the 
thymus, which correlated with patterns of Foxp4 mRNA detected in real-time PCR 
assays. The highest levels of foxp4 transcript were detected in sorted DN3 cells, which 
develop in the thymic cortex before migrating into the medulla. Upregulation of Foxp4 
early in thymic development suggests a critical role for this FoxP family member during 
TCR checkpoints in DN cells. Alternatively, upregulation of Foxp4 in DN3 cells may not 
be part of a developmental program, but a consequence of successful β rearrangement. 
Mature T cells stimulated through the TCR exhibit increased Foxp4 levels. β signaling 
also induces TCR signals, which may alter Foxp1 levels and induce Foxp4 expression.  
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To determine whether Foxp4 is required for T cell development, Cre-mediated 
deletion of the Foxp4FLOX locus can be induced at an earlier stage of development. 
Preliminary studies introduced Cre expression under the lck promoter. In Foxp4cKO 
LckCre mice, Foxp4 is deleted in the T lineage early in the DN stages of thymic 
development. Preliminary data showed decreased thymic cellularity was detected in 
Foxp4cKO LckCre mice, and decreased numbers of developing thymocytes compared to 
CreNEG littermates. However, similar effects on thymic development were observed in 
Foxp4cHET LckCre mice, suggesting a Cre-specific effect. Alternatively, loss of one allele 
of Foxp4 in Foxp4cHET LckCre mice may be sufficient to alter development. Further 
experiments may prove the maturation from DN to DP to be a critical stage for Foxp4 
expression.  
We also induced Foxp4 deletion in hematopoietic precursor populations by 
introducing Cre under the vav promoter. Vav proteins are guanine nuclear exchange 
factor for proteins in the Rho family, and Vav expression in mature T and B cells plays a 
critical role in activated lymphocyte signaling cascades (Ogilvy et al., 1998). Because 
Vav is expressed in hematopoietic precursors, Vav-mediated deletion affects both T and 
B cells (de Boer et al., 2003; Ogilvy et al., 1999). In preliminary studies of Foxp4cKO 
VavCre mice, we detected signs of defective T and B cell development. Numbers of 
Foxp4cKO VavCre total thymi were decreased compared to Foxp4cHET VavCre controls, 
and defects extended to both DN and SP thymocytes. B cell development appeared 
impaired in the generation of immature B cells. FoxP family member Foxp1 is known to 
be important for B cell development (Hu et al., 2006). Therefore, defects in Foxp4-
deficient B cell development fits with known FoxP family member functions. Further 
investigation of both T and B cells from VavCre mice will likely demonstrate Foxp4-
specific defects not observed in Foxp4cKO CD4Cre mice.  
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II. Foxp1 and Foxp4 in the regulation of lymphocyte development. 
In Chapters III-V, we reported the results of the first studies of conditional 
Foxp1/4 double knockout T cells. Unlike Foxp4 conditional deletion studies, the 
consequences of Foxp1 and Foxp4 deletion were observed in both T cell development 
and function. CD4SP and CD8SP thymocytes in both Foxp1cKO and cDKO mice 
expressed abnormally high levels of CD44, but developed in normal numbers despite 
decreased numbers and frequencies of DP cells. Peripheral lymphocytes maintained an 
activated cell surface phenotype, and persisted in reduced numbers. Both CD4 and CD8 
populations appeared to acquire effector functions and undergo abnormal effector 
differentiation. Defective development appeared to occur upon deletion of FoxP proteins 
in developing thymocytes, suggesting thymocyte selection or maturation is altered 
without Foxp1 expression. Consequences of abnormal naïve T cell generation extended 
into CD4 and CD8 T cell number, function, and survival. 
 
cDKO thymocytes exhibit altered T cell receptor signaling. 
In Chapter V, developing thymocytes were stimulated with anti-CD3 and anti-
CD28 to assess signaling pathways involved in Treg differentiation. We found cDKO 
thymocytes have significantly increased levels of phosphorylated Akt and Erk1/2 
proteins immediately after stimulation in vitro. During thymic selection, strong TCR-
generated signals drive CD4SP clones with self-reactive TCR complexes out of the T 
cell repertoire by inducing apoptosis (Gascoigne and Palmer, 2011; Hsieh et al., 2012; 
Jordan et al., 2001; Kishimoto and Sprent, 2000). It is thought thymic Tregs may develop 
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from CD4SP clones receiving strong TCR signals that do not quite reach the threshold 
for clonal deletion (Jordan et al., 2001). Although it is still unknown how strong TCR 
signals directly induce Treg differentiation, one model is that TCR signals drive 
differentiation of a Treg precursor population, called preTregs (Burchill et al., 2008; Lio 
and Hsieh, 2008). In cDKO CD4SP thymocytes, thymic Treg precursor generation may 
be intact due to strong TCR signaling.  
The implications for strong TCR signals for selection of Foxp3- CD4SP and 
CD8SP clones are unclear, however. Although the TCR signaling studies described in 
this thesis focused on cDKO thymocytes, previously published work has demonstrated 
abnormal Erk1/2 signaling in Foxp1cKO peripheral T cells (Feng et al., 2011). Therefore, it 
may be reasonable to assume Foxp1 deletion somehow alters Erk1/2 signaling process 
in both Foxp1cKO and cDKO T cells. Our findings do not extend to other TCR signaling 
pathways that may be dysregulated in cDKO thymocytes. Further work to determine 
whether c-Jun N-terminal kinase (JNK) activity, NFκB, NFAT or calcium signaling is also 
increased in mutant thymocytes would clarify if total TCR signals are altered in cDKO 
mice, and whether thymic selection of a protective T cell repertoire is intact. 
 
Defects in cDKO T cells suggest Akt/Foxo1 dysregulation. 
We find similarities between Foxp1cKO and cDKO Erk1/2 activity, but whether 
Foxp1 deletion is also associated with Akt signaling remains unknown. Levels of 
phosphorylated Akt (pAkt) were significantly increased in cDKO thymocytes compared to 
CrePOS thymocytes, which may explain why Foxo1 gene targets appeared dysregulation 
in cDKO T cells. TCR signaling induces Akt phosphorylation of Foxo1, which prevents 
Foxo1 from translocating into the nucleus (Merkenschlager and von Boehmer, 2010). 
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When Foxo1 is sequestered in the cytoplasm, this forkhead factor is unable to induce 
expression of gene targets including the IL-7Rα chain, and transcription factor Kruppel-
like Factor 2 (KLF2). KLF2 directly induces expression of CD62L, and chemokine 
receptors including CCR7 (Kerdiles et al., 2009; Kerdiles et al., 2010). Both CD62L and 
CCR7 support lymphocyte trafficking to peripheral lymphoid tissues including the lymph 
nodes.  
In cDKO T cells, we find reduced expression of CD62L expression and 
significantly reduced frequencies and numbers of CD4, CD8, and regulatory T cells in 
LN, relative to lymphocytes detected in the spleen. Further evidence for altered KLF2 
regulation was generated from preliminary data to assess expression of another KLF2 
gene target, s1pr1, which encodes sphingosine 1-phosphate receptor type 1, which is 
another cell surface receptor important for lymphocyte trafficking. In cDKO T cells, s1pr1 
were decreased relative to CrePOS controls (data not shown). Therefore, one possible 
mechanism of cDKO T cell migration and IL-7 sensitivity is altered Foxo1 activity, and 
impaired KLF2 expression. 
However, one caveat of this model is that increased pAkt levels were observed 
after strong, direct TCR stimulation, and it is unclear whether baseline, homeostatic 
signals generated by interactions with MHC:self-peptide complexes also induced 
increased pAkt. cDKO lymphocytes characterized throughout these studies were 
harvested and analyzed without TCR stimulation, but still expressed an altered cell 
surface phenotype. Furthermore, resting thymocytes expressed minimal defects in pAkt 
levels, which were not significantly different from levels in resting CrePOS thymocytes. 
Therefore, future work may demonstrate increased pAkt levels are a phenomenon 
limited to stimulated cDKO T cells.  
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Figure 6.1. Model of TCR signaling defects in cDKO T cells. General model of 
signaling through the TCR complex in cDKO T cells. Increased pErk1/2 and pAkt and 
relative changes in downstream targets are indicated by red arrows. *Altered CD62L 
expression may be caused by transcriptional and/or post-translational regulation. 
 
Instead of Akt-dependent Foxo1 sequestration, a possible alternative explanation 
for cDKO cell surface phenotype is a requirement of FoxP protein co-regulation of Foxo1 
gene targets. Forkhead factors Foxp1/4 and Foxo1 may be required to bind the 
promoters of KLF2, or CD62L itself, to induce transcription. Foxp1 and Foxp4 may share 
redundant functions at these loci, accounting for relatively normal KLF2 target 
expression in Foxp1cKO or Foxp4cKO T cells.  
Characterization of cDKO T cells suggests altered regulation of Foxo1 and KLF2 
targets. Taken together with pAkt levels downstream of TCR stimulation, it is possible 
that Foxo1 activity is impaired by Akt-dependent phosphorylation, preventing nuclear 
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translocation in cDKO T cells. But how does the loss of FoxP family members affect total 
TCR signaling pathways? One possibility is that Foxp1/4 regulates expression of 
negative regulators important for modulating TCR signals. For example, phosphatase 
and tensin homologue (PTEN) is a negative regulator of Akt activity in T cells (Suzuki et 
al., 2001; Wang et al., 2000). No evidence exists for direct or indirect FoxP protein 
regulation of PTEN or other phosphatases involved in TCR signal downregulation, 
however, so the grounds for this mechanism are purely hypothetical. Therefore, 
extensive studies are required to investigate whether Foxp1, and possibly Foxp4, 
negatively regulate TCR signaling, to prevent downstream activation of developing 
thymocytes. Or whether Foxp1 maintains a broader program of T cell quiescence and 
chromatin regulation that prevents TCR signaling during thymic selection from causing 
activation and abnormal differentiation of thymocytes. 
 
Foxp1 and Foxp4 regulation of IL-7 receptor signaling and survival. 
Cytokine signaling mechanisms in cDKO T cells also appeared dysregulated. T 
cell lymphopenia in cDKO mice and competitive disadvantages in mixed bone marrow 
chimeras suggested FoxP proteins are required for normal persistence of both CD4 and 
CD8 T cells. Further studies of CD4 T cells cultured in vitro demonstrated poor survival, 
despite addition of excess cytokine. These findings contradicted our predictions that 
increased IL-7R and pSTAT5 levels in cDKO T cells would provide increased survival 
signals.  Instead, both TCR and cytokine pathways exhibit significant defects without 
Foxp1/4 expression, suggesting the FoxP family is critical for T cell development and 
maintenance. 
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Although IL-7Rα expression may be altered due to multiple mechanisms, 
including Foxo1 dysregulation, it was unclear why cDKO T cells also exhibited defects in 
STAT5 regulation. Although cDKO T cells exhibited increased pSTAT5 levels after 
cytokine stimulation, it appeared STAT5 failed to elicit normal Bcl-2 expression and 
survival. It is also unknown whether IL-7R signaling and survival is disconnected in all T 
cells, or whether CD4 T cells and Foxp3+ Tregs are solely affected by loss of Foxp1/4 
expression. Further work to understand how Foxp1/4 regulation affects cytokine receptor 
expression and regulation of STAT5 gene targets may reveal important roles for FoxP 
proteins in T cell homeostasis. 
 
Future Directions: Foxp1 and Foxp4 regulation of immune responses in vivo. 
During an immune response, both antigenic and interleukin signals are vital for T 
cell function. Cumulative defects in both TCR and cytokine signaling pathways 
suggested cDKO T cells may not perform normally during infection in vivo. Preliminary 
experiments in which cDKO mice were infected with T. gondii demonstrated T cell 
responses were significantly impaired. A cohort of mice was sacrificed 10 days after 
infection with Me49 cysts. T cell numbers were significantly reduced compared to CrePOS 
controls, and both CD4 and CD8 T cells exhibited altered cytokine responses in vitro. 
From these studies it was unclear whether effector T cells exhibited impaired survival, 
altered expansion, failed to differentiate, or were susceptible to some combination of 
these defects. Most strikingly, cDKO mice infected with T. gondii did not survive longer 
than 21 days.  
The studies described in this thesis have focused on naïve, uninfected cohorts of 
mice, but future work using model pathogens in single cKO and cDKO mice will provide 
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further insights into how Foxp1 and Foxp4 regulation are required for T cell-specific 
immune responses in acute and chronic infections. Furthermore, Foxp1 and Foxp4 may 
be required for maintenance of memory T cell populations. Cytokine signals support 
long-term survival of antigen-specific memory T cells, which protect the host from 
recurrent infections. It will be interesting to learn whether cDKO mice are capable of 
maintaining CD4 and CD8 memory recall responses and surviving rechallenge. In vivo 
models of infection may demonstrate additional roles for Foxp1 and Foxp4 regulation in 
T cell biology. 
 
III. Foxp1 and Foxp4 regulation of Foxp3+ Treg generation 
Altered generation of regulatory T cells was one of the most profound defects we 
found in the cDKO mouse model. Tregs are fundamental to maintaining peripheral 
tolerance (Gambineri et al., 2003; La Cava, 2009; Ochs et al., 2007; Sakaguchi et al., 
2006; Ziegler, 2006). Regulatory T cell development function requires expression of 
transcription factor Foxp3. Induction of Foxp3 expression requires both TCR- and 
cytokine-generated signals, and participation by multiple downstream transcriptional 
regulators (Hori et al., 2003; La Cava, 2008; Lio and Hsieh, 2008; Merkenschlager and 
von Boehmer, 2010; Passerini et al., 2008; Sauer et al., 2008; Turka and Walsh, 2008; 
Vang et al., 2008; Wuest et al., 2008). Because FoxP proteins can interact through 
leucine zipper domains, we were particularly interested in Treg development in models 
of FoxP protein deletion in T cells. However, previous reports of Foxp1cKO mice and our 
own findings in Foxp4cKO models demonstrated Foxp3+ Tregs developed and functioned 
normally in single cKO mice. 
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Further investigation of Treg development in cDKO mouse models demonstrated 
FoxP proteins do play an important role in the maintenance of Treg populations. cDKO 
mice exhibited reduced frequencies of thymic Treg, and abnormal expression of cell 
surface markers associated with Treg activation. Furthermore, competitive bone marrow 
chimeras revealed significant developmental disadvantages in cDKO Tregs. Putative 
GITR+CD25+Foxp3- thymic Treg precursors exhibited competitive defects in mixed 
bone marrow chimeras, suggesting thymic development of Tregs was impaired at the 
earliest stages of differentiation.  
Under competitive conditions, cDKO thymic Treg development was significantly 
impaired. In bone marrow chimeras, cDKO-derived preTreg and tTreg expressed 
decreased IL-2Rα (CD25), which correlated with reduced pSTAT5 signaling. Signaling 
through γc chain receptors is required for normal induction of Foxp3. IL-2 signaling in 
particular is a critical regulator of Treg development and maintenance. Loss of IL-2 
signaling likely contributed to significantly reduced chimerism in tTreg and peripheral 
Treg populations.  
 
Future Directions: Rescuing cDKO Treg development 
Questions remain regarding the regulation of CD25 in cDKO Tregs. Altered 
CD25 may be caused by several defects: loss of Foxp1 and Foxp4 directly affects CD25 
transcription, abnormal TCR signals in cDKO T cells results in abnormal CD25 
expression, or Foxp3 itself fails to maintain increased CD25 levels. Abnormal expression 
of CD25 on Foxp3- preTreg populations suggests initial induction of CD25 is impaired. 
TCR signaling in CD4SP is thought to induce expression of CD25 on preTreg 
populations. Subsequent IL-2 signaling induces Foxp3 expression. TCR signals regulate 
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CD25 expression through activity of transcription factors, NFAT and AP-1 (Wu et al., 
2006). FoxP family members interact with NFAT, but it remains unclear whether Foxp1/4 
bind the il2ra promoter to induce CD25 expression. Further studies to examine Foxp1/4 
binding of the il2ra promoter using chromatin immunoprecipitation should clarify direct or 
indirect FoxP family regulation of cytokine signaling pathways. 
Because IL-2 signaling appears deficient in cDKO Tregs, supplying STAT5 
signals artificially may rescue defects in cDKO Treg cellularity and survival. Here we 
propose infection of cDKO T cells with retroviral transgenic vectors encoding 
constitutively active STAT5 (CA-STAT5) to rescue Treg development. If the main defect 
in Treg development is loss of normal IL-2 signals, CA-STAT5 expression should rescue 
Treg numbers. Additionally, similar defects in STAT5 signaling may cause T 
lymphopenia and poor survival of conventional cDKO T cells. Parallel studies with 
artificial STAT5 or transgenic Bcl-2 expression in conventional cDKO T cells may repair 
cytokine signaling defects and produce improved cDKO T cell numbers and survival. 
Secondly, it remains unknown whether Foxp3 itself is a target of Foxp1/4 
regulation. Decreased expression of Foxp3 was detected in Tregs from both cDKO mice 
and cDKO:WT bone marrow chimeras. These data suggest loss of Foxp1/4 results in 
altered Foxp3 expression and/or maintenance. While cDKO T cells appear capable of 
inducing Foxp3 expression, it is possible that stabilization of Foxp3 protein requires 
Foxp1/4 protein interaction. Co-immunoprecipitation of Foxp3 and FoxP family members 
indicates these proteins can bind, but the purpose of these interactions remains unclear. 
Alternatively, Foxp3 does not require direct binding with Foxp1/4 proteins, but with 
transcription factors regulated by FoxP family members. Runx family members Runx1 
and Runx3, as well as FoxO proteins, Foxo1 and Foxo3, play vital roles in the 
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expression and stability of Foxp3 (Kerdiles et al., 2010). FoxP family interactions with 
FoxO and Runx proteins have already been reported (Feng et al., 2011; Kerdiles et al., 
2010; Klunker et al., 2009; Merkenschlager and von Boehmer, 2010; Zhang et al., 2008), 
but how Foxp1 and Foxp4 may interact with these transcription factor families in Tregs 
has not been investigated. 
 
Future Directions: Investigation of Foxp1/4 regulation of Treg maintenance 
Studies described in this thesis are limited to CD4Cre-mediated deletion of both 
Foxp1 and Foxp4. cDKO Treg development under competitive conditions demonstrated 
defects in cytokine signaling and Foxp3 expression. Further investigation of how 
Foxp1/4 regulates Treg maintenance may be potentially complicated by combined 
defects in generation and homeostasis. To limit our focus to Foxp1/4 regulation in Treg 
maintenance, we have bred Foxp1FLOXFoxp4FLOX mice to Foxp3Cre mice, which express 
Cre under the foxp3 promoter (Rubtsov et al., 2008). In these mice, T cells develop 
normally, until Foxp3 expression is induced during Treg generation. Cre-mediated 
deletion is limited to Foxp3+ regulatory T cells, which allows us to study Foxp1/4-
deficient Tregs without the complications of lymphopenic conditions and activated T cells 
in cDKO CD4Cre mice. Furthermore, Foxp3Cre activity in Tregs can be determined by 
YFP reporter expression (Rubtsov et al., 2008).  
Preliminary results from cDKO Foxp3Cre mice suggest cDKO YFP+ Tregs 
develop in reduced frequencies and numbers compared to undeleted Tregs in the same 
mouse. Similarly altered patterns of cell surface markers are expressed, but it remains 
unclear whether that is a cell-intrinsic event. Together with cDKO CD4Cre data, these 
findings suggest Foxp1/4 regulation is not only important generation of Tregs, but also 
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for Treg survival and maintenance.  In addition to future directions in cDKO CD4Cre 
mice described above, further investigation of Treg maintenance in cDKO Foxp3Cre 
mice will expand models of Foxp1 and Foxp4 regulation in Foxp3+ Tregs. 
 
Future Directions: Runx:FoxP family interactions 
The Runx (Runt-related transcription factor) family of transcription factors are 
critical for T lineage development and function (Collins et al., 2009; Egawa et al., 2007; 
Grueter et al., 2005; Tani-ichi et al., 2013; Wong et al., 2011a). The Runx family 
expresses the highly conserved RUNT DNA-binding domain. Three proteins (Runx1-3) 
comprise the Runx family, but only Runx1 and Runx3 are expressed in T cells (Collins et 
al., 2009; Egawa et al., 2007; Wong et al., 2011a). Runx1 is highly expressed in CD4 T 
cells, and Runx3 expression is highest in CD8 T cells and CD4 T cells polarized to the T 
helper 1 (Th1) subset (Collins et al., 2009; Wang and Bosselut, 2009; Wong et al., 
2012). In both CD4 and CD8 T cells, Runx family members control lineage commitment, 
cell cycle and proliferation, and differentiation (Blyth et al., 2005). Previous studies have 
also demonstrated Runx1/3 regulation is necessary for expression of Foxp3 and stability 
of Foxp3 protein in regulatory T cells (Klunker et al., 2009; Rudra et al., 2009). As 
discussed earlier, abnormal Treg development and altered expression of Foxp3 protein 
on a per cell basis may correlate with reduced Runx1 regulation in the CD4 T lineage.  
Characterization of cDKO T cells revealed further defects that closely resemble 
dysregulation observed in Runx family knockout T cell models. Known interactions 
between Foxp3 and Runx family members Runx1 and Runx3 further support models of 
FoxP:Runx protein interactions in T cells (Bruno et al., 2009; Klunker et al., 2009; Ono et 
al., 2007). However, it must be asserted that the FoxP:Runx models discussed below 
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are purely speculative, and intended to generate hypotheses. Similarity between Runx 
and FoxP findings are simply correlative and require extensive work to prove causation. 
Runx1 regulation in developing thymocytes provides anti-apoptotic signals, and 
Runx1-deficient DP thymocytes were detected in reduced numbers (Egawa et al., 2007; 
Wong et al., 2012). Runx1-/- DP exhibited increased expression of Fas and Bim, pro-
apoptotic proteins, and poor survival (Wong et al., 2012). In Chapter III, we determined 
reduced thymic cellularity was due to reduced numbers and frequencies of DP 
thymocytes. A possible explanation for decreased DP populations in cDKO thymi may 
be loss of Runx-dependent survival signals.  
 
 
Figure 6.2. Schematic of Runx1-regulated gene targets in the CD4 T lineage.  
Runx1 expression in the CD4 T lineage promotes CD4SP thymocyte development and 
homeostasis of peripheral CD4 T cells, partially through regulating IL-7R expression. 
Runx1 inhibits apoptosis of double positive thymocytes during selection, and impedes IL-
2 production by naive CD4 T cells. 
 
Runx1cKO T cells exhibit the CD44hiCD62Llo phenotype described in cDKO T cell 
populations (Wong et al., 2012). Separate studies with Runx1cKO cells expressing the 
Bcl-2 transgene were designed to prevent cell death and assess populations of 
peripheral Runx1-deficient CD4 T cells (Wong et al., 2012). Runx1cKO Bcl-2Tg CD4 and 
CD8 T cells acquired an activated phenotype, including increased expression of CD44 
and decreased CD62L, similar to that observed in cDKO cells (Wong et al., 2012). This 
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defect proved to be a cell intrinsic effect of losing Runx1 regulation. This phenotype 
mirrors CD4 T cells in cDKO mice, and mixed bone marrow chimeras demonstrated this 
phenotype is also a cell-intrinsic phenomenon. However, activated Runx1-deficient T 
cells caused pathology in the lungs of Runx1cKO mice (Wong et al., 2012). We do not see 
similar signs of pathology in cDKO mice. One reason for the lack of pathology in cDKO 
mice may be because cDKO T cells do not survive long enough to cause substantial 
pathology. cDKO T cells are not supported by Bcl-2 expression and may experience a 
shorter lifespan relative to Runx1cKO Bcl2Tg populations. 
Effector T cell functions also require Runx1 expression (Wong et al., 2011a; 
Wong et al., 2012; Wong et al., 2011b; Zhang et al., 2008). Runx1 represses IL-2 
production in CD4 T cells (Wong et al., 2011b). Loss of Runx1 and FoxP regulation may 
explain abnormally high IL-2 production by cDKO T cells in vitro. Furthermore, Runx1 
participates with RORγT to upregulate IL-17 production and support Th17 commitment 
(Zhang et al., 2008). In Foxp4cKO mice, slightly increased Th17 effector functions were 
observed in polarized CD4 T cells. In cDKO cells, the frequency of IL-17-producing 
effector T cells immediately ex vivo was reduced. Further work is required to investigate 
whether cDKO T cells are incapable of mounting Th17 responses.  
Th1 differentiation of CD4 T cells also requires either Runx1 or Runx3 regulation 
(Lee et al., 2009; Wong et al., 2011a; Wong et al., 2012; Zhang et al., 2008). Runx1/3 
interact with T-bet, the prototypical regulator of Th1 gene programs (Lee et al., 2009). 
Together, these factors are potent inducers of IFNγ production. Stimulation of both CD4 
and CD8 cDKO T cells revealed decreased IFNγ responses. CD4 T cells expressed 
nearly undetectable levels of IFNγ, suggesting complete loss of IFNγ regulation. But 
without Th1 polarizing studies, it remains unclear whether Foxp1/4-deficient CD4 T cells 
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are capable of differentiating into any T helper subsets. Therefore, future work is 
required to assess how cDKO T cells react to polarization. Further studies to observe 
whether Foxp1/4-deficient CD4 T cells are resistant to differentiation, or whether multiple 
Runx-dependent pathways are dysregulated, will refine or refute this model. 
 
Figure 6.3. Models of Foxp1/4 and Runx regulation of selected gene targets in CD4 
T cells. (Left) FoxP proteins induce Runx1 expression, indirectly regulating downstream 
targets and gene programs. (Right) Foxp1/4 bind to Runx1 gene targets to co-regulate 
Runx targets. Loss of Foxp1/4 in either case results in loss of Runx1 gene target 
regulation. 
 
 Perhaps the best evidence for Runx family dysregulation in cDKO T cells is 
abnormal expression of CD4 protein, as discussed in Chapter IV (Collins et al., 2011; 
Egawa et al., 2007; Taniuchi et al., 2002; Wang and Bosselut, 2009). CD4 levels are 
increased on both CD4 and CD8 T cells in cDKO mice. These data suggested 
dysregulation of Runx-dependent regulation of CD4. Runx3 is required for silencing of 
the cd4 locus in CD8 T cells (Taniuchi et al., 2002; Wang and Bosselut, 2009). The 
population of CD4dimCD8 T cells observed in cDKO mice correlates with loss of cd4 
silencing. Runx3 directs chromatin remodeling that normally mutes CD4 expression on 
MHC Class I-restricted CD8 T cells (Taniuchi et al., 2002). However, it is unclear 
whether FoxP family members directly participate in CD4 silencing, or indirectly control 
CD4 levels through regulating Runx1/3 expression. 
Runx1 
IL-2, apoptosis 
Foxp1/4 
FoxP protein regulation of Runx1 expression FoxP:Runx1 cooperative regulation of gene targets 
IL-7R, homeostasis 
Runx1 
IL-2, apoptosis 
Foxp1/4 
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Several caveats permeate this model, however. Runx1 also promotes CD4SP 
differentiation. Whereas other findings suggest loss of Runx1 activity, we observe 
increased frequencies of CD4SP cells in cDKO thymi. Inconsistencies in CD8 T cell 
findings also suggest Runx regulation is not the entire solution to altered cDKO T cell 
development. 
In CD8 T cells, Runx3 regulation suppresses CD4SP development and promotes 
differentiation of CD8SP thymocytes (Collins et al., 2009; Grueter et al., 2005; Wang and 
Bosselut, 2009). Deletion of Runx3 causes disruption of the CD4:CD8 T cells ratio 
observed in both thymus and peripheral lymphoid organs (Djuretic et al., 2009; Grueter 
et al., 2005). cDKO mice do not appear to have the same phenotypic changes as 
Runx3cKO mice. It has been reported that Runx1 and Runx3 can compensate for one 
another (Collins et al., 2009; Wong et al., 2011a; Wong et al., 2012), but we must just as 
quickly accept Runx3 function may be normal in cDKO CD8 T cells.  
In conclusion, several questions surround the interactions between Forkhead 
transcription factors and Runx family proteins. However, the correlation between several 
reported Runx1cKO defects and the cDKO phenotype in T cells provokes further 
investigation.  
 
The relationship between Foxp1 and Foxp4 in T cells 
Several features of the relationship between Foxp1 and Foxp4 became apparent 
from these studies. Setting aside the specific effects of single or combined FoxP protein 
deletion in T cells, these studies illustrate important lessons about the behavior of Foxp1 
and Foxp4. Firstly, Foxp1 and Foxp4 regulate both sovereign and common gene targets 
in the T lineage. Secondly, Foxp1 and Foxp4 regulation is different in CD4 and CD8 T 
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cells. Lastly, naïve and activated T cells appear to require different FoxP family member 
regulation. 
Previous experiments in cardiac tissues demonstrated Foxp1 and Foxp4 have 
non-redundant roles: Foxp1 is required for shaping normal vasculature and controlling 
cell growth in cardiomyocytes (Bai and Kerppola, 2011), while Foxp4 directs localization 
of cardiac tissues during embryogenesis and controls cell death of cardiopulmonary 
tissues (Li et al., 2004b). In contrast, pulmonary epithelial tissues exhibit specific 
requirements for Foxp2 for cell maturation and differentiation, but Foxp1 and Foxp4 
serve redundant roles. Similarly, we find evidence in T cells of specific Foxp1 gene 
programs, such as maintaining naïve T cells, and suppressing effector-like 
differentiation. Foxp4 is not capable of compensating for loss of Foxp1 to maintain these 
gene targets.  
However, we identified at least two cases in which Foxp1 and Foxp4 can partially 
compensate for one another: the expression and repression of CD4, and supporting 
cytokine receptor expression on thymic Tregs. Foxp3+ regulatory T cell development 
progresses relatively normally with either Foxp1 or Foxp4 expression, suggesting these 
proteins may be functionally redundant in this process. Therefore, Foxp1 and Foxp4 
regulate specific gene targets in T cells, but some examples support redundant Foxp1/4 
compensation function redundantly.  
FoxP family member regulation of gene targets is different in CD4 and CD8 T 
cells. Differences in the frequency of CD62Llo CD4 and CD8 T cells suggest altered 
development or maintenance of Foxp1/4-deficient cells expressing effector memory or 
central memory phenotypes. CD8 T cells consistently included more CD62Lhi cells than 
CD4 populations. Similarly, patterns of IL-7R expression in CD4 and CD8 T cells 
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indicate disproportionate regulation at another locus. Expression of many different 
transcription factors contribute to CD4 versus CD8 T cell differentiation, so the finding 
that FoxP members regulate targets differently in either population is perhaps obvious. 
Transcription factors in either the CD4 or CD8 T lineage likely shape the availability and 
accessibility of FoxP gene targets. However, these data strongly support the conclusion 
that Foxp1 and Foxp4 regulation is tailored to each cell type. 
Lastly, naïve T cells appear to require Foxp1 for normal development, while 
activated effector or antigen-experienced memory T cells rely on Foxp4 regulation. Our 
data and others’ support a model in which Foxp1 is highly expressed in naïve T cells to 
maintain a dormant, naïve state. Upon T cell activation, Foxp1 is downregulated, and our 
data indicate Foxp4 is upregulated (Heng and Painter, 2008; Rudra et al., 2012; 
Wiehagen et al., 2012). In Th17 T cells and long-lived memory T cells, Foxp4 regulates 
effector functions, through mechanisms that remain unclear.  
In the studies described in this thesis, crossover between Foxp1 and Foxp4 
regulation appears to be limited to relatively few gene targets, and Foxp1 and Foxp4 do 
not compensate well for one another in single cKO models. Separate expression 
patterns of Foxp1 and Foxp4 may prevent complete compensatory functions in the FoxP 
family. Additionally, Foxp1 and Foxp4 may have evolved specificity for gene targets 
common to naïve or activated T cells, respectively, to moderate cell fate decisions of T 
cells requiring diverse transcriptional regulation. Once Foxp1 is downregulated following 
activation, the global changes to chromatin remodeling and transcriptional activity during 
T cell differentiation may expose Foxp4 consensus binding sites. Foxp4 is then capable 
of regulating differentiation function of activated T cells. In antigen-experienced memory 
T cells, Foxp1 expression remains reduced, which may allow Foxp4 to control the 
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stabilization of cytokine gene loci and effector programs important for long-term 
immunity. Through these opposing patterns of expression, Foxp1 may regulate FoxP 
gene targets from early in development of naïve T cells, while Foxp4 assumes 
transcriptional control in effector and memory T cells. This division of duties between 
Foxp1 and Foxp4 may then provide regulation of cell fate decisions throughout the life of 
T cells.  
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CHAPTER VII. 
Materials and Methods 
 
 
 
Generation of Foxp4cKO Mice 
Foxp4FLOX mice were generated by introducing LoxP sites flanking exons 12,13 
encoding Forkhead DNA binding domain by standard recombineering (Liu et al., 
2003). A 5′ LoxP site was introduced in the intron between exons 11 and 12, and 
a 3′ LoxP site was introduced in the intron between exons 13 and 14. Southern 
blot analysis with both 5′ and 3′ probes were used to verify homologous 
integration. Correctly targeted ES clones were injected into blastocysts to 
generate chimeric mice, which were further bred to C57BL/6 mice with 
successful germline transmission of the mutant Foxp4 allele. The neomycin 
resistance cassette was subsequently removed by intercrossing with Flpe 
transgenic mice (JAX ACTFLPe-9205Dym/J). CD4-Cre mice were purchased 
from Taconic (Lee et al., 2001). Foxp4null mice have been described (Li, Zhou et 
al. 2004).  All mice used were backcrossed to C57BL/6 for 1-2 generations.  Mice 
were housed and bred in the University of Pennsylvania mouse facility.  All 
animal experiments were performed in accordance with the University of 
Pennsylvania Institutional Animal Care and Use Committee guidelines.  
	  159	  
 
Real-time PCR and probes 
Total RNA was extracted from sorted splenocytes or thymocytes derived from 
adult mice with TRIZOL (Invitrogen, Karlsruhe, Germany) following the 
manufacturer's instructions.  Five nanograms of DNase treated RNA were 
reverse transcribed in a 20µl reaction, using First Strand cDNA Synthesis Kit 
(Amersham Bioscience, Freiburg, Germany). The following TaqMan® assays 
and primers were employed: Mm00466368_m1 (FoxP4), and FAM-MGB 
4352933E (beta-Actin). Applied Biosystems Inc. probe sequences are as follows: 
Foxp4-Fwd (5’ ATCGGCAGCTGACGCTAAATGAGA 3’), Foxp4-Rev (5’ 
AAACACTTGTGCAGGCTGAGGTTG 3’).  Expression levels of Foxp4 were 
normalized to beta-actin.  Fold changes were analyzed with the 2−ΔΔCt method. 
 
Antibodies and Flow Cytometry 
Fluorochrome-conjugated antibodies used for staining were purchased from 
BioLegend, eBioscience, Invitrogen, BD Biosciences, Beckman Coulter, or 
Caltag Laboratories. Lymphocytes from spleen were isolated after hypotonic lysis 
with BioWhittaker ACK solution (Lonza). For intracellular cytokine analysis, cells 
were stimulated in the presence of Brefeldin A with media alone, 2C11 (BioXCell, 
West Lebanon, NH), or with 5 ng/mL phorbol myristate acetate (PMA) and 1 
µg/mL Ionomycin. After stimulation, cells were harvested and stained using a 
Cytofix/Cytoperm kit (Becton Dickinson) according to the manufacturer's 
instructions. All samples were acquired using an LSRII flow cytometer (Becton 
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Dickinson) and analyzed using FlowJo Version 8 (TreeStar). A cocktail of Pacific 
Blue-conjugated CD11b (Invitrogen), CD11c (Biolegend), Gr-1 (Biolegend), B220 
(Biolegend), NK1.1 (Biolegend) and F4/80 (Caltag) was used to identify lineage 
negative thymocytes for sorting and real-time PCR.  
 
Proliferation assay 
Spleens were harvested and dissociated into single cell suspension between the 
frosted sides of two glass slides. Erythrocytes were lysed by hypotonic shock, 
and splenocytes were washed in T cell media (RPMI [Invitrogen] with 10% FBS, 
1% penicillin/streptomycin, 10 mM HEPES, and 1 × 10−5 M 2-ME). Cell counts 
were performed using a hemocytometer and Trypan Blue dead cell exclusion. 
Cells were labeled with CFSE by washing with room temperature PBS, 
resuspending at 1 × 107 cells/ml PBS, and mixing with an equal volume of PBS 
containing CFSE (2µM final concentration). Cells were gently mixed continuously 
for 3 minutes. The reaction was quenched with 100% FBS, and cells were gently 
mixed for an additional 2 min in the presence of quench before centrifugation. 
CFSE-labeled unfractionated splenocytes were plated at 1 × 106 cells/well in 100 
µl T cell media into round-bottom wells of a 96-well plate coated overnight with 
serial dilutions of anti-CD3 (2C11) in PBS and washed three times with PBS. On 
the fourth day, cells were harvested, stained, and analyzed by flow cytometry. 
Live cells were detected by flow cytometry by staining with LIVE/DEAD Fixable 
Aqua Dead Cell Stain Kit (Invitrogen). 
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Generation of iTreg 
Single cell suspensions were prepared from spleens as described above, and 
cells were stained with FITC-CD4 (eBioscience), PerCPCy5.5-CD25 (BD 
Pharmingen), Pacific Blue-CD44 (Biolegend), and APC- or PECy7-CD62L (BD 
Pharmingen or Biolegend, respectively). Naïve T conventional cells, defined as 
CD4+CD25-CD44loCD62Lhi, were separated using flow cytometric sorting on Aria 
(BD Biosciences), and plated in a 48-well flat bottom plate. Cells were plated at 
0.5 × 105 cells/well in a total of 400µL T cell media (RPMI [Invitrogen] with 10% 
FBS, 1% penicillin/streptomycin, 10 mM HEPES, and 1 × 10−5 M 2-ME) including 
stimulus. Wells were pre-coated with 5µg/ml anti-CD3 (2C11) and cultured in the 
presence of 5µg/mL soluble anti-CD28, 50U/mL IL-2 (R&D) in the presence or 
absence of 5ng/mL TGFβ (R&D). After 4 days, wells were harvested and cells 
were stained for cell surface expression of CD4 and CD25, and intracellular 
Foxp3 protein using Invitrogen anti-Mouse/Rat Foxp3 Staining Set (APC) as per 
manufacturer’s instructions. Live cells were detected by flow cytometry by 
staining with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Invitrogen). 
 
In vitro T cell activation marker upregulation 
Whole splenocytes were isolated, counted, and suspended at 1 × 107 cells/mL. 
Wells of a 96-well round bottom plate were coated overnight with 1µg/mL anti-
CD3 (2C11) and washed three times with PBS before plating. 1 × 106 
unfractionated splenocytes in 100µL T cell media were plated on coated wells 
with 5µg/mL soluble anti-CD28, or left unstimulated in media in uncoated wells.  
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After a 24-hour stimulation, half of the wells were harvested and stained for 
PacificBlue-CD4, APCCy7-CD8, PerCP-Cy5.5- CD69, PECy7-CD127, FITC-
CD44, APC-CD62L for polychromatic flow cytometry on LSRII. Four days after 
plating, the remaining wells were harvested and cells stained with the same 
cocktail. 
 
Infection with Toxoplasma gondii  
An i.p. injection of 20 cysts of T. gondii ME49 strain, isolated from brains of 
infected CBA/CaJ mice, was used for infection. For measurement of parasite 
burden, the 35-fold repetitive T. gondii B1 gene was amplified by real-time PCR 
as described (Stumhofer et al., 2006). Soluble tachyzoite antigen was prepared 
from tachyzoites of the RH strain as described (Sharma et al., 1983). BMNCs 
from individual chronically infected mice were isolated in accordance with a 
published protocol(Wilson et al., 2005). 
 
Infection with Lymphocytic Choriomeningitis Virus  
Mice received 2 × 105 plaque-forming units (PFUs) of LCMV-Armstrong by 
intraperitoneal injection. 
 
Analysis of IFNγ production by ELISA 
A two-site enzyme-linked immunosorbent assay (ELISA) was employed to assay 
levels of IFN-γ as previously described (Cai et al., 2000; Sander et al., 1993). 
Briefly, spleens were dissociated in complete RPMI (10% heat-inactivated fetal 
	  163	  
calf serum, 2 mM glutamine, 1,000 U of penicillin per ml, 10 µg of streptomycin 
per ml, 0.25 mg of amphotericin B [Fungizone], 10 mM HEPES [Gibco, Grand 
Island, N.Y.], 1 mM sodium pyruvate, 1% [vol/vol] nonessential amino acids 
[Gibco], 5 × 10−5 M 2-mercaptoethanol) to give a single cell suspension. Brain 
tissues were processed as previously described (Wilson et al., 2005). After lysis 
of erythrocytes, cells were washed twice and plated out at 105/well in a final 
volume of 200 µl. Cultures were stimulated with anti-CD3 or RH strain Soluble 
tachyzoite antigen (STAg) or in media for 24 hours. rmIFN-γ was purchased from 
Genzyme (Cambridge, Mass.) 
 
Statistical Analyses 
Where indicated, p values were determined by a 2-tailed unpaired Student t-test 
or one-way ANOVA. Dunnett of Bonferroni post-tests were used, as described in 
figure legends. p values <0.05 were considered statistically significant. All graphs 
show mean ± SD calculated in Prism software (GraphPad). 
 
Generation of cDKO Mice. Foxp1FLOX and Foxp4FLOX have been previously 
described (Feng et al., 2010; Li et al., 2012; Zhang et al., 2010). CD4-Cre mice 
were purchased from Taconic (Lee et al., 2001). B6.CD45.1 mice were originally 
obtained from Taconic and were maintained in our facility.  All mice used were 
backcrossed toward C57BL/6 for at least 1–2 generations. Mice were housed 
and bred in the University of Pennsylvania mouse facility. All animal experiments 
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were reviewed and approved by the University of Pennsylvania Institutional 
Animal Care and Use Committee.  
 
Generation of Foxp3GFP reporter cDKO Mice. cDKO mice (described above) 
were crossed with mice expressing the Foxp3-GFP knock-in transgene as 
described in (Bettelli et al., 2006). Wild-type mice expressing CD4Cre were also 
bred as controls to express the Foxp3 reporter (CrePOS Foxp3-GFP mice). 
 
Generation of mixed bone marrow chimeras. Bone marrow harvested from wild-
type CD45.1+ C57Bl/6, Foxp1+/+Foxp4+/+Cre+ (CrePOS), Foxp1Flox/FloxFoxp4+/+Cre+ 
(Foxp1cKO), Foxp1+/+Foxp4Flox/FloxCre+ (Foxp4cKO), and 
Foxp1Flox/FloxFoxp4Flox/FloxCre+ (cDKO) mice were depleted of CD4 (GK1.5 clone) 
and CD8 (2.43 clone) expressing cells by magnetic separation. CrePOS, 
Foxp1cKO, Foxp4cKO or cDKO T-depleted bone marrow was then mixed in a 9:1 
ratio with wild-type marrow cells, and injected intravenously into lethally irradiated 
wild-type CD45.1+/CD45.2+ C57Bl/6 mice. Chimerism was determined in B cell 
gated bone marrow at the time of analysis. 
  
Antibodies and Flow Cytometry. Fluorochrome-conjugated antibodies used for 
staining were purchased from BioLegend, eBioscience, Invitrogen, BD 
Biosciences, Beckman Coulter, or Caltag Laboratories. Thymocytes were 
isolated, counted, and stained in FACS buffer (1% FCS in PBS) for 30 minutes. 
Intracellular staining for Foxp3 was performed using a Foxp3 Staining Buffer kit 
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(eBioscience, cat. 00-5523-00) with Pacific Blue Foxp3 (BD Biosciences, 
561182) or APC Foxp3 (eBioscience, 17-5773), according to the manufacturer’s 
instructions. All samples were acquired using an LSRII flow cytometer (Becton 
Dickinson) and analyzed using FlowJo Version 8 (TreeStar). 
 
In vitro stimulation and intracellular staining for STAT5 phosphorylation.  
Freshly isolated thymocytes were rested two hours in a 37°C water bath. 5x106 
cells were stimulated with 100U IL-2 (Sigma) for 30 minutes, or 1ng/mL IL-7 for 
20 minutes, or left unstimulated. At end of stimulation, cells were fixed in 10% 
paraformaldehyde for 10 minutes at room temperature, washed in PBS, and 
pelleted. Cells were resuspended in 90% ice-cold methanol and incubated on ice 
for at least 30 minutes.  Cells were then washed in staining buffer and allowed to 
reconstitute for 30 minutes on ice in PBS with 2% FCS before incubation with 
antibodies to surface markers for 30 min at room temperature.  
 
In vitro survival assay. 
Spleen and LN cells were pooled from cDKO or CrePOS mice. CD4+TCRβ+ 
Foxp3GFP- conventional T cells or CD4+TCRβ+ Foxp3GFP+ Tregs were sorted 
by flow cytometry using FACS Aria II. Cells were washed, counted, and plated at 
50,000 cells/well. Cells were cultured at 37C. in cRPMI supplemented with 
recombinant IL-2 (10 ng/ml) or recombinant mouse IL-7 (10 ng/ml) (R&D 
Systems), or cRPMI alone. Wells were harvested 24, 48, or 72 hours after 
plating, and stained for Live CD4+ TCRβ+ and GFP reporter expression. 
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In vitro thymocyte stimulation assay for phosphorylated Akt or Erk1/2. 
Whole thymocytes harvested from cDKO or CrePOS mice were aliquoted at 5x106 
cells/mL and rested for 3 hours in eppendorf tubes at 37C. Cells were then plated 
on wells coated with 10µg/mL anti-CD3 and 10µg/mL anti-CD28. After 15 
minutes cells were harvested and incubated in PhosFlow buffer (BD) and treated 
according to manufacturer’s instructions. Staining for cell surface and intracellular 
epitopes were performed following phosphatase inactivation. 
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